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UBA1Y Ubiquitin-like modifier-activating enzyme 1Y (testes specific 
isoform) 
Uba3 Ubiquitin-like protein-activating enzyme 3 
Uba52 Ubiquitin ribosomal fusion 
UBA6 Ubiquitin-like modifier-activating enzyme 6 
Uba80 Ubiquitin ribosomal fusion 
Ubb Polyubiquitin B 
UBB+1 Mutant misread ubiquitin with 19 residue C-terminal extension 
Ubc Ubiquitin-conjugating enzyme 
Ubc4/5 Ubc4 and Ubc5 
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Ubc4/5/6/7 Ubc4, Ubc5, Ubc6, and Ubc7 
Ubc6/7 Ubc6 and Ubc7 
Ube Polyubiquitin C 
UBE1 Ubiquitin-like modifier-activating enzyme E1 
UBE2K Ubiquitin-conjugating enzyme E2 K 
Ubi1 Ubiquitin ribosomal fusion (S. cerevisiae) 
Ubi2 Ubiquitin ribosomal fusion (S. cerevisiae) 
Ubi3 Ubiquitin ribosomal fusion (S. cerevisiae) 
Ubi4 Ubiquitin 5 tandem repeats (S. cerevisiae) 
UBL Ubiquitin like protein 
UBP Ubiquitin specific protease domain 
Ubr1 Ubiquitin protein ligase E3 component n-Recognin 1 
UCH Ubiquitin carboxy-terminal hydrolase domain 
UCHL1 Ubiquitin carboxy-terminal hydrolase isozyme L1 
UCHL3 Ubiquitin carboxy-terminal hydrolase isozyme L3 
Ula1 Ubiquitin-like activating-activating enzyme  
ULP Ubiquitin like protease domain 
UPR Unfolded protein response 
UPS Ubiquitin proteasome system 
URA Uracil 
Urm1 Ubiquitin related modifier-1 
USP Ubiquitin specific protease domain 
USP21 Ubiquitin specific protease domain protein 21 
23 
 
 
V Volts 
v/v Volume/volume 
w/v Weight/volume 
WB Western Blot 
WT Wild type 
X g Times gravity 
XIAP X-linked inhibitor of apoptosis 
yeast Saccharomyces cerevisiae 
YPAD Yeast extract-peptone-dextrose-plus Adenine 
Yuh1 Yeast ubiquitin hydrolase 
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Amino Acid Code 
 
Amino acid Three letter code One letter symbol 
Alanine Ala A 
Arginine Arg R 
Asparagine Asn N 
Aspartic acid Asp D 
Cysteine Cys C 
Glutamic acid Glu E 
Glutamine Gln Q 
Glycine Gly G 
Histidine His H 
Isoleucine Ile I 
Leucine Leu L 
Lysine Lys K 
Methionine Met M 
Phenylalanine Phe F 
Proline Pro P 
Serine Ser S 
Threonine Thr T 
Tryptophan Trp W 
Tyrosine Tyr Y 
Valine Val V 
 
 
Cullin molecular weights by species 
Cullin Human (kD) Mouse (kD) Yeast (kD) 
cullin 1 (Cdc53) 89.7 89.7 93.94 
cullin 2 87 86.9   
cullin 3 (Cul3) 88.9 88.9 86.11 
cullin 4a (Rtt101) 87.7 87.8 99.33 
cullin 4b (Rtt101) 104 110.7 99.33 
cullin 5 100 100   
cullin 7 191.2 192.3   
cullin 9  281.2 209.2   
Yeast cullins are named parenthetically alongside their homologs.  Cullin 9 is 
also commonly known as PARC. 
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Summary 
 
NEDD8 is a small ubiquitin like modifier (UBL) essential for life in almost all known 
eukaryotes. The primary objective of this work is to determine NEDD8 specific 
regulatory mechanisms.  Like ubiquitin, NEDD8 is first matured and then conjugated 
via a tripartite conjugation cascade (E1, E2, E3).  Although Arg72 in ubiquitin prevents 
misactivation of ubiquitin by the NEDD8 E1, the ubiquitin E1 is not as 
selective(Souphron et al., 2008).  Under conditions of stress or NEDD8 overexpression, 
the ubiquitin E1 can be charged with NEDD8(Hjerpe et al.; Hjerpe et al., 2012b; 
Leidecker et al., 2012).  Most ubiquitin E2s can accept the aberrantly activated 
NEDD8which then ultimately becomes conjugated to substrates that are normally 
ubiquitylated(Hjerpe et al., 2012a).  Consequently, maintaining the ratio of NEDD8 to 
ubiquitin is important for maintaining the integrity of the ubiquitin pathway.  
 
The mechanism by which the ubiquitin to NEDD8 ratio is regulated remains unclear. In 
order to insulate the ubiquitylation pathway from NEDD8, we postulated that the ratio 
of free NEDD8 to free ubiquitin would be tightly controlled.  The rapid turnover 
reported to exist for NEDD8(Hipp et al., 2004) could be one means of regulating that 
ratio.   However, we have discovered that in yeast that tagging the NEDD8 homolog, 
related to ubiquitin 1 (Rub1) results in abnormally fast degradation through the 
unfolded protein response (UPR).  Endogenous Rub1 is actually quite stable.  The 
pathway by which endogenous NEDD8 is degraded remains unknown. 
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Another way of distinguishing the two pathways and uncovering NEDD8specific 
regulation is to identify genuine substrates of the neddylation pathway.  We were unable 
to uncover novel substrates in yeast.  We used several methods to enrich and identify 
NEDD8 substrates in mammalian cells including cultured human cancer cells and wild 
type mouse tissue.   
 
Mouse testeshave an increased neddylation profile by Western Blot (WB).  We 
therefore attempted to identify NEDD8 substrates in mouse testes.  We examined both 
the NEDD8 associated proteome and NEDD8 conjugates by using native and 
denaturing immunoprecipitation experiments paired with mass spectrometric (MS) 
analysis.  First, we are confident in these experiments because we identified NEDD8 
itself.  We also observed the cullin family of proteins which have been well 
characterized as the main substrates of neddylation.  One surprising find in the NEDD8 
associated proteome was cullin associated, NEDD8 dissociated 1 (CAND1) which 
binds to the cullins and precludes NEDD8 conjugation to the cullins.  We show that 
CAND1is unneddylated itself but comes down in association with neddylated proteins. 
Interestingly, we also found the ubiquitin E1associated with NEDD8, indicating that 
there may be endogenous charging of the ubiquitin E1with NEDD8 at low levels.The 
only directNEDD8 conjugates well established in this work were the cullins. Further 
work is needed to completely rule out the existence of non-cullin substrates of the 
neddylation machinery.  
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Chapter 1: Introduction 
It is through the presence, absence, structural change, and modification of proteins that 
life is capable of functioning. Posttranslational modifications (PTMs) such as 
neddylation, ubiquitylation, and phosphorylation allow for dynamic regulation of 
protein functions such as translating genetic code, coordinating responses to changes in 
the environment, recognizing and propagating signals from outside the cell and serving 
in cellular transportation networks.  In order to control these molecular switches, PTMs 
are themselves regulated.  For example, NEDD8, the small protein responsible for 
neddylation is synthesized in an inactive form and requires the activity of several 
enzymes before it can modify its eventual substrate.  
 
1.1 Protein turnover 
There is a constant flux betweenthe synthesis of new proteins and the degradation of old 
proteins.  This balance is carefully and specifically regulated to prevent conflicting 
signals from coexisting and to keep nonfunctional proteins from damaging overall 
cellular health.  The importance of this system is highlighted by the fact that the 
accumulation of proteins that would normally be degraded is a hallmark of many 
neurodegenerative diseases such as Alzheimer’s Disease (AD)(Upadhya and Hegde, 
2007) and Parkinson’s Disease(Lim and Tan, 2007), and neurological insults such as 
ischemic strokes(Lim and Tan, 2007).  While it can be difficult to determine whether 
such accumulation is the causative agent or a consequence of these diseases, it is known 
thatthe aggregation of these proteins can further exacerbate the inhibition of the 
degradation machinery(Howlett, 2003). The degradation of key cell cycle and cell death 
regulators also plays an important role in cell survival, propagation, and growth, so 
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misregulation of degradative machinery is associated with many types of 
cancers(Edelmann et al., 2011).  For this reason, the ubiquitin system is a growing 
target of chemotherapeutic research and the study of degradation is a burgeoning field 
for those interested in a range of health issues(Chauhan et al., 2005). 
 
1.1.1 Lysosomal degradation 
There aretwo main protein degradation pathways. First, lysosomal degradation is 
mediated by highly conserved acidic membrane bound organelles packed with proteases, 
lipases, and nucleases known as the lysosome (or vacuole in plants and yeast).  
Lysosomes are capable of processing complex mixtures taken in by the cell from its 
surroundings, whole organelles from within its boundaries, and even some specific 
internal proteins. Lysosomes are large enough to accomplish the degradation of old or 
damaged organelles and nonspecific enough to perform proteolysis on a diverse array of 
substrates.The acidic (pH ~5) membrane bound lysosome/vacuole protects the rest of 
the cell from the harsh environment necessary for both the activation of the specific 
lysosomal proteases (which function best in acidic environments) while simultaneously 
disrupting the structures and inactivating the proteins destined for degradation 
(Ciechanover, 2005). 
 
1.1.2 Ubiquitin Proteasome System  (UPS) 
 
1.1.2.1 UPS: overview 
The second important pathway in protein turnover, the ubiquitin proteasome system 
(UPS),is much more specific.  Proteins to be degraded via this route are tagged with 
ubiquitin,an 8.5 kD protein called first discovered in 1975. Ubiquitylation (alternatively 
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called ubiquitination/ubiquitinylation) of substrate proteins can result in a variety of 
outcomes including endocytosis, DNA repair, activation of protein kinases, nuclear 
export, and substrate degradation.  The importance of ubiquitin regulated degradation 
was acknowledged when Aaron Ciechanover, Avram Hershko, and Irwin Rose were 
awarded the Nobel Prize in Chemistry in 2004 for their work with ubiquitin-mediated 
proteolysis (The Nobel Prize).  
 
While ubiquitylation may in a few instances result in degradation via the lysosomal 
pathway (Hicke, 1997), it is far more typical for ubiquitin modification to signal for 
substrate degradation via the ubiquitin proteasome system (UPS).  The UPS is essential 
for viability and,when misregulated,is associated with many diseases. Typically, 
ubiquitin acts as a posttranslational modifier targeting substrates for degradation in a 
multisubunit cellular recycling plant known as the proteasome.  The 
proteasome,through a series of 2 chymotrypsin-like, 2 trypsin-like, and 2 caspase-like 
proteolytic active sites, cleaves the proteins into 7-9-amino-acid long peptides.(Chauhan 
et al., 2005) 
 
1.1.2.2 UPS: Importance of the system 
Despite the inability of the proteasome to degrade whole organelles, and therequirement 
for ATP dependent ubiquitylation of individual substrate proteins, proteasomes are 
responsible for alarge amount of protein turnover. In fact, approximately 30% of newly 
synthesized cellular proteins are degraded by the proteasome after failing to pass 
through quality control checkpoints.  In addition to these short-lived proteins, the UPS 
also processes the turnover of many other types of proteins such as cell cycle regulators, 
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pro-apoptotic proteins, and damaged proteins.  In order to address the large volume of 
proteins that are regulated by this system, there are approximately 30,000 proteasomes 
in a single human cell. Furthermore the importance of this pathway is highlighted by its 
misregulation in many diseases and targeting by viruses (such as human 
immunodeficiency virus), and is essential for life because of its central role in the UPS.  
(Chauhan et al., 2005) 
 
Figure 1.1.  UBL conjugation cascade. UBLs are synthesized as inactive 
precursors that are matured by C-terminal cleavage revealing the diglycine 
motif(denoted by the green rectangle) which is then used in the conjugation 
cascade.  The UBL is activated in an energy dependent step (denoted by the red 
arrow) and becomes covalently conjugated to the E1 activating enzyme.  The UBL 
is then transthioesterified to the active site cysteine of the E2 conjugating enzyme.  
Then through the action of an E3 ligase the UBL becomes covalently conjugated to 
a substrate protein. Deconjugation is accomplished through the action of a 
deubiquitylating enzyme. 
 
1.1.2.3 UPS: Ubiquitin 
In order to posttranslationally modify substrates, ubiquitin followsa highly controlled 
mechanism (Figure 1.1).  In mammals ubiquitin is encoded by four genestwo of which, 
uba53, and uba80, are ubiquitin ribosome subunit fusions and the remaining two, ubb 
and ubc are head to tail tandem ubiquitin pentamers whose expression is induced by 
cellular stress.  Similarly in yeast, ubiquitin is synthesized fused to a ribosome subunit 
(Ubi1, Ubi2, Ubi3 ) or in cases of stress as a pentamer (Ubi4).  Ubiquitin monomers are 
released from these fusion proteins to reveal a diglycine motif at the C-terminus.The 
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terminal glycine is utilized in conjugation to enzymes of the ubiquitylation pathwayand 
also eventually to substrate proteins.  (Shabek and Ciechanover, 2010) 
 
1.1.2.4 Ubiquitin conjugation cascade 
Once monoubiquitin is released, it can proceed througha tripartite conjugation cascade 
(Figure 1.1). First,ubiquitin is activated by the ubiquitin E1 also known as the ubiquitin 
activating enzyme (UAE). In humans there are two ubiquitin E1 activating enzymes 
(UBA6and UBE1), in mice there is an additional testes specific isoform (UBA1Y).  In 
yeast there is only one UAE (Uba1). The UAE functions by forming a high-energy 
ubiquitin-adenylate intermediate with the digylcine motif of ubiquitin in an ATP 
dependent step.  AMP is released as a thiol-ester bond is formed between this charged 
ubiquitin and the UAE active site cysteine. A second ubiquitin is recruited to form a 
ubiquitin-adenylate intermediate such that there are two ubiquitin molecules 
simultaneously bound to the E1.  
 
The E1thiol-ester linked ubiquitin is then transferred from the active site cysteine of the 
UAE to the active site cysteine of an E2 conjugating enzyme(E2) where it forms a thiol-
ester bond. There are approximately 60 human E2 enzymes and 13 in yeast.  A few E2 
enzymes do not conjugate ubiquitin but rather ubiquitin like proteins (UBLs) such as 
SUMO or NEDD8.   
 
The third enzyme in the conjugation cascade, the E3 ligase (E3), is responsible for 
conjugation of ubiquitin to substrate proteins.  Some E3 enzymes, such asthose that 
function using a Homologous to the E6-AP Carboxyl Terminus (HECT) domain, 
directly bind ubiquitin and then transfer ubiquitin to substrates.  Other E3s, such 
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ascontaining Really Interesting New Gene (RING) domains,never directly accept 
ubiquitin but rather provide structuralscaffolding to facilitate the transfer of ubiquitin 
from a ubiquitin charged E2 to the substrate protein.  There are over 600 human RING 
family E3 enzymes.  There are other much smaller E3 families including U-box domain 
containing proteins as well as the RING-between-RING family.  By sheer force of 
numbers, E3s surpasses the number of kinasesin the human genome indicating the 
relative significance of this pathway. (Deshaies and Joazeiro, 2009) 
1.1.2.5 Ubiquitin system specificity 
There is a common misconception that substrate specificity for the ubiquitin system 
radiates out from the E1, with the E2 slightly narrowing the field of eventual substrates 
and the E3 providing ultimate specificity.  The passage of ubiquitin to an E2 narrows 
the field of proteins that can be modified and then the E3 enzyme provides yet another 
layer of specificity. This is largely true; however, some substrate specificity is 
determined at the E2 level. E2s can be paired with specific substrates. In yeast for 
example, Ubc8 has only one known eventual substrate while other E2s are implicated in 
ubiquitylation of a variety of substrates (Table 1.1).   Some E3 enzymes will interact 
with different substrates depending upon their E2 pair (Madura et al. 1993; Kumar et al., 
2010). 
1.1.2.6 E2 enzymes and substrate selection 
The enzyme UBiquitin protein ligase E3 component n-Recognin 1 (Ubr1), for example, 
ubiquitylates proteins in two distinct pathways.  The way in which Ubr1 functions is 
determined by the E2s with which it interacts.  In yeast, the E2 Ubc2 interacts with 
Ubr1 to ubiquitylate substrates bearing destabilizing N-terminal residues (Madura et al. 
1993).  This results in quick degradation.  The destabilization of proteins via N-terminal 
residue recognition and ubiquitylation is known as the N-end rule.  (Kumar et al., 2010) 
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Ubr1 can also function in conjunction with a chaperone protein (Ssa1/2/3/4) in order to 
degrade unfolded proteins (Nillegoda et al., 2010).  The unfolded protein response 
(UPR) mediated degradation of proteins is an important quality control mechanism.  
The UPR prevents nonfunctional protein accumulation.  In order to fulfill this role, 
Ubr1 functions primarily with two extremely similar promiscuous E2 enzymes (Ubc4/5) 
(Sadis et al., 1995). To a lesser extent, Ubr1 can function with two other E2 enzymes 
(Ubc6/7) in the UPR as well (Stolz, 2011).  However, Ubc4/5/6/7 cannot be substituted 
for Ubc2 with Ubr1 in the N-end rule pathway (Kumar et al., 2007; Kumar et al., 2010; 
Seufert et al., 1990).  If we are to take Ubr1 as an example, it is the E2 that mediates the 
eventual substrate selection.  There is a delicate interplay between E2s and E3s in order 
to select the eventual substrate of ubiquitylation.  
1.1.2.7 E2 enzymes and linkage type specificity 
Ubiquitin is typically conjugated to a substrate lysine.  This modification can occur at a 
single amino acid residue (monoubiquitylation) or several residues within the same 
protein (multi-mono-ubiquitylation).  Ubiquitin can also modify itself to form 
polyubiquitin chains connected to one of the seven lysine residues in ubiquitin.  
Ubiquitin chains can start with ubiquitin or a non-ubiquitin substrate and are further 
diversified by the ability to branch (Fushman and Wilkinson, 2011).  These different 
linkage types have different conformations and may be of any length. E2 contributions 
to substrate selection include selection of linkage type (David et al., 2010). Though E2s 
are believed to play a role in determining which type of ubiquitylation is to occur, this 
process and the nature of chain type specificity are currently active areas of research 
within the field. 
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Yeast 
human 
ortholog known function 
UBC1 Ube2K Involved in a variety of processes including the degradation of 
short-lived and abnormal proteins, ERAD, and vesicle 
formation.   
Ubc2 Ube2A 
and 
Ube2B 
Functions as a heterodimer in a variety of responces including 
postreplication repair (with Rad18), N-end rule protein 
degradation (with Ubr1), and checkpoint control (with Bre1) 
Ubc3 Cdc34  works with yeast CRL complexes containing Skp1, Rbx1, 
Cdc53, and an F-box to ubiquitylate substrates, regulation of 
cell cycle by regulating levels of important regulators like Sic1, 
regulation of expression of methionine biosythetic genes 
Ubc4 Ube2D 
family 
Very promiscuous.  Interacts with many SCF ligases and is 
involved in polyubiquitylation of many substrates.  Has been 
implicated in the degradation of abnormal or excess proteins, 
misfolded proteins, and cell stress response. Heavy 
compensation between Ubc4 and Ubc5 (and to a lesser extent 
Ubc6 and Ubc7).  Expression is heat inducible (part of heat 
shock response) but typically Ubc4 is expressed in growing 
cells rather than yeast in stationary phase. 
Ubc5 Ube2D 
family 
Very promiscuous.  Interacts with many SCF ligases to 
polyubiquitylate many substrates.  Has been implicated in 
degradation of excess and misfolded proteins as well as 
functioning in stress response.  Expression is induced by heat 
(part of heat shock response) but typically Ubc5 is expressed in 
stationary cells rather than growing cells.  Heavy compensation 
between Ubc4/5 (and to a lesser extent Ubc6/7) 
Ubc6 Ube2J2 Associated with cytosolic side of ER membrane and involved in 
ERAD.  Some compensation with Ubc7 and Ubc4/5 
Ubc7 Ube2G2  Can be recruited to ER and is involved in ERAD.  Possible role 
in chromatin assembly. 
Ubc8 Ube2H Not many known substrates. Degrades fructose-1,6-
bisphosphatease to regulate gluconeogenesis.  Also reported to 
ubiquitylate histones in vitro but is a cytoplasmic enzyme and 
this might not happen in vivo.   
Ubc9 Ube2I  Highly specific for functioning as a SUMO E2 enzyme 
Ubc10   Peroxisomal E2 
Ubc11   Similar to Xenopus enzyme Ube2-C but is not a functional 
homolog.  No known substrates in yeast. 
Ubc12 Ube2M/F NEDD8 specific E2 enzyme 
Ubc13 Ube2N Involved in DNA postreplication repair 
 Table 1.1. Yeast E2 enzymes, their human orthologs, and their known functions. 
Data compiled from Seufert and Jendtsch, 1990, Chen et al., 1993, and the 
Saccharomyces Genome Database (www.yeastgenome.org). 
 
35 
 
 
 
1.1.2.8 Degradation within the proteasome 
When a protein is tagged with ubiquitin for degradation, that proteinis then shuttled to a 
macromolecular complex known as the proteasome for processing.  Once the protein is 
delivered to the proteasome, itis denatured and fed through a cylindrical channel at the 
center of the proteasome. This channel contains 6 distinct proteolytic active sitesthat 
work sequentially to achieve breakdown of the protein into short peptides. Ubiquitin is 
released by deubiquitylating enzymes (DUBs) associated with the lid of the proteasome 
before the substrate is fed into the complex.  The released ubiquitin can then be reused. 
Once the denatured protein is processed, the proteasome isready to accept the next 
protein.(Chauhan et al., 2005) 
 
1.1.2.9 Ubiquitin stability and turnover 
Although ubiquitylation and degradation go hand in hand, ubiquitin itself is stable even 
under conditions of extreme temperature(Jackson, 2006), pH(Jackson, 2006), and 
exposure to proteases(Kitahara et al., 2006b).  The reportedhalf-lifeof ubiquitin varies 
between the different tissues, cell lines, and organismsturnover rate has been measured 
in(Shabek and Ciechanover, 2010).  For example, in yeast, the ubiquitin half-life was 
identified as 2 hours (Hanna et al., 2003)while in HeLa and Chinese hamster ovary cells 
the half-lifehas been measured atapproximately 9 hours, and about 320 hours in human 
fibroblasts(Shabek and Ciechanover, 2010).    
 
Ubiquitin turnover has beenreported to be both energy and proteasome dependent.  
Inhibition of the lysosome only mildly impacted ubiquitin turnover indicating that 
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degradation of ubiquitin is proceeding through the proteasome.(Shabek and 
Ciechanover, 2010) 
 
There are several theories on how ubiquitin is degraded.  It is possible that in vivo 
degradation is a combination of all of them.  First, ubiquitin can be degraded as a fusion 
protein with a C-terminal tail of 20 or more residues (Shabek and Ciechanover, 2010).  
Second ubiquitin can be pulled into the proteasome along with the substrates it is 
tagging (Shabek and Ciechanover, 2010).  This is frequent when the proteasome has a 
high volume of ubiquitylated substrates to process(Carlson et al., 1987). Alternatively, 
ubiquitin can be degradedas a monomer that becomes ubiquitylated itself and is 
degraded by the proteasome.  Current evidence indicates that the rate of ubiquitin 
turnover is independent of conjugation status.  There are two reported methods used to 
study ubiquitin turnover.(Shabek and Ciechanover, 2010) 
 
1.1.2.9.1 Ubiquitin turnover: Pulse chase 
A pulse chase system using radiolabeled amino acids has been used to study ubiquitin 
turnover(Carlson and Rechsteiner, 1987; Shabek and Ciechanover, 2010). This method 
is useful because it avoids both mutationsand tagging thatmay result in off target effects. 
 
It is possible that this method may not have an entirely accurate readout either. 
Ubiquitin is a modifier that binds various proteins.  Modifiers may have different 
stabilities depending modification status or the protein that is modified.  Ubiquitin 
cycling on and off of substrates complicates analysis as apparent variations in the 
ubiquitin level could be due to conjugation rather than degradation. If one were to judge 
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free ubiquitin levels as a general readout of ubiquitin stability,problems arise when 
radiolabeled ubiquitin binds substrates.  In this case, the free pool of ubiquitin would 
display reduced labeling but this would not indicate degradation.  Furthermore, while 
ubiquitin conjugated to specific proteins like histone H2A (Chin et al., 1982) have been 
studied with the pulse chase assay, ubiquitin modified proteins may have substrate 
specific half-lives so the stability of ubiquitin bound to histone H2A may not serve as 
an indication of the stability of ubiquitin bound to an unrelated protein.  Free ubiquitin 
may also be more or less stable than ubiquitin conjugated to substrates.  In order to 
minimize these concerns, comparisons have been made between nonconjugateable and 
conjugateable ubiquitin.  Experimental results suggest that ubiquitin turnover is 
independent of conjugation(Shabek and Ciechanover, 2010). 
 
1.1.2.9.2 Ubiquitin turnover: Diglycine mutation 
The second method used to study ubiquitin turnover resolves some of these problems.  
By preventing conjugation to substrates,the behavior of the ubiquitin monomer could be 
easily and clearly followed.  Initial attempts to prevent conjugation were made by 
mutatingthe C-terminal glycine (G76) required for thiol-ester bond formation.  Mature 
ubiquitin bearing a mutation of G76 to a nonfunctional alanine does not abrogate 
interaction with the conjugation cascade,as the penultimate residue is also a glycine that 
can be utilized by pathway enzymes.  However, the G76A mutation inhibits 
deubiquitylation(Hodgins et al., 1992). Thus, rather than being used as a tool to study 
free ubiquitin, this method was reported to be a successful means of identifying 
endogenous substrates of ubiquitylation such as Histone H2B (Geng and Tansey, 2008).   
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Multiple groups have successfully generated nonconjugateable ubiquitin by mutating 
(G75/76V, or G75/76A) or deleting the two terminal glycines (∆GG)(Shabek and 
Ciechanover, 2010). Such mutations eliminate the Glycine involved in interactions with 
the E1, E2, substrates, and some E3 enzymes.  The diglycine motif is at the end of a 
short unstructured region at the very C-terminus of ubiquitin(Pickart and Eddins, 2004) 
which is not believed to contribute much to structural integrity under non-extreme 
temperatures (Jackson, 2006).  The diglycine mutation methodreducesthe concern that 
apparent ubiquitin degradation is due to conjugation because it can no longer become 
conjugated.   
 
1.2 Ubiquitin like Proteins 
Ubiquitin like modifiers (UBLs) share some sequence, regulatory, and structural 
similarity with ubiquitin. These UBLsinclude NEDD8, small ubiquitin-like modifier 
(SUMO), interferon-stimulated gene-15 (ISG-15), ubiquitin related modifier-1, and 
Human leukocyte antigen-Fassociated transcript 10(FAT10). (Jentsch and Pyrowolakis, 
2000) 
 
1.2.1NEDD8 
Neurologically Expressed Developmentally Downregulated 8 (NEDD8), the UBL most 
like ubiquitin, was identified in 1992 in mouse neural precursor cells (Kumar et al., 
1992). In some species, such as baker’s yeast, the NEDD8 homolog is known as related 
to ubiquitin 1 (Rub1). NEDD8 and ubiquitin share the highest degree of homology to 
ubiquitin of any of the ubiquitin like modifiers;approximately 60% similarity and 80% 
homology (Figure 1.2).  Like ubiquitin, NEDD8 is highly conserved in eukaryotes, 
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shares a similar backbone topology and is synthesized as an inactive precursor that, 
once processed, isable to function as a posttranslational modifier.  These UBLs share 
similar conjugation cascades dependent upon the activity of E1, E2, and E3 enzymes to 
conjugate their C-terminal diglycine motif to a substrate lysine.  The bulky Arg 72 in 
ubiquitin (Ala in NEDD8) acts as a selectivity gate to insulate the neddylation pathway 
from consuming ubiquitin(Souphron et al., 2008).   
 
Figure 1.2. Comparison between human and yeast ubiquitin and 
NEDD8/Rub1 sequences.  Residues which are found to be significantly 
different are highlighted in red.   Similar residues are indicated by the + sign. 
 
1.2.1.1 Importance of NEDD8 
NEDD8 is essential for viability in all organisms tested with the exception of 
Saccharomyces cerevisiae (yeast).  In yeast the NEDD8 homolog, Rub1 functions much 
like NEDD8 but is nonessential.  While the loss of Rub1 results in some phenotypic 
changes, yeast lacking the rub1 gene is still viable and grows well under standard 
conditions.(Finley et al., 2012) 
 
1.2.1.2 Ubiquitin and NEDD8 maturation 
In order to become conjugated and deconjugated from substrates, ubiquitin and NEDD8 
typically follow parallel but demonstrably unique conjugation cascades (Figure 1.1). 
They are both synthesized as precursors that need to have their C-terminal extensions 
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cleaved to reveal a diglycine motif (G75/76). This maturation is believed to be 
accomplished primarily through the proteolytic activity of ubiquitin C-terminal 
hydrolase (UCH) domain containing deubiquitylating enzymes. Interestingly UCHL3, 
the DUB primarily responsible for maturation of NEDD8 has dual specificity for both 
ubiquitin and NEDD8. (Watson et al., 2011) 
 
1.2.1.3 Ubiquitin and NEDD8 conjugation cascade 
Following maturation, ubiquitin and NEDD8are activated by an E1 activating enzyme 
(UAE and NAE, respectively). In the case of NEDD8/Rub1 the NAE is a heterodimer 
composed of UBA3 and APPBP1 (Uba3 and Ula1 in yeast). The UBLs are 
subsequently transferred from the active site cysteine of the E1 to the active site 
cysteine of an E2 conjugating enzyme. There are many E2s that can accept ubiquitin 
from the UAE but only UBC12 and UBE2F can accept NEDD8 from the NAE in 
mammals (only Ubc12 in yeast) (Gong and Yeh, 1999; Huang et al., 2009; Wada et al., 
2000).  Lastly, through the action of an E3 ligase,the UBLs become conjugated to 
substrates (Figure 1.1). The terminal glycine of the UBL is bound to the substrate most 
characteristically through an isopeptide bond.  As with ubiquitylation, neddylation 
occurs on a substrate lysine. While ubiquitin has a great deal of diversity in available E3 
enzymes, in the neddylation pathway,defective in cullin neddylation (DCN) proteins 
coordinate witha RING domain protein(RBX1 or 2) to facilitate substrate 
neddylation(Finley et al., 2012; Watson et al., 2011).Other E3 enzymes have been 
reported, such as MDM2 (Watson et al., 2006), but these enzymes have not been shown 
to be dependent upon the NAE. 
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1.2.1.4 Ubiquitin and NEDD8 crosstalk 
Under endogenous unstressed conditions crosstalk between the NEDD8 and ubiquitin 
pathways has not been reported.  However, overexpressing NEDD8 or inducing cellular 
stress responses can perturb the ratio of ubiquitin to NEDD8and some crosstalk can 
occur(Hjerpe et al., 2012a; Hjerpe et al., 2012b; Leidecker et al., 2012; Whitby et al., 
1998). While ubiquitin is not activated by the NAE (Souphron et al., 2008), activation 
of NEDD8 by the UAE is observed in vivo whenNEDD8 levels are elevated or 
ubiquitin levels are depleted(Hjerpe et al., 2012a; Hjerpe et al., 2012b; Leidecker et al., 
2012; Whitby et al., 1998). Once NEDD8 is conjugated to the UAE, it can proceed via 
the ubiquitylation machinery.  One of the great pioneers in the field, Cecil Pickart 
demonstrated in vitro that misloading of E2-25k with NEDD8occurred with about the 
same efficiency as loading with ubiquitin(Whitby et al., 1998).  Relatedly, we recently 
published that numerous E2s can be loaded with NEDD8(Hjerpe et al., 2012a).  Once 
NEDD8 is activated by the UAE, it can proceed relatively unhindered through most 
ubiquitin E2 enzymes and ultimately become conjugated to substrates that are normally 
ubiquitylated such as Hif1α(Hjerpe et al., 2012b).  
 
1.2.1.5 Substrates of neddylation 
While there are numerous endogenously identified substrates of ubiquitylation, there are 
comparatively few neddylated proteins identified to date.  The most well-known 
substrate of neddylation is the cullin family of proteins(Watson et al., 2011). 
Neddylation of the cullins epitomizes the interplay between neddylation and 
ubiquitylation because cullins are a key component of the largest class of E3 ubiquitin 
ligase.  
 
42 
 
 
1.2.1.5.1 Non-cullin NEDD8 substrates 
Reports of neddylation of non-cullin proteins rely heavily upon overexpression. 
NEDD8 substrates identified by NEDD8 overexpression include proteins like AICD, 
XIAP, and p53 (see Table 1.2 for a list of non-cullin neddylated proteins). Recent 
articles elucidating the accepted means of identifying neddylated proteins still rely upon 
overexpression (Leidecker and Xirodimas, 2012). However, as we have reported, 
overexpression can shunt NEDD8 onto the ubiquitin pathway(Hjerpe et al., 2012a). 
There is growing evidence that many of these reported substrates proteins are 
neddylated in a UAE rather than a NAE dependent manner (Table 1.2).  Neddylation of 
p53, for example, is heavily dependent upon the UAE (UBE1) rather than the 
neddylation pathway (Hjerpe et al., 2012b).    
 
Some of the reported non-cullin NEDD8 substrates could be neddylated endogenously.  
Gao et al. demonstrated that co-overexpression of BCA3 and p65 is sufficient for 
neddylation of BCA3 even without NEDD8 overexpression.  Under such conditions, the 
risk of NEDD8 misactivation is minimized and the described interaction may be real.  
Inhibition of the NAE could confirm this interaction.  The neddylation of another 
putative substrate, p73, has mostly been studied using overexpression but, Watson et al. 
also immunoprecipitates endogenous p73 and finds weak modification by NEDD8.  
BCA3 and p73 may be endogenously neddylated. While other reported non-cullin 
proteins may be endogenously neddylated, this has not been conclusively demonstrated 
(Table 1.2).   
 
Protein Neddylation Reference Rebuttal Reference 
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Table 1.2. Reportedly neddylated non-cullin proteins. Proteins besides the cullins which 
are reportedly neddylated are listed by sources supporting or denying their neddylation 
status.   
1.2.1.5.2 Cullins 
The cullin family contains the most robustly supported endogenously neddylated 
proteins identified to date. 
1.2.1.5.2.1 Cullin neddylation  
The cullins all share a conserved C-terminal neddylation site downstream of a 
conserved cullin homology domain. With the exception of cullin 7 the cullins have been 
shown to be neddylated.  Although the neddylation site and cullin homology domain are 
conserved in cullin 7, it is unclear whether this cullin is endogenously 
neddylated.(Sarikas et al., 2011) 
 
AICD (Lee et al., 2008)   
BCA3 (Gao et al., 2006)   
Caspase 7 (Broemer et al., 2010) (Hjerpe et al., 2012b 
(Nagano et al., 2012) 
EGFR (Oved et al., 2006)   
HIF1α (Ryu et al., 2011) (Hjerpe et al., 2012b) 
HIF2α (Ryu et al., 2011)   
MDM2 (Xirodimas et al., 2004) 
(Watson et al., 2010) 
  
p53 (Abida et al., 2007) 
(Xirodimas et al., 2004) 
(Leidecker and Xirodimas, 2012) 
(Hjerpe et al., 2012b) 
p73 (Watson et al., 2006)   
pVHL (Russell and Ohh, 2008) 
(Stickle et al., 2004) 
  
Ribosomal proteins  
(ex. L11) 
(Xirodimas et al., 2008)   
XIAP (Nagano et al., 2012)   
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1.2.1.5.2.2 Cullin function 
Cullin RING Ligases (CRLs), the main class of E3 ubiquitin ligases, facilitate the 
movement of ubiquitin from E2 to substrate by acting as a scaffold for the assembly of 
the whole E3 complex.  Substrates are linked to the N-terminal region of the cullin via 
an adaptor and a substrate recognition protein.  At the C-terminal region of the cullin, a 
RING finger protein (Rbx1/2) joins the cullin to the ubiquitin charged E2 enzyme.  
Neddylation at a conserved residue of the C-terminal domain of the cullin allows for the 
C-terminal flexibility required to bridge a 50Å gap between the substrate and the 
ubiquitin (Figure 1.3 adapted from (Duda et al., 2008)).  
 
 
Figure 1.3.  Schematic of the regulation of CRL complexes by NEDD8 and 
CAND1/Lag2.  N8 denotes NEDD8, Ub denotes ubiquitin, Rbx denotes the RING 
proteins from the Rbx family. 
 
1.2.1.5.2.3 Regulation of cullin neddylation 
Cullin associated neddylation dissociated1 (CAND1, Lag2 in yeast) binds to cullins 
such as Cul1, 2, 3, 4A, and 4B preventing conjugation of NEDD8 (Figure 1.3) (Chua et 
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al., 2011; Zheng et al., 2002). There are conflicting reports on the importance of 
CAND1 binding to CRL function. There are some groups that have used proteomic 
approaches to argue that cycles of neddylation and deneddylation are not significant in 
overall CRL function(Bennett et al., 2010).  Others report that CAND1 is an important 
regulator of the CRL network(Goldenberg et al., 2004; Sela et al., 2012).  Recent work 
by Schmidt et al., 2009, andwithin our lab, primarily by Aleksandra Zemla,indicate that 
the role CAND1 plays may be specific to certain CRLs by regulating substrate adaptor 
exchange.  Such behavior would explain these divergent observations.  
 
1.3 Deubiquitylases and deneddylases 
One of the key elements of the posttranslational UBL modification scheme is that it is 
reversible.  UBLs may be removed from substrates through cleavage of the isopeptide 
bond by DUBs. There are six families of DUB each bearing unique defining 
characteristics (Table 1.3 adapted from Reyes-Turcu et al., 2009).  Some DUBshave a 
high degree of specificity for a specific UBL or for leaving group size while others are 
fairly promiscuous.  For example, NEDD8 specific protease 1 (NEDP1) has a 60,000 
fold higher specificity for NEDD8 than for ubiquitin(Gan-Erdene et al., 2003)but 
ubiquitin carboxyl-terminal hydrolase isozyme L3 (UCHL3) has dual specificity for 
NEDD8 and ubiquitin(Frickel et al., 2007).   
1.3.1 Deneddylases 
Most DUBs do not process NEDD8 at all.  The only reported mammalian deneddylases 
to date are NEDP1(Gan-Erdene et al., 2003), CSN5(Cope et al., 2002), UCHL3(Frickel 
et al., 2007), USP21(Gong et al., 2000), UCHL1(Hemelaar et al., 2004), and Ataxin-3 
(Ferro et al., 2007).  Of these 6 putative deneddylases, the evidence for the first 3 is 
strong while the evidence for the other 3 is relatively weak. 
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Family Alias type of protease Notable Characteristics 
UCH Ubiquitin  
C-terminal 
hydrolase 
domain 
Papain-like 
Cysteine 
proteases 
Preferentially cleave small 
leaving groups 
UBP/ 
USP 
Ubiquitin 
specific 
protease domain 
Papain-like 
Cysteine 
proteases 
Preferentially cleave larger 
leaving groups. Largest family 
(56/85 DUBS in humans, 16/19 
DUBS in yeast), very diverse 
with low sequence similarity but 
high conservation in the USP 
domain fold 
OTU   Ovarian tumour 
domain 
Papain-like 
Cysteine 
proteases 
Not all OTU domain proteins 
have DUB activity 
MJD Machado-
Josephin 
domain 
Papain-like 
Cysteine 
proteases 
Structure similar to the UCH 
domain  
JAMM Jab1/MPN/ 
Mov34 
Metalloenzyme 
domain  
zinc 
metalloproteases 
NEDD8 and K63-linked ubiquitin 
ULP Ubiquitin like 
protease domain 
Adenain family 
of cysteine 
proteases 
Specificity for UBLsrather than 
ubiquitin.  Some debate as to 
whether it should be listed as a 
DUB 
Table 1.3. Families of DUBs. Distinguished by protease type and notable 
characteristics as adapted from Reyes-Turcu et al., 2009.
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1.3.2 Commonly accepted deneddylases 
 
1.3.2.1 NEDP1 
NEDP1 is a cysteine protease of the ULP family that can act as a deneddylase in fission 
yeast, plants, and animals but is not present in S. cerevisiae(Mendoza et al., 2003).  
Though no endogenous NEDP1 substrate has been identified, it has been shown in a 
variety of overexpression and in vitro experiments to cleave NEDD8 from many 
substrates. NEDP1 displays very pronounced specificity for NEDD8 over ubiquitin but 
is fairly promiscuous with respect to the protein to which NEDD8 is conjugated.  
 
Little work has been published about NEDP1 at the endogenous level.  One possible 
endogenous substrate is breast cancer-associated protein 3 (BCA3).  BCA3 was 
identified as a NEDP1 interaction partner by yeast-2-hybrid screening.  While most of 
the work done relating these two proteins involved overexpression (and therefore could 
be the result of misactivationof NEDD8or deneddylation of the cullins), there is some 
evidence of genuine BCA3/NEDP1 interaction.  For example, knocking down 
NEDP1expression by siRNA results in an increase in a higher molecular weight form of 
endogenous BCA3 in the nuclear fraction of HeLa cells(Gao et al., 2006).  Furthermore 
when BCA3 is overexpressed, and immunoprecipitated, a NEDD8 modified form is 
visible even when NEDD8 is not overexpressed(Gao et al., 2006).  Such evidence could 
indicate that BCA3 may be a genuine substrate of NEDP1.   
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1.3.2.2 CSN 5 
CSN5(Rri1 in yeast) is a subunit of the mutlimeric COP9 signallosome containing a 
JAB1/JAMM metalloenzyme domain responsible for deneddylation of the cullins.  
CSN5 has a well established role in cullin deneddylation.There are no other reported 
substrates deneddylated by CSN5. (Wei and Deng, 2003) 
 
1.3.2.3 UCHL3 
UCHL3 (Yuh1 in yeast) is unique in that it is the only one of the well-established 
deneddylases to cross react with ubiquitin.  It has been shown that UCHL3 protects the 
ubiquitin dimer(Setsuie et al., 2009a) and plays a role in ubiquitin maturation.  UCHL3 
even cleaves the 19-residue extension on a misread ubiquitin product known as 
UBB+1(Dennissen et al., 2011).  The accumulation of the uncleaved form is found in 
AD affected regions of the brain and is transiently upregulated in affected areas of the 
brain following a stroke. There is also compelling evidence demonstrating that UCHL3 
matures pro-NEDD8.  UCHL3 is also able to interact with a NEDD8 reactive species at 
the right molecular weight for a NEDD8 dimer (Setsui et al., 2009a) but this species has 
not been conclusively identified.  
 
Of the three well-established deneddylases, UCHL3 has been most extensively studied.  
Misregulation of UCHL3is connected to cancer(Miyoshi et al., 2006). UCHL3 
knockout mice have tissue specific phenotypes incuding short term memory loss(Wood 
et al., 2005), enlarged mitochondria and oxidative stress apoptosis in the photoreceptors 
of the retina(Sano et al., 2006), and susceptibility to heat stress in testicular germ 
cells(Kwon et al., 2004).  In skeletal muscle the knockout mice also display 
accumulation of polyubiquitylated proteins, activation of the unfolded protein response, 
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heat shock response, and degeneration(Setsuie et al., 2010).  These mice also presented 
with resistance to diet induced obesity as well as a reduction in visceral fat and 
increased fatty acid oxidation in skeletal muscles (Setsuie et al., 2009b). It is unclear 
whether these phenotypes are a result of the failure of UCHL3 as a deneddylase, a 
deubiquitylase, or both.  
 
1.3.2.4 Reported deneddylases with questionable activity 
While USP21 and UCHL1 have demonstrable deubiquitylase activity, there are 
conflicting reports on whether they also have deneddylase activity.  The most recent 
data suggests that they are not NEDD8 reactive(Wada et al., 1998; Ye et al., 2011).  The 
data suggesting that Ataxin-3 has deneddylase activity was reported from one source 
alone (Ferro et al.2007) using in vitro and overexpression conditions which can both 
result in misregulation of NEDD8.  
 
1.4 Regulation of NEDD8 
NEDD8ultimate buster 1 (NUB1) was originally reported as a regulator of NEDD8 
stability.  As reported by Hipp et al. in 2004,the NUB1/NEDD8 interaction is largely 
tag dependent and NUB1 is actually regulating the turnover of the UBL FAT10. 
NEDD8 turnover is reportedly rapid (half-life of 3.5 hours in HEK293 cells) and not 
highly regulated by NUB1. Recent publications reinforce acceptance of the observation 
that NEDD8 turnover is rapid (Buchsbaum et al., 2012) but the mechanism of turnover 
has not been elucidated.   
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1.5 Inhibition of Neddylation 
Defects in the regulation of cullin neddylation can result in cell cycle defects (Tateishi 
et al., 2001). This trait is being exploited in the development of a new anti-cancer agent 
known as MLN4924 (Nawrocki et al., 2012). The functional success of MLN4924 as a 
drug may be related to inhibition of cullin neddylation, but if there are other NAE 
dependent substrates of neddylation these too would be affected by treatment with 
MLN4925 because NEDD8 cannot procede beyond the NEDD8 E1.  
 
1.6 Aims 
The primary aim of this work is to understand NEDD8 specific regulatory mechanisms.  
We are primarily focused on the basic biological question of how NEDD8 is regulated 
to prevent cross-talk with the ubiquitin pathway.  We have parsed this question into two 
parts.  First, how is free NEDD8 regulated to prevent alterationsin the ratio of NEDD8 
to ubiquitin that may result in misactivation by the UAE.  Second, which substrates are 
endogenously neddylated in a NAE dependent manner. Beyond a basic question of 
biology, this project has health implications as well.  The targeting of the neddylation 
machinery as an anti-cancer treatment may impact pathways that are not well defined.  
Until we know which proteins are genuinely neddylated we will be unsure what 
MLN4924 does to patients at a molecular level. 
 
In order to address these concerns we used yeast to examine Rub1 turnover and 
conjugation but were unable to identify the endogenous degradation pathway or non-
cullin substrates.  We also attempted to identify novel substrates of neddylation in 
cultured cells and mouse tissues.   We were unable to clearly identify substrates of 
neddylation beyond the cullin family.  However we were able to determine that 
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neddylation is upregulated in testes.  We were also able to identify certain families of 
proteins coimmunoprecipitating with NEDD8 in testes including coatomer, matrin-3 
associated proteins, and structural maintainence of chromosome proteins.  Other 
members of the NEDD8 associated proteome include CAND1 as well as cullin 7 (the 
only cullin not shown to be neddylated (Skaar et al., 2007; Sarikas et al., 2011)).  
Overall, we were unable to identify novel regulatory mechanisms or substrates of 
neddylation. 
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Chapter 2: Materials and Methods 
2.1 Materials 
2.1.1 Commercial reagents 
-  Amicon Ultra “ultracel 5K” (Millipore)  
- 0.05% Trypsin-EDTA (Invitrogen) 
- 0.22 µm sterile syringe filters (Sartorius Stedium) 
- 1kb DNA ladder (New England Bio Labs) 
- 20X MES Running buffer (Invitrogen) 
- 20x MOPS Running buffer (Invitrogen and Formadium) 
- 20X Transfer buffer (Invitrogen) 
- 3mm chromatography paper (Whatman) 
- 4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic acid N-(2-Hydroxyethyl)piperazine-N'-(2-
ethanesulfonic acid) HEPES (BDH) 
- 6-Well plates and T75 flasks (Corning) 
- 6x DNA loading dye (Promega) 
- Acetic acid (BDH) 
- Acetone (BDH) 
- Acetonitrile (ACN) (Millipore) 
- Acid-washed glass beads (Sigma) 
- Acrylamide (Flowgen Biosciences) 
- AminoLink Plus Immobilization Kit (Pierce)  
- Ammonium bicarbonate (ABC) (Fluka) 
- Ammonium persulfate (BDH) 
- ATX Ponceau S red staining solution (Fluka analytical) 
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- BCA Protein Assay Kit (Pierce) 
- BD granulated agar (Merck) 
- Beta-mercaptoethanol (Calbiochem) 
- Biophenol (BDH) 
- Bis-Tris NuPAGE Gels (Invitrogen) 
- Bovine serum albumin (Roche) 
- Bromophenol Blue (Merck) 
- Calcium chloride (BDH) 
- Carbenicillin (amp) (Formedium) 
- Centrifuge tubes for TL-100 Ultracentrifuge (Beckman) 
- Chemiluminescence X-Ray films (GE Healthcare) 
- ClonNat (Werner BioAgents) 
- Cobalt (II) chloride (Sigma) 
- Complete EDTA-free Protease Inhibitor Cocktail (Roche) 
- Control agarose resin (Sigma) 
- Coomassie protein assay reagent (Thermo) 
- Crosslink immunoprecipitation kit (DSS crosslinking) (Pierce) 
- Cuvettes (Starstedt) 
- Dehydrated culture media (agar granules for yeast plates) (BD Difco) 
- Dithiothreitol (DTT) (Formedium) 
- DMSO (BDH) 
- Dried skimmed milk (Marvel, Premier Beverages) 
- Dulbecco's Modified Eagle Medium (DMEM) (Invitrogen) 
- EDTA (BDH) 
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- Enhanced Chemiluminescent reagent (ECL) (Millipore) 
- Ethanol (BDH) 
- Ethidium Bromide (BDH) 
- Glycerol (BDH) 
- Glycine (BDH) 
- High Fidelity Polymerase Kit (Roche) 
- His drop out mix (Formedium) 
- Human CSN5 ON-TARGET plus SMARTpool siRNA  (Dharmacon)  
- Human Senp8 ON-TARGET plus SMARTpool siRNA  (Dharmacon)  
- Human Senp8 siRNA (Ambion) 
- Human UCHL3 ON-TARGET plus SMARTpool siRNA  (Dharmacon)  
- Innoculating Loops (Thermo) 
- Instant Blue (Expedeon) 
- Iodoacetamide (Sigma) 
- Isopropanol (BDH) 
- Kanamycin (Formedium) 
- L-glutamine (Invitrogen) 
- Lipofectamine RNAiMAX for siRNA knock-down (Invitrogen) 
- Lithium acetate (Alpha Aesar) 
- Magnesium Chloride (Sigma) 
- Magnesium sulfate (BDH) 
- MG132 (Enzo) 
- Microspin C18 silica column (Nest group) 
- Monoclonal  anti-HA agarose conjugate (Sigma) 
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- N,N,N',N'-Tetramethylethylenediamine (TEMED) (BDH) 
- NHS-activated M-PV magnetic beads (Perkin Elmer) 
- Nitrocellulose membrane (GE Healthcare) 
- Novex tricine gels for small protein separation (Invitrogen) 
- Novex tricine SDS loading buffer (Invitrogen) 
- Novex tricine SDS running buffer (Invitrogen) 
- OptiMEM (Invitrogen) 
- PCR Purification Kit and Plasmid DNA Minprep kit (Qiagen) 
- PCR Tubes (Thermo) 
- Penicillin and Streptomycin (Invitrogen) 
- PhosSTOP Phosphatase Inhibitor cocktail (Roche) 
- Photographic Fixer and Developer Solutions (Redichem) 
- Polyethylene glycol 3550 (BDH) 
- Polyethylene glycol 4000 (BDH) 
- Potassium acetate (BDH) 
- Potassium chloride (BDH) 
- Potassium hexacyanoferrate (III) (Sigma) 
- Protein G agarose (Pierce) 
- QIAprep Spin Miniprep Kit (Qiagen) 
- Roswell Park Memorial Institute (RPMI) 1640 GlutaMAX (Invitrogen) 
- Salmon Sperm DNA (Sigma) 
- See Blue Plus 2 protein ladder (Invitrogen) 
- Sequencing grade modified trypsin (Promega) 
- Silver Stain for Mass Spectrometry (Pierce) 
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- Sodium bicarbonate (BDH) 
- Sodium chloride (BDH) 
- Sodium Dodecyl Sulfate (BDH) 
- Sodium hydroxide (BDH) 
- Sodium thiosulfate (Sigma) 
- Sterile filter units (Millipore) 
- Trichloroacetic acid (BDH) 
- Triethyl ammonium bicarbonate (TEABC) (Sigma) 
- Trifluoroacetic acid (TFA) (Thermo) 
- TRIS(hydroxymethyl)aminomethane (BDH) 
- Tween-20 (BDH) 
- UltraPure Agarose (Invitrogen) 
- Ura drop out mix (Formedium) 
- Urea (BDH) 
- Yeast extract (Merck) 
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2.1.1.1 Commercial antibodies 
The commercial antibodies used in this project are listed below in Table 2.1. 
 
Antibody Name Company 
Product 
number  Source 
Anti-Actin Millipore mab1501R Mouse 
Anti-GFP Roche 11814460001 Mouse 
Anti-HA (HA.11) Covance MMS-101R Mouse 
Anti-HA-HRP Sigma H6533 Mouse 
Anti-NEDD8 
(Epitomics) 
Epitomics 1571-1 Rabbit 
Anti-NEDD8 (Mil10) Millenium Pharmaceuticals N/A Rabbit 
Anti-protein G-HRP Abcam AB7250 Rabbit 
Anti-Tubulin Sigma T9026 Mouse 
Anti-ubiquitin Dako Z0458 Rabbit 
Anti-UCHL3 Cell Signalling 3525 Rabbit 
Mouse-HRP Biorad 170-5047 Goat 
Rabbit-HRP Biorad 170-5046 Goat 
Sheep-HRP Abcam ab97130 Rabbit 
 
Table 2.1.Commercially produced antibodies used in this project.  Mil10 was a gift 
from Millennium Pharmaceuticals and is not available for sale but all others were 
purchased. 
 
2.1.1.2 Instruments 
- Automatic film processor SRX-101A (Konica Minolta) 
- Avanti J-25 Beckman 
- Balances: PL300-S (Mettler Toledo), LP2200P (Sartorius), Acculab 
- Centrifuge 581R Eppendorf 
- Centrifuge Beckman Coulter J6-Mi 
- Centrifuge Beckman TL-100 Ultracentrifuge 
- DNA Engine Peltier Thermal Cycler (BioRad) 
- EnVision 2104 Multilabel reader (Perkin Elmer) 
- Epson Perfection V700 PHOTO scanner (Hertfordshire, UK) 
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- Freezer Mill 6770 Spex Sample Prep 
- Heat block (Eppendorf) 
- Infors HT Multitron Incubators 
- Microscope Primo Star (Zeiss) 
- Milli-Q Biocel system (Millipore) with a Quantum EX Ultrapure Organex cartridge 
(Millipore) 
- Mini-SubCell GT (BioRad) 
- Molecular Imager Gel Doc XR+ Imaging System (BioRad) 
- Multichanel pipettes (Star Lab) 
- NanoVue version 4282.V2.0.3 (Nanodrop)  (GE Healthcare)  
- Odyssey Infrared Imaging Systim (Li-COR) 
- pH meter (Hanna Instruments) 
- Pipette-Aid (Gilson) 
- Power-Pac Basic Power Supply (BioRad) 
- Rotator Drive (wheel) STR4 (Stuart) 
- Savant SPD131 DDA SPeedVac Concentrator (Thermo) 
- See-saw rocker SSL4 (Stuart) 
- Solution mixer/heater CB162 (Stuart) 
- Sonicator (Bandelin Electronic) 
- Spectrophotomeer Ultraspc 2100 pro (Amersham Biosciences) 
- Static Incubators (Binder) 
- Table top centrifuges: Heraeus Pico 17 and Heraeus Fresco 17 (Thermo) 
- Tissue culture CO2 Incubators (Binder) 
- Tissue culture lab microscope (Leica) 
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- Tissue culture safety cabinet BioMAT-2-SF (Medical Air Technology) 
- Vortex-Genie (Scientific Industries) 
- X-Cell Sure Lock Mini-Cell Electrophoresis system and X-Cell II Blot Module 
(Invitrogen) 
2.1.2 In house reagents 
Both liquid media and agar plates for yeast and bacteria culture were prepared by the 
Kitchen Service, University of Dundee. The only difference between the recipes for 
liquid media or agar plates was the omission of agar from the liquid media.   
Luria Bertani (LB) broth 
1% tryptone 
0.5% yeast extract 
1% sodium chloride  
2% bacto-agar 
YPAD 
1% bacto-yeast extract 
2% bacto-peptodne 
2% glucose 
0.004% adenine sulfate 
2% bacto-agar 
Synthetic Dextrose Minimal Media (SD) 
0.67% bacto-yeast nitrogen base without amino acids 
2% glucose 
2% bacto-agar 
Supplemened with appropriate amino acids or a drop-out mix for plasmid 
selection 
Table 2.2.  Media recipes used to generate growth media for bacteria and yeast. 
 
10X TBS and PBS were also prepared by the Kitchen Service. MLN4924 was 
synthesized by Natalia Shapiro at the University of Dundee. 
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2.1.2.1 Primers 
Oligonucleotide primers for yeast DNA were designed using the sequences available on 
the Saccharomyces Genome Database (www.yeastgenome.org) and DNA Strider 1.4 for 
OS X.  Primers were synthesized by the University of Dundee Oligonucleotide 
Synthesis Service upon request and are listed below in Table 2.3. 
 
Identification 
number 
Target 
gene 
Oligonucleotide 
location (bp) Sequence 
oSC10 UBC12 268 upstream CTGCCTTAAACGAGTGGCG 
oSC11 UBC13 253 upstream GCCTTCTCTACATGTGAAC 
oSC12 UBC4 251 upstream GTACCGGCGGTCACATGG 
oSC13 UBC5 251 upstream GATGTATTGCTAGTGCTAG 
oSC14 UBC8 ~250 upstream GCTCGTGTGCACATCTGCG 
oSC18 UBC1 274 downstream CCGCAGTCGGTCCCCTGATCGC 
oSC29 UBA3 464 upstream CTCAAGCAACACTGAGGTCAC 
oSC30 UBA3 359 downstream, 
reverse 
CGTGACATCCACCACTTTC 
oSC6 UBC10 255 upstream CGCGTTACCCGTATCATC 
oSC7 UBC7 276 upstream GCACACGCATATTTGTTCCC 
oSC8 UBC2 277 upstream GTGTGAGCTAACCATGCT 
oSC9 UBC11 253 upstream CAATAGTCCTGCATACGTAGC 
oTK82 RUB1  Downstream TATCGTAATCGCATTTTACATAA
GG 
oTK83 RUB1 Upstream  AATCAGACCATATATAGCC 
oTK98 KAN Center reverse 
Kan casette 
 GATGGTCGGAAGAGGCATAA 
Table 2.3.  Primers used in this project.  All primers were generated in house. The 
oligonucleotides designed by myself are denoted with an oSC number while the three 
oligomers designed by Thimo Kurz are denoted by oTK numbers. 
 
2.1.2.2 Plasmids 
All plasmids, cloning, subcloning, and mutagenesis was performed by Nicola Wood, 
Zoey Gage, Thomas Macartney and Melanie Wightman of the MRC/SCILLS Cloning 
Service, University of Dundee, upon request using the QuickChange site directed 
mutagenesis method (Stratagene # 200518).  The resultant PCR product was subcloned 
into pYES2 or pRS413 vectors.  For galactose inducible overexpression constructs, the 
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pYES2 vector was used while the centromeric pRS413 vector was used for a lower 
level of constitutive expression.  The backbones both carry ampicillin resistance, which 
was used to select for bacterial transformants.  Sequencing was confirmed by the 
University of Dundee DNA Sequencing Service using DYEnamic ET terminator 
chemistry (Amersham Biosciences) on automated DNA sequencers (Applied 
Biosystems). The plasmids were subsequently maintained and amplified in competent 
DH5α E. coli. 
 
Vector 
5' 
UTR Expressed protein 
3' 
UTR 
Cloning 
Service 
T. 
Kurz 
pYES2   3HA-Rub1 ∆GG  x  
pYES2   3HA-GFP-8 x Gly-Rub1  x  
pYES2   3HA-GFP-8 x Gly-Rub1G75/76A  x  
pYES2  HA-Rub1 G75/76A  x  
pYES2  Rub1  x  
pYES2  Rub1 G75/76A  x  
pRS413 x Rub1  x  
pRS413 x Rub1 x x  
pRS413 x Rub1 G75/76A x x  
pRS413 x HA-Rub1 G75A x x  
pRS413 x HA-Rub1 G75/76A x x  
pRS413 x HA-Rub1 ∆N77 x x  
pRS413 x HA-Rub1 G75A ∆N77 x x  
pRS413 x HA-Rub1 G75/76A ∆N77 x x  
pRD54 x 3HA-6 x HIS-Rub1   x 
pRD54 x 3HA-6 x HIS-Rub1 ∆GG   x 
Table 2.4. Plasmids used in this project. The plasmids are identified by backbone, 
inserted sequence and source. 
 
The 5’UTR (Rub1 promoter) was defined by the following sequence: 
CTCGAGCTCAAAAAAGATATTCTGTCATGAGCATAGCTATGAATTTTTCT 
TTATAAACCGAAATATAGTTATACGCTTTGAGTAAAGACACAGGTTATCA 
ATTATAACGTGAAAGGTTTTGCAACTGTCACCTTGTAAAGCTGTACACAC 
TGAGGACTTCCCATCCCGCTTTTCTCGTTTCAATAAGTTTCACATTCCAT 
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TTGTAAGTATCGACAAACCTCTTAATGACTTCTTTAGGCTTATTTCTTGC 
ACAAAATAATATATATGCAACACCATCTGGAGAAAGAATTTGTTCTAATT 
GTCGTAGCAGTTTATCAGTAATCGCCATCCCGTCTTTTCCACCCAATAAC 
GCTAAATCTAGCCATTGGTCTGCCTCCTCTCTTGATCCTGGGACATCTGG 
CACACATTCTGCTGGCACATATGGTGGGTTAAATATTAGGACATCAACCT 
GATTATTCCGAATACTGGAGTTTAAATCAGCTTGAATCACTTCTAAAAAA 
GAACTTTTACATGAATTTAACTTCGCAGTATCCAAAGTTGCTTCGAGCGC 
CCATGGGTTGATATCAACAGCTAAGTGGATGGAATTTTCCTGCGGTATTA 
TTTTGTTTTGCATTAGAAATGTTGTGACGATACCTGATCCCGAACCAATT 
TCGCAAACGATGGCCAAACGATTACCAAATTTCTGTTTCAAAAAATCATG 
CTCTTTTTCCAAACAGTCCAGTATGAGGAAGCTATCCTCAGCAGGCTCAT 
ATACTTTATCGTAATCGCATTTTACATAAGGGGTCGGTAGCATACTTCAC 
CTTTCTCACCCTGTGTTAAGTTTATCAATATTATATTTCAGAGTATAATT 
ATATCAATATTTATATGAAATCAAATTCCGATGGCGTCTTCGGGAAGGCA 
AACGAACAACTTTTAGCTGAAAAACCAAAATTCTGTTATTCAAATGAAGT 
ATTCCGACAGAGGAATAAATAAAGGAAGGTAATTAACTTCCTTACAGCCG 
TAACCGGAATTC 
 
The 3’UTR was defined by the following sequence: 
AACCATTTTCCGTCATTTATGGAATTTTATCGAAGGTGTTCATTAGAAAAGA
AGACAAAACGAACATAAGTTCACTTGGACTTTGGAAGGCTACCGCCCCCAA
TTTGTCAAAAAAAAAAATACATACAATTTAGTCTATAGAGTCTGTTATAATA
AATTAATTGTTTTTAGACGAGAAATGTGAACTAAAACTGTTTAGTATCTATC
AAATTATCCGTTATAGCATAGTACGGCTATATATGGTCTGATTGCTGGTCTC
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ATATGACTTTATGGTTTAAATTTCATAAAGCTGGCCATTGCATGGTTCGCGC
TGGAAAGAGAGGAAAAGCGTGGTGATAAAGAGCAAACCAAGCATACTGTT
ATATGCGATTACAGACTATCTGACCAAAAGACATATTTCGCCATTTCTTCTC
AATCATGTCTTCCAGGGCAATTTTGTAAGCACGATTGGATGTCCTCTTGTAG
TATACCGAATTTCTCATTAAGAAAAGCATCCTTTGCGCGGCCGC 
 
2.1.2.3 Proteins 
The following proteins were obtained from the Scottish Institute for Cell Signalling 
Protein Purification and Assay Development Team (PPAD), led by Dr. Axel Knebel at 
the University of Dundee:  
GST, GST-NEDP1 C163A, His-HA-NEDP1 C163A, NEDD8, Rub1, yeast 
ubiquitin, and human ubiquitin 
PPAD expressed these proteins in bacteria and purified them from inclusion bodies 
using ion exchange and size exclusion chromatography.  Proteins were then aliquoted 
and stored in Ubiquigent Buffer (50mM HEPES pH 7.5, 10% glycerol, 150mM NaCl, 
1mM DTT) at -80°C and thawed on ice as needed.   
 
2.1.2.4 In house antibodies 
There were a series of antibodies produced in-house by the Division of Signal 
Transduction Therapy (DSTT), University of Dundee, utilized in this project.  
Additionally, pre-immune IgG was purified by the DSTT from non-immunized sheep 
serum using a protein G-sepharose column.  All antibodies were affinity purified on 
CH-sepharose covalently coupled to the appropriate antigen.  These antibodies are as 
listed below in Table 2.5.  Additionally, the anti-NEDP1 antibody was developed for 
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the laboratory of Dr. Dimitri Xirodimas and an aliquot was generously donated to the 
Kurz laboratory to validate NEDP1 knockdown experiment.   
Name Animal Number Immunogen Sequence 
For 
this 
project 
CAND1 Sheep S292D GST-CAND1 (5-245 of human 
CAND1) 
  
Cdc53 Sheep S251D GST-Cdc53 (1-288 of S. 
cerevisiae) 
 
Rabbit anti-
NEDD8 
Rabbit R2911 Human NEDD8 (11-32) 
CKEIEIDIEPTDKVERIKERVEE 
x 
Rub1.1 Sheep S105D Yeast Rub1 (21-35) 
CDLVYHIKELLEEKEG 
x 
Rub1.2 Sheep S105D Yeast Rub1 (44-58) 
CIFQGKQIDDKLTVTD 
x 
Sheep anti-
NEDD8 
Sheep S203D Human NEDD8 (11-32) 
CKEIEIDIEPTDKVERIKERVEE 
x 
 
Table 2.5.  Antibodies produced by DSTT for the Kurz laboratory. Antibodies produced 
for this project were validated by myself whereas the other antibodies were validated by 
other members of the laboratory. 
 
2.1.3 Yeast strains 
The following single deletion yeast strains (Table 2.6) were obtained in BY4741 
background from the haploid Open Biosystems/Thermo Yeast Mat a knock out 
collection (# YSC1053).  
Miscellaneous E3 Deletions DUB deletions  
pep4 ubr1 ubp1  ubp11  
E1 deletion san1 ubp2  ubp12  
uba3   ubp3 ubp13 
E2 deletions   ubp4 ubp14 
ubc2 ubc8 ubp5 ubp15  
ubc4 ubc10 ubp6  ubp16 
ubc5 ubc11 ubp7  yuh1 
ubc6 ubc12 ubp8  otu1 
ubc7   ubp9  otu2  
Table 2.6.  Open Biosystems Kan KO strains used.  List of the strains obtained from the 
Open Biosystems collection where single geneshave been replaced with a KAN 
resistance cassette.  Obtained from the Mata KO collection for use in this project. 
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Double deletion mutants were generated by PCR-based knockout methods. Strain uba1-
204 and the isogenic wild type (WT) were from Professor Raymond Deshaies (Division 
of Biology, California Institute of Technology, Pasadena, CA, U.S.A.). Strain cdc34-2 
and the isogenic WT were obtained from Thimo Kurz (University of Dundee).  The 
double and quadruple E2 mutant strains, ubc4::Trp1 ubc5::Leu2, ubc6::His3 ubc7::Leu2, 
and ubc4::Trp1 ubc5::Leu2 ubc6::His3 ubc7::Leu2 and the isogenic WT were obtained 
from Professor Mark Hochstrasser (Department of Molecular Biophysics and 
Biochemistry, Yale University, New Haven, CT, USA).   
 
 
Background Genotype Source 
S288C ubc12::Nat rub1::Kan Thimo Kurz 
BY4741 ubp3::Kan rub1::Nat This project 
BY4741 ubp3::Kan uba3::His This project 
S288C pdr5::Kan  rub1::Nat This project 
S288C uba3::His Thimo Kurz 
S288C rub1::Nat Thimo Kurz 
S288C Wild Type Thimo Kurz 
W303 Wild Type Thimo Kurz 
MHY501 ubc4::Trp1 ubc5::Leu2 Mark Hochstrasser  
MHY501 ubc6::His3 Ubc7::Leu2 Mark Hochstrasser  
MHY501 ubc4::Trp1 ubc5::Leu2 
ubc6::His3 ubc7::Leu2 
Mark Hochstrasser  
MHY501 Wild Type Mark Hochstrasser  
W303 uba1-204  Ray Deshais 
W303 Wild Type Ray Deshais 
W303 cdc34-2 Thimo Kurz 
Table 2.7.  Yeast strains from other sources.  These strains do not come directly from 
the Open Biosystems yeast KO library.  Most were generated using PCR mediated 
substitution techniques.  The two temperature sensitive (TS) strains uba1-204 and 
cdc34-2 were grown at 25°C and shifted to the restrictive temperature of 37°C as 
required by experiments. 
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2.1.4 Buffers 
 
Buffer Composition 
1,10-Phenanthroline 
(OPT) (Aldrich) 
200 mM stock was made from powdered 1,10-
Phenanthroline and ethanol and kept at -20° for up to 
1 month and used as needed 
20% (w/v) glucose 20% (w/v) glucose in water; filter sterilized 
3X reducing sample 
buffer 
62.5M Tris pH 6.8, 10% (v/v) glycerol, 2% (w/v) 
SDS, 6M urea, 5% (v/v) beta-mercaptoethanol, 
bromophenol blue added to colour. 
50% glycerol 50% glycerol, 50% water (autoclaved to ensure 
sterility) 
DNA extraction buffer 2% (v/v) Triton, 1% (w/v) SDS, 100mM sodium 
chloride, 1x TE 
Farmer's Reducer 30mM Potassium hexacyanoferrate (III), 30mM 
sodium thiosulphate (made fresh just before use) 
Gel Extraction Buffer 5% formic acid, 50% acetonitrile 
Homemade gel transfer 
buffer 
48mM Tris base, 39mM glycine, 20% methanol 
Lithium acetate mix 100mM lithium acetate in 1x TE 
Lysis Buffer A (cultured 
cells) 
50 mM Tris pH 7.4, 250 mM NaCl, 0.1% NP-40, 
10% glycerol, 2 mM OPT, 10 mM IAA, Complete 
mini protease inhibitor from Roche  
Lysis buffer B (cultured 
cells) 
50 mM Tris pH 7.4, 250 mM NaCl, 0.1% NP-40, 
10% glycerol, 10 mM IAA, Complete mini EDTA 
free protease inhibitor from Roche  
Lysis buffer C (cultured 
cells) 
50 mM Tris pH 7.4, 250 mM NaCl, 0.1% NP-40, 
10% glycerol, 10 mM IAA, Complete protease 
inhibitor from Roche in 5x excess 
MilliQ water (MilliQ) water filtered through a Milli-Q Biocel system 
(Millipore) with a Quantum EX Ultrapure Organex 
cartridge (Millipore) 
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Nondenaturing lysis 
buffer for yeast 
2 mM OPT, 10 mM IAA, 50 mM Tris pH 7.4, 250 
mM NaCl, 10% (v/v) glycerol, 0.1% NP-40, 
complete protease inhibitor (5x excess) 
Nonreducing sample 
buffer 
320 mM Tris pH 6.8, 8% (w/v) SDS,32% (v/v) 
glycerol, 0.01% Bromophenol blue 
One step yeast 
transformation buffer 
250mM lithium acetate, 47% (w/v) polyethylene 
glycol 3550 
PBST blocking buffer 12 mM phosphate, 137 mM NaCl, 2.7 mM KCl, 
pH7.4, 0.1% (v/v) Tween-20 
PCR master mix (per 
tube using high fidelity 
polymerase kit from 
Roche) 
0.5 µL genomic DNA, 35.25 µL MilliQ water, 
0.5 µL 400 mM dNTP, 5 µL high fidelity buffer + 
MgSO4, 5 µL 50% DMSO, 0.75 µL TAQ high 
fidelity DNA polymerase, 1.5 µL mM forward 
primer, 1.5 µL mM reverse primer 
PEG mix 40% (w/v) Polyethylene glycol 4000 dissolved in 
lithium acetate mix 
PPAD lysis buffer 50mM Tris pH 7.5, 150mM sodium chloride, 1% 
(v/v) Triton, 1mM EDTA, 1mM EGTA, 2mM TCEP, 
1µM PefaBloc, 0.01% (w/v) leupeptin 
PPAD PreScission 
protease buffer 
50mM HEPES pH 7.0, 150mM sodium chloride, 
1 mM DTT, 10% (v/v) glycerol 
RIPA Buffer (for 
tissues) 
50 mM Tris pH 7.5, 1 mM EDTA, 1% (v/v) Triton 
X-100, 150 mM NaCl, 10 mM IAA, 2 mM OPT, 
complete mini EDTA free protease inhibitor  
TAE 40mM Tris acetate, 1mM EDTA 
TBST blocking buffer 50mM Tris, 150mM sodium chloride, 0.1% (v/v) 
Tween-20, 5% (w/v) dried skimmed milk, 1% (w/v) 
BSA 
TE buffer 0.1M Tris pH 7.5, 10mM EDTA 
Transfer buffer 
(commercial gels) 
1x Transfer buffer (invitrogen), 20% ethanol 
Tris/HCl buffer 
solutions pH range 6.8-
8.8 
Tris buffers were adjusted to the required pH using 
concentrated (37%) HCl solution. 
Tris-base buffer 0.1M Tris-base pH 9.2, 10mM DTT 
Ubiquigent Buffer 
(PPAD Storage buffer) 
50 mM HEPES pH 7.5, 150 mM sodium chloride, 
1 mM DTT, 10% (v/v) glycerol 
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Wash buffer (TBST) 50mM Tris, 150mM sodium chloride, 0.1% (v/v) 
Tween-20 
Yeast IP wash buffer A 125 mM NaCl, 1% NP-40, 120 mM Tris HCl pH 7.4 
Yeast IP wash buffer B 250 mM NaCl, 1% NP-40, 120 mM Tris HCl pH 7.4 
Yeast IP wash buffer C 500 mM NaCl, 1% NP-40, 120 mM Tris HCl pH 7.4 
Table 2.8.  General Buffer recipes. 
 
Component Function 
EDTA Chelates divalent cations 
glycerol protein stabilization 
Iodoacetamide alkylating agent to block disulfide bond formation 
NaCl Maintain ionic strength of buffer 
NP40 nonionic detergent less harsh than SDS but can still 
help with membrane disruption and protein 
solubilization 
OPT metalloprotease inhibitor  
Phosphatase inhibitor 
tablet 
Inhibits phosphatase activity 
protease inhibitor 
cocktail 
inhibit aspartic-, metallo-, serine-, and cysteine- 
proteases 
Tris pH 7.5 buffer to maintains near physiological pH 
Triton protein solubilization 
Table 2.9.  Lysis buffer component functions. 
2.1.5 Mouse Tissues 
Mouse tissues were obtained from several sources.  Tissues panels were provided by 
Esther Sammler and Susanne Bandau both of the University of Dundee.  Testes were 
obtained from Esther Sammler, Francisco Inesta-Vaquera, Vanessa Houde, and Ana 
Belen Perez-Oliva of Dr. Dario Alessi’s Laboratory, University of Dundee. Additional 
brains and livers were collected and donated by Brian Dill.  All organs were frozen in 
liquid nitrogen immediately after harvesting and stored at -80° until lysis. 
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2.2 Methods 
2.2.1 Common laboratory techniques 
2.2.1.1 Estimation of protein concentration by the Bradford method 
The Bradford assay first described by (Bradford, 1976)makes use of the shift of 
Coomassie Brilliant Blue G-250 dye from 465 nm (red spectrum) to 575 nm (blue 
spectrum) upon binding to basic amino acids such as arginines, lysines, and histidines.  
For this project, protein concentration was estimated using 500 µLCoomassie protein 
assay reagent (Thermo) diluted with 500 µL of water. Lysis buffer alone was added as 
the blank whereas a serial dilution of purified BSA was used to generate a standard 
curve.  Absorbance was measured at a wavelength of 595 nm a using an Ultrospec2100 
pro (Amersham biosciences).  Proteins were diluted to fall within the linear range.  
Bradford measurements were done in triplicate.  
2.2.1.2 Estimation of protein concentration by the bicinchoninic acid assay 
The bicinchoninic acid (BCA) assay described originally by Smith, 1985, was done 
using a kit adapted by Thermo and measurements were made using an EnVision 2104 
Multilabel reader (Perkin Elmer). 
2.2.1.3 Estimation of DNA concentration 
DNA concentrations were analyzed by applying 2µL to a nanodrop (NanoVue version 
4282.V2.0.3, General Electric). Pure samples were defined by an A260/280 ratio higher 
than 1.8. 
2.2.1.4 Agarose gel electrophoresis of DNA 
To separate DNA by molecular weight (MW) DNA gels were run on a mini-subcell GT 
system (BioRad).  To pour these gels, 1% (w/v) agarose in 1X TAE was heated to 
boiling in a microwave, then allowed to cool slightly with constant stirring.  Agarose 
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was poured into the mold and 2 µL ethidium bromide was added. Samples were 
suspended in 6X DNA loading dye (Promega). Samples were then loaded alongside a 
1 kB Quick-Load DNA Ladder (New England Biolabs) and electrophoresed using the 
mini-subcell GT system (BioRad) at 90V for 40-60 minutes and visualized using a 
transilluminator (Molecular Imager Gel Doc XR+ Imaging System, Biorad).  
2.2.1.5 Polymerase Chain Reaction (PCR) 
 
For amplification of a gene typically 5 x 50 µL PCR tubes were prepared from a master 
mix. For confirmation of gene deletion, typically 1 tube was used.  A typical mix made 
with the high fidelity polymerase kit from Roche is listed below (Table 2.10) 
 
Typical PCR mixture µL 
Hi-FI buffer +MgSO4 5 
400 mM dNTPs 0.5 
50% DMSO 5 
TAQ Hi-FI DNA 
polymerase 
0.75 
3.3 mM Forward primer 1.5 
3.3 mM Reverse primer 1.5 
MilliQ Water 35.25 
genomic DNA 0.5 
Table2.10. Typical PCR mixture for one tube. 
 
A BioRad DNA Engine Peltier Thermal Cycler was used for PCR reactions.  Conditions 
normally used were as follows: 
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Step 1:  95° for 5 minutes 
Step 2:  95° for 1 minute 
Step 3:  55° for 45 seconds (anneal) 
Step 4:  68° for 1 minute/kB (amplify) 
Step 5:  Repeat from step 2 for 25-35 cycles 
Step 6:  72° for 10 minutes 
Step 7:  9° Final hold 
 
The success of the PCR reaction was analyzed using a 1% agarose gel.  If the target 
gene presence or deletion was confirmed that strain would be used for further 
experiments.  For gene amplification experiments the 5 tubes were then pooled and 
purified using the Qiagen PCR cleanup kit.   
 
2.2.1.6 Protein visualization 
2.2.1.6.1 Sodium Dodecyl Sulfate Poly-Acrylamide Gel Electrophoresis (SDS-PAGE) 
Protein samples were diluted in 3x reducing sample buffer or 4x nonreducing sample 
buffer and separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis 
(SDS-PAGE) using the XCell SureLock Mini-Cell Electrophoresis System with Biorad 
PowerPac HC.  Typically, NuPAGE 4-12% Bis-Tris Gels with 10, 12, or 15 wells 
(Invitrogen) were run in MES (Invitrogen) or MOPS (Invitrogen) buffers.  For 3HA -
Rub1∆GG overexpression chase experiments in the pep4∆ and single E2∆ strains, and 
for the characterization of the Rub1 antibody, samples were run on 10-20% tricine gels 
with 1X Novex tricine SDS running buffer (Invitrogen).  
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Homemade gels were made using the Fisherbrand Gel tank complete supercooled for 
precast or handcast gels (formerly from SciPlus).  These gels were poured with the 
following composition (Table 2.11).  For gradient gels, the lower and higher percentage 
separating gel solutions were mixed using a gradient former.  Gels were run in TGS 
buffer at 36mA, 300V. 
 
 
Separating Gel 4.5% Stacking Gel TGS 
375mM Tris pH 8.8 4.5% acrylamide 25mM Tris pH 8.6 
0.1% SDS 125 mM Tris pH 6.8 192mM glycine 
0.1%APS 0.1% SDS 0.1% SDS 
0.001% TEMED 0.1%APS  
 0.001% TEMED  
Table 2.11. Recipes for homemade polyacrylamide gel componentsand running buffer. 
The separating gel contained the appropriate amount of acrylamide (typically 10% 
although 12%, 6-18% and 4-12% gels were also run).   
 
2.2.1.6.2 Gel Staining 
Two methods for directly staining gels from SDS-PAGE were used; (1) Silver staining 
(Silver Stain for Mass Spectrometry, Pierce) or (2) Coomassie staining.  Silver staining 
was accomplished as directed by the manufacturer.  There were two methods of 
Coomassie staining utilized.  First, instant stain was used as directed by the 
manufacturer (Instant Blue, Expedeon) for gels produced during optimization that were 
not to be sent for MS analysis.  However on important gels bound for MS analysis, a 
homemade stain procedure was used because of its higher sensitivity.  In this method, 
gels were fixed in 40% methanol 10% acetic acid for 20 minutes then rinsed with water 
and incubated in a solution containing 0.08% Coomassie Brilliant Blue G250, 1.6% 
ortho-phosphoric acid, 8% ammonium sulphate, and 20% methanol overnight.  Gels 
were destained with water or 1% acetic acid.  Gels were scanned using an Epson 
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Perfection V700 PHOTO scanner (Hertfordshire, UK).  Contrast and brightness were in 
some cases altered using Photoshop (Adobe, San Jose, California) while making figures. 
 
2.2.1.6.3 Transfer of proteins to nitrocellulose membranes 
Following SDS-PAGE of commercial gels, proteins could be transferred using an X-
Cell Sure Lock Mini-Cell Blot system (Invitrogen) packed as follows: 
Cathode 
3 Sponge pads 
Filter paper 
Filter paper 
Protein gel 
Nitrocellulose membrane 
Filter paper 
Filter paper 
3 sponge pads 
Anode 
 
For commercially poured gels, the X-Cell Sure Lock system was then filled with 
NuPage transfer buffer (Invitrogen) at 30-35V for 1 hour to 1 hour and 15 minutes on a 
Biorad PowerPac HC. The only difference for homemade gels was the composition of 
the transfer buffer and, as the gels were thicker, transfer time was increased to 1.5 hours.   
 
Protein transfer was confirmed by rinsing the membrane with MilliQ filtered water then 
applying ATX Ponceau S red staining solution (Fluka Analytical).  The membranes 
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were then rinsed with MilliQ water again until the background was nearly white.  Areas 
where protein had transferred were then visible as pink bands.  Areas without protein 
remained white.  Membranes were placed within a page protector and scanned on an 
Epson Perfection V700 PHOTO scanner.   
 
2.2.1.6.4 Immunoblotting/Western Blotting 
To perform a Western Blot (WB), proteins are first transferred from polyacrylamide 
gels to nitrocellulose membranes (GE Healthcare). Membranes were blocked with 5% 
milk 1% BSA in TBST for at least one hour then incubated with primary antibody in 
5% milk 1% BSA in TBST for one hour to overnight. Primary antibodies and secondary 
anti protein G were typically saved after use at -20°C and thawed for reuse.  After 
primary incubation was complete, the membrane was washed 3-4 times with TBST for 
5-10 minutes.  Secondary antibody was then added at 1:5000-1:10000 for ~ 45 minutes.  
The membrane was then rinsed twice with TBST and washed n TBST 3 times 10 
minutes and once for 5 minutes.  The HRP conjugated antibodies were incubated with 
Millipore Immobilon Western chemiluminescent HRP substrate for enhanced 
chemiluminescence (ECL) for 1.5 minutes. Amersham hyperfilm ECL from GE was 
then exposed to the membranes in a dark room and the films were developed using an 
SRX-101A Medical Film Processor (Konica Minolta, Tokyo Japan).  Films were 
scanned using the Epson scanner.  Contrast and brightness were in some cases altered 
using Photoshop (Adobe, San Jose, California) while making figures. 
 
2.2.1.6.4.1 Exceptions to typical WB procedure 
In order to develop a blot where the primary antibody was already conjugated to HRP 
(as with HA-HRP), membranes are blocked as above then incubated with the primary 
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antibody overnight.  Membranes are then washed 4 times for 10 minutes in TBST and 
developed as described above. 
 
The sheep anti-Rub1 antibody has many nonspecific interactions and worked most 
efficiently if the heavily banded area (20-60 kD) of the membrane was removed. The 
bottom portion of the membrane (free Rub1) and the high molecular weight region (the 
cullins) were then Western Blotted using PBST based buffers. Anti-Rub1 antibody was 
used 1:500 overnight and could not be reused.   
 
In order to increase the signal for lower molecular weights forms of ubiquitin and 
ubiquitin conjugates (monomer dimer etc), the nitrocellulose membrane was boiled in 
water for 30 minutes prior to blocking and the primary Dako anti-ubiquitin antibody 
was incubated for 1-2 hours at RT.  The rest of the procedure is as above. 
 
2.2.1.6.4.2 Membrane stripping 
If the membrane used for a WB had bands in an area that needed to be reprobed with 
another antibody (for example to obtain the image for the loading control), the Abcam 
procedure for Medium stripping was used (Abcam).  The only difference to the 
procedure described is that during the second wash with stripping buffer, the membrane 
was warmed slightly in the microwave before being allowed to incubate for 5-10 
minutes. 
 
2.2.1.6.5 Dot blot 
To test antibody reactivity to purified protein, serial dilutions of the target protein were 
made both native (in Ubiquigent buffer) and denatured (In 3x reducing sample buffer).  
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To control for nonspecific binding at least one other protein was treated in the same 
manner.  All proteins to be analyzed were then applied to a nitrocellulose membrane 
(GE Healthcare) in 1-5 µL aliquots.  The membrane was subsequently blotted as with a 
normal WB using primary antibody dilutions of 1:500 overnight.  
 
2.2.1.7 Antibody production schemes 
The antibodies generated for this project were tested for specificity and possible uses as 
follows. 
 
2.2.1.7.1 Rub1 polyclonal antibody 
Peptides to be used for this project were selected by Thimo Kurz.  A single sheep was 
immunized against yeast Rub1 residues 21-35 and 44-58.  Three bleeds of Sheep-anti-
Rub1 were purified against the antigens.  Antibodies were then tested by dot blot to 
determine if they specifically recognized Rub1 without ubiquitin crossreactivity.  As the 
antibody purified against Rub1 residues 44-58 displayed some crossreactivity with 
ubiquitin, the other Rub1 antibody (purified against residues 21-35) was used.  
Antibodies were tested for efficacy via WB of whole cell lysate.  The third bleed was 
also tested for immunoprecipitation (IP) capability.  
 
2.2.1.7.2 NEDD8 polyclonal 
A sheep and a rabbit were immunized against residues 11-32 of human NEDD8. Serum 
purified against the antigen was checked by dot blot for NEDD8 specificity, cross 
reactivity with ubiquitin, and crossreaction with high levels of protein using BSA.   
Subsequently these antibodies were also tested against WB of HCT-116 lysate.  WB 
specificity was confirmed by comparing samples with and without inhibition of the 
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NAE using MLN4924 treatment.  If the intensity of WB bands decrease following 
inhibition of the neddylation machinery they are likely genuine substrates.  In these 
initial dot blots and WBs of the NEDD8 polyclonal, results were compared to signal 
obtained using Mil10, a highly specific rabbit monoclonal anti-NEDD8 from Millenium 
Pharmaceuticals. Attempts to use the polyclonal antibodies for IP were made using the 
DSS crosslinker kit (Pierce), the AminoLink Plus Immobilization Kit (Pierce), NHS-
activated M-PV magnetic beads (Perkin Elmer) and crosslinking free experiments. 
 
2.2.1.8 Common bacterial protocols 
2.2.1.8.1 Transformation of E. coli 
DH5α cells were prepared by the DNA Cloning Service (University of Dundee, 
Scotland) as described by Inoue et al., 1990.  Competent cells were stored at -80°C and 
thawed as needed on ice. In a microcentrifuge tube, 1µL of plasmid was combined 
with100µL of bacteria and allowed to incubate on ice for 30 minutes and then heat 
shocked for one minute at 42°C.  The bacteria were returned to ice for 2 minutes then 
plated on an LB-AMP and allowed to grow at 37°C.  
 
2.2.1.8.2 Isolation of DNA from bacteria 
3mL of LB-Amp was inoculated with E. coli carrying the target plasmid and allowed to 
grow overnight shaking at 37°C 200 RPM.  It was subsequently purified using the 
QIAprep Spin Miniprep Kit (Qiagen) using the provided elution buffer and 
concentration was measured using the nanodrop method.  Plasmids were then stored at -
20°C and thawed as needed. 
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2.2.1.8.3 Preparation of bacterial glycerol stocks 
Glycerol stocks were made by combining 1mL of E. coli grown in LB-Amp liquid 
media overnight at 37°C with 1mL of 50% glycerol which had been autoclaved.  Starter 
cultures were prepared from this stock by scraping an inoculating loop across the 
surface of the stock and restreaking the bacteria onto fresh LB-Amp plates. 
 
2.2.1.9 Common yeast protocols 
2.2.1.9.1 Growth of yeast 
Yeast was grown on rich YPAD media (yeast extract-peptone-dextrose-plus Adenine) 
or in synthetic dextrose media (SD).  Selection for knock out (KO) strains and strains 
carrying expression plasmids were maintained on plates with the appropriate selection 
marker.  All wild type strains were grown on YPAD.  Yeast grown on agar could be 
saved at 4°C with parafilm around the plate for up to 1 month before being restreaked 
on a fresh plate.   
 
Yeast grown in liquid media was started as a preculture by inoculation of 5-10 mL of 
the appropriate media (KO strains and strains carrying expression plasmids in media 
with the appropriate selection marker and, wild type in YPAD) with one colony from 
the plated yeast and grown overnight at standard shaking incubator conditions (Infors 
HT Multitron at 200RPM, 30 °C for all strains except temperature sensitive (TS) strains 
which were grown at 25°C). The following day, the OD600 was measured and the yeast 
was diluted to the desired OD and volume before being returned to standard shaking 
incubator conditions. TS strains were shifted to the restrictive (37°C) temperature for 
1hour to induce TS mutation. 
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2.2.1.9.2 Measuring yeast growth in liquid media 
Yeast concentrations correlate to the optical density (OD) of cultures at a 60 nm 
wavelength.  Yeast cultured overnight obtains very high densities which are outside the 
accurate range of the OD600 /concentration correlation.  In order to more accurately 
record cell density, overnight cultures were diluted 1:10 in the medium they were 
cultivated in.  Cells harvested from the exponential growth phase did not require 
dilution.  Blanks were prepared using uninoculated medium. OD600 was measured using 
an Ultraspec 2100 pro (Amersham Biosciences). 
 
2.2.1.9.3Trichloro acetic acid (TCA) protein preparation from yeast 
6 mL of yeast was pelleted and incubated on ice or at -20°C until all samples for a 
specific experiment had been collected.  The pelleted yeast was lysed in ice-cold 1.85 M 
sodium hydroxide and 7.6% beta-mercaptoethanol and incubated on ice for 10 minutes.  
An equal volume of 50% TCA solution was then added.  Then samples were incubated 
for 10 minutes on ice to allow for proteins to precipitate.  Samples were pelleted at 4°C, 
washed in ice-cold acetone and pelleted again.  10µLof 1M Tris pH 7.5 was then added 
to the samples.  Finally, samples were resuspended in 3x reducing SDS sample buffer or 
Novex Tricine SDS Loading buffer and boiled for 5 minutes at 95°C.  These samples 
could be loaded directly on a gel.  Alternatively these samples could be stored at -20°C 
until such a time as they could be thawed/boiled (5 minutes 95°C) and loaded on a gel. 
 
2.2.1.9.4Freezer Mill preparation of proteins from yeast 
Yeast was grown in liquid culture then pelleted and resuspended in nondenaturing lysis 
buffer for yeast (2 mM OPT, 10 mM IAA, 50 mM Tris pH 7.4, 250 mM NaCl, 10% 
(v/v) glycerol, 0.1% NP40, complete protease inhibitor (5x excess)).  The resuspended 
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yeast was flash frozen in a drop-wise manner in liquid nitrogen.  In this form yeast was 
either lysed immediately or stored at -80°C for up to 4 days before lysis.  Upon removal 
from -80°C storage, yeast was returned immediately to liquid nitrogen then lysed using 
the Freezer Mill 6770 Spex Sample Prep precooled with liquid nitrogen with the 
following settings: 4 cycles with a 1 minute precool, 2 minute run, 1 minute cool time, 
and 5CPS rate.  The yeast was then thawed on ice and diluted with fresh lysis buffer.  
Protein concentration was measured using the Bradford Assay and samples were 
adjusted with lysis buffer such that all samples within one experiment were of 
equivalent concentration.    
 
2.2.1.9.5Genomic DNA preparation 
In order to prepare genomic DNA from yeast, 5mL of the appropriate selective media 
was inoculated with the target strain and grown overnight in a shaking incubator under 
standard conditions.  The stationary phase culture was then centrifuged at 2791 x g for 5 
minutes and the supernatant was discarded.  The pellet was resuspended in 1mL of 
TE1X, transferred into a microcetnrifuge tube, and pelleted at 17000xg  for 1min in a 
RT benchtop centrifuge.  The yeast pellet was combined with 200µL of DNA extraction 
buffer, approximately 0.3g of acid-washed glass beads (Sigma), and 200µL of 
biophenol (BDH) and vortexed for 4 minutes to break up the DNA.  Then 200µL of TE 
1X was added and the tubes were centrifuged at 17000xg for 5minutes at room 
temperature (RT) in the desktop centrifuge. DNA was precipitated from the aqueous 
phase with 1mL of ice-cold 100% ethanol.  The tubes were then incubated at -20°C for 
30 minutes.  The solution was centrifuged at 17000xg for 2 minutes at RT and the 
supernatant was discarded.  The DNA pellet was washed with 1mL of ice-cold 70% 
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ethanol and centrifuged again at 17000xg for 2 minutes at RT.  The ethanol supernatant 
was again discarded.  The pellet was allowed to dry under the hood for 10-15 minutes at 
RT before being resuspended in 50µL of MilliQ water.  The DNA/water solution was 
allowed to stand at RT for approximately 10 minutes before concentration was 
measured by nanodrop and DNA was frozen at -20°C until needed.                                                        
 
Figure 2.1.  Homologous recombination of PCR products into yeast. 
 
2.2.1.9.6Long yeast transformation protocol for homologous recombination 
Conveniently, the single deletions of all genes we sought to make double deletions of 
for this project were already within the Kurz laboratory library.  Two deletion strains 
could therefore be grown and a PCR based method could be used to amplify and 
transform one deletion into a background strain bearing the other deletion and thereby 
generate the double deletion strain (Figure 2.1). 
 
A::X B 
A B::Y 
1. Prepare genomic DNA from strain A::X 
2. PCR amplify A::X from the genomic DNA 
3. Confirm amplification with a DNA gel 
4. Purify PCR product 
5. Long transformation of purified A::X into strain B::Y 
6. Confirm deletion using double selective media for X and Y 
and/or PCR amplification of genomic DNA 
Strain A::X 
Strain B::Y 
A::X B::Y 
Strain A::X, B::Y 
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In order to accomplish this, the genomic DNA of the mutant strain was first prepared. 
The resistance cassette which replaced the gene of interest was amplified via PCR along 
with ~250bp of the 3’UTR and 5’UTRs immediately adjacent to the gene. The PCR 
product was then pooled and purified. The strain where the gene was to be deleted was 
grown in 5mL of the appropriate yeast media overnight shaking at 30°C.  The culture 
was then diluted 2mL into 50mL and allowed to grow to exponential face (OD600 0.4-
0.8).  The yeast was harvested via centrifugation at 1570 x g for 5 minutes at RT.  The 
supernatant was discarded and the pellet was resuspended in 500µL of Lithium acetate 
(LiAC) mix.  Salmon Sperm DNA was boiled for 5 minutes prior to transformation.  
For each transformation, 100µL of the yeast/LiAC Mix is combined with 30µL of the 
purified PCR product, 10µL salmon sperm DNA and 700µL of PEG mix.  The mixture 
was then allowed to rotate at RT for 30 minutes.  The yeast was subsequently heat 
shocked for 15 minutes at 42°C and centrifuged at 9000 x g for 2 minutes at RT.  The 
pellet was resuspended in 200 µL YPAD and allowed to incubate rotating at RT for 2-3 
hours.   
 
The yeast was then plated on the appropriate restrictive media and allowed to grow for 
several days at the appropriate temperature.  Of the colonies that grew following 
transformation, 6-8 were restreaked on the appropriate double restrictive media agar to 
confirm that the yeast really carried the double deletion. For important strains, this 
confirmation was augmented with PCR amplification of the deleted gene to prove that 
homologous recombination was successful. 
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2.2.1.9.7Transformation of plasmids into yeast 
Plasmids can be simply inserted into yeast by combining a mixture of 85 µL of One 
Step Buffer (250mM lithium acetate, 47% (w/v) polyethylene glycol 3550) with 
100 mM DTT, 50 ng of plasmid DNA and 50 µg of freshly boiled salmon sperm DNA.   
The mixture was inoculated with a colony of the appropriate parental strain.  The 
mixture was then vortexed and incubated for 30 minutes at 45°C.  The yeast was plated 
immediately following heat shock on the appropriate restrictive media.  Colonies were 
allowed to grow at 30°C.  Resulting colonies are restreaked on plates with the 
appropriate selective media.  For TS strains, the only difference is that once plated, the 
yeast is allowed to grow at 25°C and 6 colonies are subsequently restreaked onto two 
plates.  One plate is allowed to grow at the permissive temperature (generally 25°C).  
The other is grown at the restrictive temperature 37°C.  The strain grown at the 
permissive temperature should grow while the yeast grown at the restrictive temperature 
should die.  If this phenotype is not observed, then there has been an secondary 
mutation that eliminates the temperature sensitivity of the strain. 
 
2.2.1.9.8 Preparation of yeast glycerol stocks 
Approximately 3mL of YPAD was inoculated with the yeast to be frozen and allowed 
to grow overnight typically at 30°C (TS strains 25°C). Of that culture, 1mL was 
combined with 1mL of 50% sterile glycerol in a cryovial and frozen at -80°C.  Strains 
were restreaked from these stocks onto plates of the appropriate restrictive media.   
 
2.2.1.9.9 Collection of yeast samples 
To obtain samples of different strains growing in the exponential phase, 5-10 mL of the 
appropriate restrictive media or YPAD was inoculated with yeast and allowed to grow 
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overnight (generally 30°C, TS strains 25°C).  Strains were then diluted to an OD600 
between 0.2-0.4 and allowed to at least double before 3-6 mL was collected with an 
OD600 between 0.4-0.8.  Samples were pelleted and the supernatant was discarded.  The 
yeast pellet was either TCA precipitated directly or frozen at -20°C for 1-3 days before 
TCA precipitation. 
 
In experiments where collection was required at various time points, we similarly 
inoculated a preculture and grew it overnight.  The yeast was then diluted to an OD600  
of 0.2 and allowed to grow to an OD600 of 0.4.  Strains were then treated (ex. galactose 
induction, cycloheximide treatment, or addition of MG132). 
 
To grow yeast in liquid culture, 5-10mL of the appropriate liquid media was inoculated 
with yeast from the agar plate.  This preculture was grown overnight at the appropriate 
temperature (generally 30°C, TS strains 25°C).  The following day, precultures were 
diluted to an OD of 0.2-0.3 in the desired volume of media. For overexpression chases 
this volume was typically 50 mL while for strains that were being harvested purely for 
WB analysis of untreated exponentially growing cells, this volume was typically 10-20 
mL. For the IP experiments this volume could be between 0.5L and 4L.  Cultures were 
returned to the shaking incubator under standard conditions and allowed to at least 
double.  Cultures were collected in exponential phase with an OD600 between 0.4-0.8.  
 
Samples of 3-6 mL were pelleted and TCA precipitated or frozen at -20°C and TCA 
precipitated the following day. 
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Samples ≥0.5 L were spun down at 4°C, 4200 RPM for 2 hours and the OD600 of the 
supernatant was measured to confirm that the majority of yeast was in the pellet (OD of 
0.1 or less for the supernatant).  The supernatant was then discarded.  The pellet was 
resuspended in 5-8 mL of water and transferred to a 50 mL centrifuge tube.  The yeast 
was then repelleted in an Eppendorf centrifuge at 4000 RPM and resuspended in yeast 
lysis buffer. Samples were flash frozen in liquid Nitrogen and either lysed directly by 
freezer mill or stored at -80°C overnight and lysed the following day by freezer milling.  
 
2.2.1.9.10 Proteasome inhibition in yeast with MG132 
In order for the proteasome inhibitor MG132 to pass through the cell walls of the strains 
of interest, the drug pump pdr5 gene was deleted.  A 5-10mL preculture was inoculated 
and grown at standard conditions in the shaking incubator.  Yeast was then diluted to an 
OD600 of 0.2 and allowed to grow under standard shaking incubator conditions.  At 
OD600 of ~0.5, cultures were split in half.  One half was treated with 50 µM MG132 and 
the other with an equivalent volume of DMSO. Cultures were allowed to grow for an 
additional hour at standard shaking incubator settings before being harvested, TCA 
precipitated, resuspended in 3x reducing sample buffer and run on SDS-PAGE. 
 
2.2.1.9.11 Galactose induced overexpression chase assay 
Yeast carrying pYES2 galactose inducible plasmids were grown in the appropriate 
restrictive raffinose based media (SRaff- - URA).   As raffinose is the most preferred 
sugar available in this media, the Gal promoter is not activated and the protein coded for 
by the plasmid is not expressed.  Further the the Ura drop out allows for selection of 
yeastcarrying the plasmid. When the culture reaches an OD600 of ~0.4, expression of the 
protein is induced through addition of 2% final (v/v) galactose for 1 hour.  An aliquot is 
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then saved as time point zero and expression is shut off by addition of 2% glucose.  As 
glucose is a more preferred sugar, the Gal promoter is shut off and protein expression 
from the plasmid is ceased.  At various time points thereafter samples were collected.  
All samples from a single time course were TCA precipitated and resuspended in 
sample buffer concurrently.   
 
To chase protein levels in these samples, they were run on SDS-PAGE, transferred to 
nitrocellulose membranes and then Western blotted against the protein or the tag on the 
protein as indicated. 
 
2.2.1.9.12 Cycloheximide chase assay 
Cycloheximide is a drug that can inhibit ribosomes.  It is used to stop translation and 
determine stability of various proteins.  In order to use this drug on enogenous yeast 
proteins, strains were grown in rich media until reaching an OD600 of ~ 0.6. Then the 
culture was split in half.  One half was treated with cycloheximide at a final 
concentration of 35 µg/mL and one half was treated with an equal volume of the vehicle 
control. Samples are collected at various time points after drug treatment and compared 
for Rub1 levels.  For overexpression chase assays tested with cycloheximide treatment, 
the continued accumulation of the construct in WB of the vehicle control compared to 
the stability of Rub1 following cycloheximide treatment was used as a control for drug 
efficacy.  However in treatment of non-overexpressed protein, the growth curve was 
used as a positive control.  The sample treated with the ribosomal inhibitor does not 
continue to double while the sample treated with vehicle control continues to grow.  
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2.2.1.9.13 Near endogenous Rub1 level comparisons 
Yeast was grown to exponential phase in the appropriate media under standard shaking 
incubator conditions.  Then an aliquot was harvested, TCA precipitated, resuspended in 
sample buffer and then run on 4-12% Bis-Tris gels, transferred to nitrocellulose 
membranes, and Western blotted against Rub1 or HA as indicated. 
 
2.2.1.10 Common cell culture protocols 
Both U2OS and HCT116 cells were grown in DMEM supplemented with 10% (v/v) 
FBS, 1% (v/v) penicillin/streptomycin, 2mM L-Glutamine.  Cells were grown in T-75 
flasks at 37°C under 5% CO2 atmosphere and split when they reached 80-100% 
confluency.  
 
2.2.1.10.1 Splitting cells 
Medium was aspirated and cells were washed in prewarmed DPBS to remove residual 
medium. Cells were trypsinized using 3 mL of 0.05% Trypsin-EDTA for approximately 
2 minutes.  Cells were then diluted into fresh, prewarmed medium and seeded in new 
flasks to the desired density (typically cells were diluted 1:4).  
 
2.2.1.10.2 Small interfering RNA (siRNA) transfection of cultured cells 
In order to knockdown gene expression in cultured human cancer cells, siRNA was 
used.  These oligomers interfere with the expression of genes bearing complementary 
nucleotide sequences.  Therefore treating cells with UCHL3 siRNA should result in the 
specific silencing of that gene.  
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HCT116 and U2OS cells were grown in DMEM supplemented with 10% (v/v) FBS, 1% 
(v/v) penicillin/streptomycin, 2mM L-Glutamine and plated at a density of 
approximately 1.2 million cells/100 mm dish and allowed to grow overnight. Typically, 
gene expression was knocked down using 20 nM siRNA so that will be used as the 
standard protocol example.  In order to have a final volume of 4 mL at 20 nM siRNA, 
siRNA is diluted to 400nM in optimem. 195 µL optimem is mixed with 5 µL 
lipofectamine RNAiMAX.  Equal volumes of these two mixtures are then mixed and 
well and allowed to incubate for 20-30 minutes.  Then the 
siRNA/lipofectamine/optimem mixture is combined with media (400 µL/3600 µL) and 
added to the plate.  The plate is then returned to the incubator and allowed to grow for 
the prescribed time (usually 72 hours) before harvesting for downstream testing (WB, 
FACS, or IP). 
 
2.2.1.10.3 Flourescence activated cell sorting (FACS) 
Cells destined for FACS analysis were grown in 10 cm dishes and treated with siRNA 
as indicated.  Following the knockdown of target genes, samples were collected by 
trypsinization.  Samples were then pelleted by centrifugation at 1000 RPM 4°C for 10 
minutes.  Media was removed and the pellet was washed with ice cold PBS.  Cells were 
again pelleted.  The pellet was vortexed as 1 mL of 70% ethanol was added drop-wise 
to the pellet.  The samples were allowed to stand at -20°C for approximately 1 week.  
Cells were again pelleted using the same settings and washed twice with ice cold PBS.  
The cells were then resuspended in 300-500µL of staining buffer (50µg/mL propidium 
iodide, 50µg/mL ribonuclease A, in 1%BSA in PBS).  The samples were transferred to 
FACS tubes covered in aluminium foil and protected from light at room temperature for 
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20-30 minutes.  With the assistance of Dr. Yann Thomas, cells were analysed by flow 
cytometry using a FACS Calibur (Becton Dickinson) controlled using a Mac computer 
with Cell Quest data acquisition software.  Results were analysed using FlowJo 
software. 
 
2.2.1.10.4 MLN4924 treatment of cultured cells 
MLN4924 is a selective inhibitor of the NAE and therefore the neddylation machinery 
in general (Milhollen et al., 2010; Smith et al., 2012). Cells were treated with either 
2 µM MLN4924 or the equivalent volume of DMSO control for 8 hours.   
 
2.2.1.10.5 Lysis of cultured cells 
Cultured cells were lysed in several ways.  First, and most preferably if samples were to 
be immediately run on SDS-PAGE, cells were lysed by direct addition of hot 3x 
reducing sample buffer.  Cells were then scraped off in this buffer and DNA was 
fragmented by repeatedly flowing through a syringe. Samples were boiled for 5 minutes.  
Cells to be used for other downstream experiments such as pulldowns or IPs, were 
typically lysed in one of two ways.  First, cells could be harvested by trypsinization 
washed with PBS and then lysed by adding lysis buffer and incubating on ice for 5-10 
minutes while DNA was fragmented using a syringe.  Second, cells could be harvested 
by placing the plates on ice, aspirating the media, washing cells with ice cold PBS and 
then adding ice cold lysis buffer and scraping cells off of the plate. The lysis buffer 
based lysis techniques required that the samples then be clarified at 17000 x g, 4°C for 
15 minutes to remove cell debris.  Either the whole or part of the sample was then 
destined for SDS-PAGE and was diluted with 3x reducing sample buffer and boiled for 
5 minutes.  The concentration of the lysate was determined with the BCA assay. 
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2.2.1.10.6 Check for degradation 
Although a tool exists for purification of polyubiquitylated proteins (TUBES(Hjerpe et 
al., 2009)) there is currently no such tool for neddylated proteins.  It would be especially 
useful to develop such a tool given current confusion in the literature over genuine 
endogenously neddylated proteins.  Towards this end, Dr. Roland Hjerpe, the inventor 
of the TUBEs system, developed the theory required for the NEDD8affinity matrix 
(NAM).  In order to circumvent the significant similarity between ubiquitin and 
NEDD8 and specifically target only neddylated proteins, Dr. Hjerpe posited that it 
might be possible to use a catalytically inactive form of NEDP1 (NEDP1 C163A) to 
pull on neddylated proteins.  This system makes use of the high specificity NEDP1 has 
for NEDD8 thereby excluding ubiquitin.   
 
First to confirm that such a construct pulled on NEDD8 but not ubiquitin, GST-NEDP1 
C163A was used to specifically pulldown NEDD8 from an in vitro mixture of purified 
NEDD8 and ubiquitin.  Dr. Hjerpe also performed a pilot experiment to see if such a 
construct could pull down neddylated proteins from cell lysate.  I took over the project 
at this point and worked with various tags and attempted various protocol alterations to 
enhance the effectiveness of the matrix. All resin was preequilibrated with the 
appropriate lysis buffer and incubated on ice prior to the addition of any protein. 
 
In order to use a GST tagged NAM, HCT116 cells were grown to confluency then lysed 
in a Lysis bufferA containing the probe protein (either GST, GST-NEDP1 C163A, or 
His-HA-GST-NEDP1 C163A).  These lysates were clarified in a desktop centrifuge for 
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30 minutes at 4°C and high speed.  Protein concentrations were determined using the 
Bradford Assay.  Proteins were diluted such that the same quantity of protein was 
loaded for each point.  In initial experiments, proteins were precleared on control 
agarose for 1 hour but in later work this was increased to 3 x 20 minutes on control 
agarose in order to reduce nonspecific binding of neddylated and ubiquitylated proteins 
to the final resin.  The type of resin selected for each experiment depended upon the 
type of NAM tag. For the GST tagged NAM, Glutathione agarose beads were used and 
GST alone was used as a control.  For the HA tagged NAM, mouse monoclonal anti-
HA agarose beads (Sigma) were used and vehicle (Ubiquigent buffer) was used as a 
control.  Proteins in lysis buffer A containing 5µM of thepurified NAM protein was 
incubated on the appropriate beads for 1-3 hours at 4°C.  Beads were then washed three 
times with NAM wash buffer (50mM Tris, 150mM NaCl, pH 8.0) or DPBS and then 
eluted by heating the beads in a volume of Laemmli buffer equivalent to the bed volume.   
 
To ascertain the relative success of these techniques the samples were run on 4-12% 
Bis-Tris SDS Page gels and transferred to nitrocellulose membranes.  They were 
subsequently blotted for NEDD8 and ubiquitin.   
 
2.2.1.11 Mouse tissue protocols 
2.2.1.11.1 Tissue panel comparisons 
In order to compare the neddylation profile between different tissues, a selection of 
various tissues were tested.  These panels include tissues like heart, brain, testes, liver, 
and kidney.  Samples to be used for tissue panels were lysed by Esther Sammler and 
then subsequently resuspended in denaturing sample buffer (samples for other uses 
were prepared by me and not immediately placed in sample buffer).  SDS-PAGE was 
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performed using 4-12% Bis Tris gels.  Proteins were then transferred to nitrocellulose 
membranes and Western Blotted using either Mil10 or Epitomics anti-NEDD8 
antibodies. 
 
2.2.1.11.2 Tissue lysis 
Tissue lysate was prepared in RIPA buffer using a benchtop tissue homogenizer 
(Kinematica polytron PT 1200 E). Homogenized tissue was kept on ice for 15-30 
minutes and passed through a precooled syringe several times.  Homogenates were then 
clarified at high speed (17000 x g) at 4°C for 15 minutes.  Protein concentration was 
identified using the BCA assay and samples were aliquotted into precooled eppendorf 
tubes, snap frozen in liquid nitrogen, and stored at -80°C until needed.  When tissues 
were removed from storage they were allowed to thaw on ice.   
 
2.2.2 Immunoprecipitation 
All resins were preequilibrated with the appropriate lysis buffer and cooled on ice 
before protein was added to them.  Samples were prepared for immunoprecipitation in a 
nondenaturing buffer (ex. RIPA buffer), as described in the relevant sections above 
(yeast, Section 2.2.1.9.4 ; cultured cells,Section 2.2.1.10.5; tissues, Section 2.2.1.11.2). 
Samples were either used directly after preparation or were stored at -80°C until needed 
and then thawed on ice in the cold room.   
 
2.2.2.1 Native immunoprecipitation of yeast HA-Rub1 
Each strain carrying HA-Rub1 to be immunoprecipitated was grown to exponential 
phase in 2-4 L (depending on the experiment) of the appropriate restrictive media (SD-
His).  The yeast was then pelleted by ultracentrifugation and washed with water before 
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being resuspended in nondenaturing lysis buffer for yeast (2 mM OPT, 10 mM IAA, 
50 mM Tris pH 7.4, 250 mM NaCl, 10% (v/v) glycerol, 0.1% NP40, complete protease 
inhibitor (5x excess)) and flash frozen in liquid nitrogen. Frozen yeast was lysed by 
freezer milling under standard conditions.  The frozen yeast powder was then thawed on 
ice and clarified at high speed (1700 x g) at 4°C for 20 minutes.  Protein concentration 
was determined with the Bradford method. Yeast proteins were then diluted to 
approximately 140 mg of protein in 50 mL of lysis buffer and a small fraction was 
saved as input at this point.  The remainder was precleared on 600 µL of control agarose 
beads for 2 hours while protected from the light.  The control agarose beads were 
pelleted and the protein was transferred to a new 50 mL tube and incubated with 300 µL 
of mouse monoclonal HA agarose beads (Sigma) for 10-16 hours.  The flow through 
was collected by centrifugation.  Beads were washed using a graded series of wash 
buffers of different salinity in the following order: Yeast IP wash buffer A, B, C, B, A. 
All washes were 10mL for 10 minutes while rotating.   
 
Proteins were eluted by addition of 8 M urea (3 x 300 µL shaking at 37.5°C on an 
eppendorf thermomixer at 300 RPM).  The beads were then resuspended in 8 M urea 
and split into two.  The beads were pelleted again and the urea based supernatant was 
collected and added to the pool of the first three urea elutions.  One half of the 
remaining beads was boiled in 3 x reducing sample buffer while the other half was 
boiled in 4x nonreducing sample buffer for 5 minutes.  The urea elution pool was 
centrifuged again to remove any possible beads that might have been aspirated by 
accident.  An Amicon Ultra “ultracel 5K” (Millipore) was pre-wet with200 µL of 8 M 
urea and then the urea elution pool was added to it.  The spin filter was spun at 3100 x g 
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for 40 minutes in the eppendorf centrifuge at 4°C.  There was about 70 µL final urea 
elution volume and 35 µL of reducing sample buffer was added to it.  The urea elution 
pool was then boiled at 95°C for 5 minutes.  Samples were frozen at -20°C overnight.   
 
A small amount of the samples (5%) was run on a mini 4-12% BisTris gel (Invitrogen), 
transferred to a nitrocellulose membrane and blotted with the HA-HRP antibody.  The 
remainder of the samples was run on a large homemade 10% gel to separate proteins 
between 25 and 250 kD.  This gel was silver stained and bands from all three elution 
conditions were cut for mass spectrometric analysis. 
 
2.2.2.2 Native immunoprecipitation of untagged proteins 
For native/non-denaturing immunoprecipitation of non-crosslinked antibody against 
untagged protein, proteins were precleared 3 x 20 minutes on control agarose (Sigma) 
then loaded onto protein G agarose along with the desired quantity of antibody (this 
amount will be noted in all associated figure captions).  This mixture was incubated in 
the cold room for 1 hour to overnight.  The beads were washed using the following 
series of buffers: 3 x lysis buffer, 1 x water, 1 x lysis buffer.  Protein was then eluted 
from the beads by addition of 3x reducing sample buffer and boiled at 95°C for 5 
minutes.  The beads were then pelleted and the supernatant could be used for SDS-
PAGE. 
 
2.2.2.3 Denaturing immunoprecipitation 
All denaturing mammalian IPs were done following the procedure established by 
LeonandHaguenauer-Tsapisas adapted fromKragt et al., 2005,the only exceptions being 
that 200 mM OPT and 100 mM IAA were added to all 6 buffers and washes were done 
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for 3-5 minutes with gentle rotation.  Elution from resin was accomplished by direct 
addition of a volume of 3x sample buffer followed by boiling at 95°C for 5 minutes.   
 
2.2.3 Mass Spectrometry (MS) 
All samples analyzed using mass spectrometry (MS) were collected by in gel digestion 
from silver or Coomassie stained polyacrylamide gels. 
 
In-gel protein alkylation and digestion of silver stained gel slices 
Bands were extracted from silver stained polyacrylamide gels using a stringently 
cleaned scalpel, cut into small fragments, and deposited in individual Eppendorf tubes.  
Gel slices were washed 3 times with milliQ water.  Silver staining was reduced with 
Farmer’s Reducer (30 mM Potassium hexacyanoferrate (III), 30 mM sodium 
thiosulphate (made up fresh)) for 5 minutes then washed with MilliQ water until gel 
pieces became clear (typically 3 times 5 minutes).  Samples were equilibrated with 
100 mM ammonium bicarbonate (ABC) (Fluka) for 20 minutes with gentle agitation, 
washed with 50mM ABC/50% acetonitrile (ACN), and rinsed with ACN (Millipore).  
The supernatant was removed and samples were allowed to air dry (for approximately 
20 minutes).  Samples were reduced with 10mM dithiothreitol (DTT) (Formedium) in 
100mM ABC for 30 minutes at 56°C.  DTT was discarded and samples were alkylated 
with 50mM iodoacetamide (IAA) (Sigma) in 100mM ABC for 30 minutes at room 
temperature in the dark.  Gel slices were then washed twice with 50mM ABC/50% 
ACN for 15 minutes shaking at 500 RPM on an eppendorf thermomixer. Samples were 
then rinsed with 100% ACN and dehydrated with 500µL 100% ACN for 20 minutes 
with gentle agitation.  Samples were digested in 0.02 µg/µL sequencing grade modified 
trypsin (Promega) in 50mM ABC for one hour on ice followed by 37°C overnight at 
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500RPM.  The supernatant was saved.  To maximize peptide collection from the gel 
slices, samples were then sonicated in gel extraction buffer (5% formic acid, 50% ACN) 
for 15 minutes.  The gel extraction step was repeated 3 times.  The supernatant pool was 
precooled on dry ice before being dried by a Savant SPD131 DDA SpeedVac 
Concentrator (Thermo).  Samples were then cleaned on C18 columns (Nest Group). 
 
In gel alkylation and digestion of Coomassie stained gel slices for mass spectrometry 
Bands from polyacrylamide gels with Coomassie staining could be similarly picked 
with a scalpel and cut into fine pieces.  These gel slices were washed with water, then 
50% ACN, then 0.1 M ABC, then 50%ACN/50 mM ABC.  The gel slice was then 
reduced using 10mM DTT/0.1 M ABC at 37C for 20 minutes and in gel alkylated using 
50 mM IAA/0.1 M ABC in the dark for 20 minutes at RT.  Gel pieces were then washed 
with 50 mM ABC followed by 50 mM ABC/50% ACN. If the gel bands were not 
colourless at this point, the last wash was repeated as long and as often as necessary 
(usually only 2 washes with the 50 mM ABC/50% ACN was needed).  Once colourless, 
the gel pieces were dehydrated with ACN for 15 minutes.  The supernatant was 
removed and the pieces were Speed-Vaccumed to dryness.  The gel pieces were then 
swollen in 25 mM Triethylammonium bicarbonate (TEABC) containing 5 µg/mL of 
sequencing grade modified trypsin (Promega).  Gel slices were then allowed to incubate 
at 30°C for 30 minutes.  If any gel slices were completely dry at that point, more 
TEABC mixture was added and slices were reincubated.  Care was taken to standardize 
the amount of trypsin added between equivalent control and experimental slices.  Once 
all gel pieces had been rehydrated with the trypsin mixture, they were incubated at 30°C 
overnight in the thermomixer.  The following morning, the supernatant was collected 
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and dried in the SpeedVac.  Gel extraction buffer was added to the gel slices and they 
were sonicated for 3 x 15 minutes in order to maximize peptide yield.  The collected 
supernatant was added to the tubes with the dried peptides and again dried in the 
SpeedVac.  Samples were then cleaned on C18 columns. 
 
C18 clean up 
In order to remove contaminants and errant gel particulates, peptides obtained from in-
gel digestion were resuspended in 1% TFA and cleaned on a microspin C18 silica 
column (Nest group).  All spins were done at low speed (~100 x g) on a tabletop 
centrifuge.   Per manufacturer’s instructions, columns were prequilibrated by washing 
three times with ACN.  Samples were loaded onto the columns and then washed 3 times 
with 0.1% trifluoroacetic acid (TFA) in milliQ.  Peptides were eluted with 0.1% TFA in 
50% ACN then dried using a Savant SPD131 DDA SpeedVac Concentrator (Thermo).   
 
Yeast peptide MS/MS and data analysis 
For the yeast work, MS samples were prepared from silver stained gels and submitted to 
Van Kelly, Kshitiz Tyagi, and Patrick Pedrioli.Van Kelly was in charge of running and 
analysis of these samples while Kshitiz Tyagi and Patrick Pedrioli assisted with 
development of the approach, protocols, and general MS information.  MS/MS was 
performed on an Orbitrap Velos ETD (Thermo). MS data was searched against SGD 
yeast protein database concatenated to a reversed sequence databased using XTandem! 
with the k-score plugin.  Results were validated using the Trans Proteomic Pipeline 
(TPP) and proteins were filtered at a 1 percent false discovery rate. We then sorted the 
resulting hits based on strength and connection to the NEDD8 or ubiquitin pathways as 
well as possible connection to unique pathways. 
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Mouse testes peptide MS/MS and data analysis 
Mammalian samples were prepared from Coomassie stained gels and submitted to 
David Campbell, facility manager of the Proteomics and Protein Chemistry Service of 
the University of Dundee. Mass spectrometric analysis was performed by LC-MS-MS 
using a Proxeon EASY-nLC system coupled to a linear ion trap-orbitrap hybrid mass 
spectrometer (LTQ-Orbitrap, Thermo Fisher Scientific) equipped with a 
nanoelectrospray ion source (Thermo).  Peptides were injected onto a Dionex (Part 
No.160321) Acclaim PepMap100 reverse phase C18 3µm column, 75µm x 15cm, with 
a flow of 300 nl/min and eluted with a 40 min linear gradient of 95% solvent A (2% 
Acetonitrile, 0.1% formic acid in H2O) to 50% solvent B (90% acetonitrile, 0.08% 
formic acid in H2O). The instrument was operated with the “lock mass” option to 
improve the mass accuracy of precursor ions and data were acquired in the data-
dependent mode, automatically switching between MS and MS-MS acquisition.  Data 
were analysed by searching the SwissProt/Mouse database using the Mascot search 
algorithm (http://www.matrixscience.com) on an in-house system. 
 
Hits were filtered for peptide scores higher than 28 (p<0.05) indicative of identity or 
extensive homology.  Common contaminants (keratin, BSA, IgG) were eliminated.  The 
remaining hits were analyzed by searching for known pathway members.  Connections 
between identified hits were also analyzed using both DAVID 
(http://www.david.abcc.ncifcrf.gov/home.jsp) and STRING (http://www.string-db.org/), 
publically available software for analyzing gene ontology (GO) terms. Pathways 
revealed by DAVID or STRING GO analysis and repeated high scoring hits were then 
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searched for on the Gene Ontology AmiGO (http://www.amigo.geneontology.org). The 
Gene Ontology AmiGO gives a list of reported interaction partners.  The spectra 
matching our quality control parameters were then queried for the possible interaction 
partners identified using the Gene OntologyAmiGO.The reason for this added database 
search was to reveal possible pathway members that might not be recognized using the 
other search algorithms.  
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Chapter 3: Neddylation system regulation in Saccharomyces cerevisiae. 
 
3.1 Introduction 
Our initial aim was to identify NEDD8 substrates and regulatory mechanisms in 
Saccharomyces and subsequently confirm these findings in mammalian cells. We had 
planned to use overexpression as a preliminary technique for substrate identification. 
However, previous results have shown that such overexpression resulted in 
misactivation of Rub1 by the UAE and conjugation through the ubiquitylation system. 
We have therefore reported that NEDD8 overexpression results in atypical UAE 
dependent neddylation in both mammalian cells and yeast (Hjerpe et al., 2012a; Hjerpe 
et al., 2012b).  
 
This observation opened up two unique problems. First, how was free NEDD8/Rub1 
regulated to prevent atypical neddylation? We believe that the means by which free and 
conjugated NEDD8/Rub1 is regulated is central to resolving this question. Second, 
could we identify non-cullin proteins neddylated via NEDD8/Rub1 pathway enzymes at 
endogenous or near endogenous levels?  
 
3.2 Selection of Saccharomyces cerevisiae as a model system 
Baker’s yeast has the unique distinction of being the only known eukaryote where the 
NEDD8 homolog, Rub1, is nonessential (Sela, 2012). This allows us to use Rub1 
deletion strains that would not be viable in other organisms. Furthermore, many useful 
tools were available for use in such a project such as the yeast gene deletion library and 
straightforward genetic manipulation.  
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3.2 Rub1 degradation technique selection 
In order to better understand how the two systems were insulated from one another, we 
decided to investigate the mechanism by which Rub1 was turned over. NEDD8 and 
ubiquitin share significant similarity. For this reason we theorized that there must be 
some specific means of degrading Rub1 and ubiquitin independently. Due to the 
similarities between their structure and sequence, similar techniques like radioactive 
pulse chase or mutation of the diglycine motif necessary for conjugation have been used 
to study their turnover (See section 1.3.8 Ubiquitin stability and turnover). However, 
unlike ubiquitin, turnover could not be studied using overexpression of conjugateable 
Rub1. This is because alterations in the ratio of NEDD8 to ubiquitin result in charging 
of the ubiquitin E1 with NEDD8 and ultimately atypical neddylation. Conversely, the 
NAE does not charge ubiquitin (Walden et al., 2003). We assumed that such aberrant 
regulation could result in abnormal degradation kinetics. 
 
3.2.1 Tagged Rub1 
Efforts to study the regulation of free Rub1 were hampered by the lack of an effective 
Rub1 antibody for use in WB and IP. Others in the lab had found that commercially 
available anti-Rub1 antibodies cross-react with ubiquitin. We were unable to visualize 
free Rub1 directly on WB. Initially we approached this problem by using tagged Rub1 
while we developed an antibody. 
 
3.2.2 Studying protein turnover in yeast 
In yeast protein turnover is typically studied in one of a few ways: radiolabeled pulse 
chase assay (described in relation to ubiquitin, section 1.3.8.1), the cycloheximide chase 
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assay, and an overexpression chase assay. We made use of the second two methods in 
this project. Not only do such experiments allow us to examine Rub1 turnover, but we 
can also use them to test various strains. In strains lacking a component important for 
Rub1 turnover we would expect degradation to be stabilized. Therefore in identifying 
such strains we can identify components of the degradative pathway. These turnover 
assays can therefore be used to identify genes responsible for the regulation of Rub1 
levels. 
 
3.2.3 Cycloheximide chase assay 
A cycloheximide chase can be and is used to determine the stability of a given protein 
over time by halting protein biosynthesis. Translation of the mRNA into protein by 
ribosomes is inhibited using the drug cycloheximide. Then the levels of the target 
protein are chased over time. The advantage to this technique is that the protein of 
interest does not need to be overexpressed. This technique has been used to effectively 
study ubiquitin turnover in yeast (Hanna et al., 2003).  
 
The disadvantage of the cycloheximide chase assay is that it does not discriminate 
between the mRNA of interest and mRNA in general, but rather stops all ribosomal 
translation. This nonspecificity may generate many off target effects especially over 
longer time courses when proteins that are normally turned over are not re-synthesized. 
One measurable off target effect is the inhibition of the cell cycle. Growth of yeast after 
cycloheximide treatment stagnates. These off target effects are used to confirm that the 
cycloheximide treatment was effective as a growth curve or WB of quickly turned over 
proteins demonstrate the efficacy of ribosome inhibition. These side effects could also 
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indicatethe failure of regulatory mechanisms. This technique is therefore best used if 
substantiated with other methods. After obtaining a Rub1 antibody, we elected to use 
this technique to follow endogenous Rub1 turnover. Due to the possible off target 
effects we also placed this piece of evidence in context by performing several other 
experiments with untagged or endogenous Rub1. 
 
3.2.4 Overexpression chase assay 
The alternative to cycloheximide treatment used extensively in this project is the 
overexpression chase assy. This experimental set up is a sort of modified pulse chase 
where the pulse is overexpression of the protein of interest (in this case Rub1) followed 
by shut off of expression. As with a pulse chase, the presence of the protein in cell 
lysate is then chased over time. In these experiments, overexpression is regulated by an 
inducible promoter like the galactose inducible (GAL) promoter.  
 
In yeast when a gene is under the control of the GAL promoter, that gene is only 
expressed if the most preferable energy source is galactose. Expression is low to 
nonexistent if that yeast is grown in media lacking galactose or if the media has the 
more preferred sugar, glucose. Using a GAL promoter for an overexpression chase 
assay is simple as this sugar-based regulation allows for controlled gene expression. 
(Hopper) 
 
First, the strains of interest are transformed with plasmids carrying the construct of 
interest under the control of the GAL promoter. Then the yeast is grown in media 
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lacking galactose and glucose. Expression is induced by addition of galactose and 
halted by subsequent addition of glucose.  
 
3.3 Advantages to the overexpression chase for Rub1 
In order to pursue this technique with Rub1 we developed a variety of cDNA constructs 
in the pYES2 backbone, putting Rub1 variants under the control of the GAL1 promoter. 
These plasmids were transformed into various yeast strains and the overexpression 
chase assay was then run.  
 
The advantage to this technique was that we could perform it immediately while we 
waited for the Rub1 antibody to become available. Another advantage to this approach 
is that when compared to the cycloheximide chase, this approach has fewer off target 
effects. The disadvantage to the overexpression chase is that it cannot function on 
endogenous levels of protein. Another problem is that overexpression of Rub1 results in 
crosstalk with the ubiquitin system. Furthermore we did not have an antibody against 
endogenous Rub1 so a tag was used until the Rub1 antibody became available. 
 
3.4 Establishing the overexpression chase assay for Rub1 
The Rub1 system posed several unique challenges for studying turnover. Since we did 
not initially have a direct antibody against Rub1, we used a tagged construct while we 
developed that an antibody. We elected to use overexpression so that we could clearly 
visualize and chase Rub1. A GAL1 promoter was used because of the control it gave us 
over overexpression. Since overexpression can force NEDD8 onto the UAE, we used a 
nonconjugateable construct. As with ubiquitin, mutation or deletion of the G75/76 
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diglycine motif abrogates conjugation of Rub1. We have tested both the deletion of this 
motif and the mutation to dialanine and have observed the same trends with both. When 
overexpressing conjugateable Rub1 we observed consistent clear accumulation of free 
Rub1 after one hour and accumulation of most UAE dependent Rub1-conjugates appear 
after that point. We therefore only overexpressed nonconjugateable Rub1 for 1 hour to 
minimize off target effects.  
 
3.4.1 Tag selection 
We made use of both single and triple N-terminal HA tags. We selected the HA tag as it 
is short (9 residues: YPYDVPDYA), unstructured, not targeted by the N-end rule, and 
would allow for easy detection and immunoprecipitation of HA-Rub1. We also 
attempted to use GFP tagged Rub1 but this was not efficient. Furthermore there would 
be questions over the viability of any data observed using such a tag, as it is 
approximately 3 times larger than NEDD8 itself. Nonetheless, two of the three yeast 
cullins are clearly neddylated by GFP-Rub1 following overnight overexpression in 
galactose containing media. Prior to my arrival in the lab HA-6xHIS-Rub1 was also 
utilized for work with endogenous Rub1 turnover and proteasome inhibition.  
 
3.4.2 Plasmid selection 
A galactose inducible promoter was selected as a means of specifically regulating Rub1 
expression in initial screening while minimizing off target effects. Tagged Rub1 was 
inserted into the pYES2 vector. The pYES2 vector bears the 2µm origin of replication 
allowing for episomal maintenance of high plasmid copy numbers (10-40 copies/cell). 
This backbone also carries ampicillin resistance for selection of bacteria carrying the 
plasmid as well as the uracil biosynthesis gene URA3 for selection of transformed yeast 
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(2009). Overexpression of either 3HA-Rub1∆GG or HA-Rub1 G75/76A was induced 
with galactose for one hour and then shut off of by addition of glucose.  
 
3.4.3 Time course for overexpression chase assays 
We followed a simple procedure to observe the degradation profile of 3HA-Rub1∆GG 
or the dialanine equivalent. We overexpressed the protein for one hour. We chose a 
short expression time for two reasons. First it was to minimize artifacts as most 
overexpression conjugates observed using the conjugatable HA-Rub1 appear after that 
time and we reasoned that off target effects might be more likely following that time. 
Second we selected one hour because using the conjugateable form of HA-Rub1, free 
Rub1 is clearly and consistently visible after 1 hour of expression. We shut off 
expression by direct addition of glucose and collected samples at various time points for 
analysis of HA-Rub1 levels. Samples were prepared for SDS-PAGE using the TCA 
technique. Samples were run on SDS-PAGE then transferred from the resultant gel to a 
nitrocellulose membrane that was then used for WB. When a component of the 
degradation pathway is impeded, the degradation of the construct should also be 
impeded. In such an instance, HA-Rub1 is neither produced, because we have shut off 
expression, nor degraded, because we have eliminated an essential member of the 
degradation machinery. In such cases, the construct should appear to stabilize on WB. 
 
3.5 Ubiquitin Proteasome System (UPS) mediated degradation 
 
3.5.1 UPS dependence 
Using this overexpression chase technique in wild type yeast reveals that 
nonconjugateable 3HA-Rub1∆GG is degraded readily with significant decreases visible 
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by 15 minutes (Figure 3.1). This is in agreement with current opinion that NEDD8 is 
cleared quickly (Hipp et al., 2004). 
 
3.5.2 Proteasome dependence 
There are two main degradative pathways—the vacuole/lysosome and the proteasome. 
The yeast equivalent of the lysosome is known as the vacuole. Although when 
compared to the lysosome the vacuole has increased functions, such as storage, it still 
fills an important role in protein degradation (Armstrong, 2010). In yeast the main 
initiator peptidase of the vacuole is known as Pep4 (Liao et al., 2005). In a strain 
deleted for Pep4 degradation of 3HA-Rub1∆GG is not impeded (Figure 3.1 A). This 
indicates that degradation is not proceeding in a vacuole dependent manner.  
 
Inhibiting the proteasome provides a similar test case for UPS mediated degradation. 
The peptide aldehyde MG132 is a potent proteasome inhibitor (Liu et al., 2007). In 
order for yeast to take up this drug, the drug pump pdr5gene must first be deleted in the 
strains of interest (Liu et al., 2007). When strains lacking PDR5 were treated with 
MG132, the levels of 3HA-Rub1∆GG appeared to stabilize on WB against HA (Figure 
3.1 B). This indicates that upon inhibition of the proteasome degradation of 3HA-
Rub1∆GG was impaired.  
108 
 
 
 
Figure 3.1 Degradation of 3HA-Rub1∆GG is dependent upon the UPS and 
proceeds through the UPR.3HA-Rub1∆GG was overexpressed in the 
indicated strains for 1 hour.  Expression was shut off and samples were taken at 
the indicated time points, TCA precipitated, resuspended in reducing sample 
buffer, run on polyacrylamide gels then Western blotted for HA.  Stability 
indicates that the levels of the protein are stable even after expression is shut off.  
The strains where the HA signal is stabilized are impaired in degrading the 
construct.The tagged protein is not degraded via the lysosome as the pep4∆ 
strain does not have impaired clearance of the tagged construct (A).  The 
proteasome inhibition (B) and uba1-204 data suggesting that the protein is 
degraded in a proteasome and ubiquitin dependent manner was collected by 
Thimo Kurz prior to my arrival in the laboratory (C).  The double deletion of 
ubc4 and ubc5 partially stabilizes the protein and the quadruple deletion strain 
enhances that phenotype (D). San1 (E) is not in the HA-Rub1∆GG degradative 
pathway but Ubr1 is involved in clearance of the tagged protein (F). 
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3.5.3 Ubiquitin activating enzyme dependence 
After proteasome dependence was established, we asked whether degradation was also 
ubiquitin dependent. Another UBL, FAT10, is degraded in a ubiquitin proteasome 
dependent manner (Buchsbaum et al., 2012) and we wanted to confirm if Rub1 was 
similarly degraded by ubiquitin. We believed this would be unique because of the high 
similarity between ubiquitin and Rub1. To test this hypothesis we reran the 
overexpression chase assay in a temperature sensitive (TS) UAE mutant (uba1-204). At 
the restrictive temperature, HA-Rub1 levels are stabilized in this mutant (Figure 3.1 C). 
These data suggest that HA-Rub1 ∆GG requires both the ubiquitin system and the 
proteasome in order to be degraded.  
 
3.5.4 E2 identification 
There are 13 E2 enzymes in yeast. We obtained deletion strains for 10 of them from our 
yeast KO collection and a TS mutant of the essential E2 ubc3 (cdc34-2). The two E2 
deletion strains which were not included in this screen were ubc1 and ubc9.The ubc9∆ 
strain was omitted partially because there was no deletion or mutation strain available in 
the laboratory.  This omission is not believed to be significant because the gene is a 
Sumo specific E2 and does not participate with Rub1 or ubiquitin.  The ubc1 deletion 
strain was not in our deletion library or other laboratory collections and wastherefore 
not included in this screen.  
 
The 11 E2 deletion/mutation strains were transformed with pYES2 3HA-Rub1∆GG and 
the overexpression chase experiment was run. None of the E2 deletion strains had 
impaired clearance of 3HA-Rub1∆GG.Similarly, at the restrictive temperature the ubc3 
TS mutant strain displayed no change in 3HA-Rub1∆GG clearance compared to the 
110 
 
 
wild type. These findings indicate that no single E2 tested was associated with 
stabilization of 3HA-Rub1∆GG.  
 
There are some E2s, such as Ubc4 and Ubc5, which share significant similarity and are 
known act extremely promiscuously and to compensate for one another (Seufert and 
Jentsch, 1990). For this reason, a ubc4/5 double deletion strain was included in this 
overexpression chase degradation panel. To a much lesser extent, Ubc6 and Ubc7 can 
compensate for the lack of Ubc4/5 (Chen et al., 1993) so the quadruple deletion strain 
was also included in this screen.  
 
The multi-E2-deletion strains were transformed with the pYES2 3HA-Rub1∆GG 
plasmid. The overexpression chase assay was run and presence of 3HA-Rub1∆GG was 
tested for by WB against the HA tag. While the deletion of the individual E2 genes 
ubc4, ubc5, ubc6, and ubc7 alone did not inhibit normal degradation of 3HA-Rub1∆GG, 
the ubc4/5 double deletion resulted in increased stabilization of the construct. The 
quadruple deletion strain (ubc4/5/6/7 ∆) increased the strength of the 3HA-Rub1∆GG 
signal by WB (Figure3.1 D). Since the protein is stabilized, these enzymes are 
important in HA-Rub1 turnover. Degradation of 3HA-Rub1∆GG requires one or all of 
these 4 E2 enzymes. As some compensation may occur only in cases where one gene 
has been deleted it is impossible to ascertain which enzyme or enzymes is primarily 
responsible for the degradation in vivo. 
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3.5.5 E3 identification 
There are many known yeast E3s (54 in yeast, 1000 in humans (Staub and Rotin, 2006)). 
Due to the large number of known possible E3s, it was important to narrow the field of 
possible enzymes before running the degradation assay. We considered several 
approaches to this problem while working to identify the E2s involved in HA-Rub1 
degradation.  
 
There is some NMR and biochemical data on the structure of NEDD8. NEDD8 is 
almost topologically identical to ubiquitin but it spends more time in a semi-unfolded 
state and unfolds more easily than ubiquitin. Further, when exposed to proteases, like 
chymotrypsin,NEDD8 is degraded quite readily while ubiquitin is not fragmented. 
(Kitahara et al., 2006b).  
 
There is very little that distinguishes the structures of Rub1/NEDD8 from ubiquitin and 
we postulated that a propensity to unfold could specifically target Rub1/NEDD8 for 
degradation while maintaining the integrity of the pool of free ubiquitin. We 
hypothesized that the UPR was responsible for selective Rub1 degradation. There are 2 
UPR E3s in yeast—the nuclear San1 (Gardner et al., 2005) and the cytosolic Ubr1 
(Eisele and Wolf, 2008). As we did with the possible E2s involved in degradation, we 
obtained san1 and ubr1 deletion strains from our KO library. These strains were 
transformed with pYES2 3HA-Rub1∆GG. The overexpression chase experiment was 
run again and results were checked by WB against HA. Deletion of san1 did nothing to 
abrogate HA-Rub1∆GG turnover (Figure 3.1 E). This indicates that San1 is not likely 
involved in 3HA-Rub1∆GG turnover. Deletion of ubr1 resulted in clear stabilization of 
the HA-Rub1∆GG construct (Figure 3.1 F). We further confirmed this finding by 
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transforming the ubr1∆ strain with HA-Rub1 G75/76A where there is only a single HA 
tag and the diglycine motif necessary for conjugation was mutated to nonfunctional 
dialanine rather than simply deleted. We again performed the overexpression chase 
assay and observed the same stabilization by WB. 
 
Interestingly, Ubr1 can function in two pathways. First, N-end rule based degradation, 
requires the E2 Ubc2 (Kumar et al., 2010; Sadis et al., 1995; Xia et al., 2008). When 
working with the E2s Ubc4/5/6/7, Ubr1 is associated with the UPR (Eisele and Wolf, 
2008). The stabilization of 3HA-Rub1∆GG in the Ubr1 deletion strain, in conjunction 
with the stabilization of the same construct in the UPR associated E2 deletion strains 
ubc4/5/6/7∆ provides dual confirmation that degradation is going through the UPR. 
Furthermore, thisfinding is in agreement with our hypothesis that Rub1 might be 
distinguished from ubiquitin by some fundamental feature like low structural integrity. 
 
3.6 Unfolded protein response mediated degradation might be artifactual 
3.6.1 Degradation of near endogenous nonconjugatable Rub1 
After identification of the overexpressed HA-Rub1∆GG degradative pathway, we 
sought to confirm that UPR mediated degradation was also maintained at the 
endogenous level. In the absence of an effective Rub1 antibody we again relied upon 
tagging Rub1. Initially it was assumed that using a centromeric plasmid bearing the 
Rub1 promoter, two N-terminal tags (HA and His) and the rub1 gene would generate 
near endogenous levels of Rub1. This is in line with common yeast practice. Free Rub1 
does not accumulate sufficiently to be seen at WB levels (picograms of protein) in this 
experiment. However, we are able to see accumulation following proteasome inhibition 
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by MG132 (Figure 3.2 A). This finding indicated both that this protein was present in 
yeast extract at very low levels and that the proteasome was required for turnover of 
HA-His-Rub1∆GG.  
 
3.6.2 Endogenous expression of Rub1 
As a control to ensure that expression of tagged Rub1 was at near endogenous levels, 
we decided to test cullin neddylation levels. We reasoned that if neddylation were 
similar to wild type we would have more confidence in our expression levels even 
without the ability to directly test Rub1 levels. We therefore expressed Rub1 on a 
centromeric plasmid and compared yeast bearing this plasmid to wild type yeast. It 
appeared by WB that Cdc53 neddylation was artificially low (Figure 3.2 B).  
 
Including the 3’UTR as well as the Rub1 promoter on the centromeric plasmid returned 
cullin neddylation to normal levels (Figure 3.2 C). Addition of the 3’UTR also allowed 
us to observe free HA-Rub1 without proteasome inhibition. When we obtained a Rub1 
antibody we were further able to confirm that the pRS413 Rub1 pr. Rub1 3’UTR and 
the equivalent HA tagged construct produce near normal free Rub1 levels. This finding 
demonstrates that the 3’UTR plays an important role in Rub1 expression that the Rub1 
promoter (5’ UTR) alone cannot compensate for. As it is nonstandard to include the 
3’UTR when cloning yeast genes it is possible that this finding may be important for 
work on other genes. More testing will be needed to identify if other 3’UTRs similarly 
influence expression levels so greatly.  
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Figure 3.2.  Regulation of near endogenous Rub1, tag dependence, and 
antibody characterization.  Rub1 expressed under the endogenous promoter 
bearing His/HA tags accumulates only under conditions of proteasome 
inhibition (A).  Expression of Rub1 requires the 5’ and 3’ UTRs for normal cullin 
neddylation levels (B).  Rub1 under the control of the 3’ and 5’ UTRs expresses 
at near normal levels with and without tagging (C).  A single HA tag on Rub1 is 
cleaved at near endogenous expression levels (D).  Apparent degradation of 
tagged overexpressed Rub1 might have been due to tag cleavage (E).  The Rub1 
antibody specifically recognizes Rub1but has numerous nonspecific bands on 
WB (F) and does not recognize denatured Rub1 very strongly (G). 
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3.6.3 Diglycine mutation partially destabilizes Rub1 
Once we had developed the correct settings to visualize HA-Rub1 by WB, we asked if 
the C-terminal mutations used to prevent conjugation were responsible for the observed 
instability and unfolding. Ubiquitin bearing a G76A mutation has been used in substrate 
studies because it interferes with the deconjugation by DUBS (Hodgins et al., 1992). 
However the ubiquitin needs to be mature—pro-ubiquitin bearing the G76A mutation 
does not become conjugated to substrates.  
 
Similarly pro-Rub1 bearing a G76A mutation on a centromeric plasmid and expressed 
in a yeast background lacking endogenous Rub1 can be visualized by WB but is not 
effectively conjugated to the cullins. Interestingly, the level of free HA-Rub1 is fairly 
consistent between the G76A mutant and the wild type construct (Figure 3.2D). The 
G75/76A dialanine mutant on the other hand displays a marked decrease in free Rub1 
when compared to both the single mutant and the wildtype (Figure 3.2 D). This data 
indicates that the dialanine or ∆GG mutations used to prevent conjugation could be a 
significant destabilizing factor in our degradation assays. This line of evidence suggests 
that free Rub1 is maintained at stable levels independent of its conjugation status but 
that the mutation of the diglycine motif in the short unstructured C-terminal region can 
be destabilizing.  
 
3.6.4 Rub1 antibody development and testing 
While working with both overexpression and tagging systems, we attempted to establish 
techniques for visualizing endogenous Rub1 directly. We initiated an antibody 
production campaign in sheep using an antigen from endogenous Rub1.  We tested the 
antibody against purified ubiquitin and Rub1 (to test for cross reactivity) and against 
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WB of yeast with and without the rub1 gene (Figure 3.2 F and G). The sheep anti-Rub1 
antibody is specific for Rub1 but has many non-specific bands on WB that fall primarily 
between the cullins and free Rub1. These bands will impede the use of this antibody for 
substrate identification. Nonetheless, this antibody can be used to look at the cullins and 
free Rub1. 
 
3.6.5 Untagged Rub1 is stable 
Tagging can sometimes lead to aberrant regulation of tagged proteins (Hipp et al., 2004). 
We had already found that the diglycine mutation was somewhat destabilizing. We next 
needed to ask if the tags used contributed further the apparent quick UPR mediated 
degradation.  
 
3.6.5.1 Untagged overexpression chase assay 
First we ran the overexpression chase assay we had used before. The difference this 
time was that the construct we transformed into the yeast was untagged (pYES2 Rub1 
G75/76A). This construct was overexpressed for one hour and then chased. Unlike the 
instability observed with the tagged construct, we observed apparent stability (Figure 
3.2 E). This indicates that our earlier findings were likely artifactual. 
 
3.6.5.2 Tag cleavage 
We next asked whether tag cleavage could have contributed to the apparent degradation 
we had observed. If the HA tag was cleaved from HA-Rub1 G75/76A blotting for the 
HA tag might make the construct erroneously appear to have been degraded. WB of the 
tagged construct with a Rub1 antibody can be used to determine if this occurs because 
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the tagged form would migrate at a slightly higher MW than the untagged form.  
Therefore if a doublet is observed, there is likely tag cleavage also occurring.  
 
 To determine if this was possible we performed several experiments. First, we looked 
at an overexpression chase assay of the HA-tagged construct using the Rub1 antibody. 
It appears that the tagged form is reduced over time while the untagged form is 
unaffected or increased. This could mean the tagged form is less stable and therefore 
degraded (this is likely because of the much higher signal in the ubr1∆ background), the 
tag is being cleaved (this is also likely because the doublet is observed even in the 
rub1∆ background), or a combination of the two. In order to more clearly discern if the 
HA tag is cleaved we examined lysate of rub1∆ yeast carrying the pRS413 HA-Rub1 
plasmid. There is clear evidence of a doublet on WB. This has been interpreted to mean 
that the HA tag is cleaved. This doublet is sometimes hard to discern but is stronger in 
strains where conjugation has been inhibited as with deletion of ubc12, the Rub1 E2 
(Figure 3.2 D).  
 
Although we did not expect a single HA tag to be cleaved, this is what we have 
observed. Such cleavage could have confounded some of our results as shifts from 
tagged to untagged Rub1 would in an anti-HA WB appear to be degradation (Figure 3.2 
E). In fact, untagged overexpressed Rub1-AA is stable in the time courses using a 
galactose inducible construct (Figure 3.3 A). The stability observed here in conjunction 
with the tag cleavage and somewhat destabilizing role of the diglycine mutation all cast 
doubt on the relevance of the quick degradation observed with the tagged mutated Rub1. 
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Figure 3.3 UPR mediated Rub1 degradation is artifactual and Rub1 is 
endogenously stable.  Overexpressed Rub1 G75/76A is stable in the 
overexpression chase assay (A).  Tag cleavage may contribute to apparent 
degradation of HA-Rub1 and expression of HA-Rub1 AA is stronger in a strain 
lacking ubr1 (B).  Deletion of the Rub1 pathway enzymes uba3 and ubc12 results 
in an increase in free Rub1 (C).  Deletion of ubr1 does not affect free Rub1 levels 
(D).  Inhibition of the proteasome does not lead to dramatic changes in 
endogenous Rub1 levels (E).  Free Rub1 levels are stable over 7 hours after 
inhibition of the ribosomes by cycloheximide treatment (F).  The growth curve 
of the samples from cycloheximide chase in F, confirms that the cycloheximide 
treatment was effective (G).   
 
3.6.7 Endogenously expressed Rub1 does not go through the UPR 
In strains lacking either the NAE (uba3) or the rub1 E2 (ubc12) conjugation via the 
Rub1 pathway is abrogated and the entire pool of Rub1 should remain free. 
Interestingly, in strains deleted for these genes, we observed an increase of endogenous 
untagged Rub1 when compared to wild type yeast (Figure 3.3 C). One possible 
explanation for this observation is that the Rub1, now in the free pool, would typically 
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be conjugated to substrates such as the cullins. If turnover was quick or closely 
controlled we would not expect such an accumulation.  
 
3.6.7.1 Ubr1 is not important for maintaining Rub1 levels 
Unlike the accumulation observed in the Rub1 pathway deletion strains, deletion of 
ubr1 does not lead to an accumulation of Rub1 (Figure 3.3 D). If Ubr1 mediated Rub1 
turnover endogenously, a similar backlog of free Rub1 might be expected to accumulate. 
There are near WT levels of free rub1 observed in WB of ubr1∆ strains. Therefore 
degradation of Rub1 is unlikely to endogenously proceed through this E3. 
 
3.6.7.2 Proteasome inhibition does not stabilize Rub1 
We further wanted to ask if Rub1 was even degraded by the proteasome. To answer this 
question, we grew yeast expressing Rub1 from the endogenous locus and then treated it 
either with the proteasome inhibitor MG132 or the equivalent volume of vehicle 
(DMSO). We then checked the level of free Rub1 by WB. Proteasome inhibition does 
not result in an accumulation of Rub1 (Figure 3.3 D). This data suggests that Rub1 is 
not turned over in a Ubr1/proteasome dependent manner. 
 
3.6.8 Rub1 is a stable protein 
Since untagged Rub1 does not appear to be degraded in a Ubr1 or proteasome- 
dependent manner, we decided to use a cycloheximide chase to follow endogenously 
expressed Rub1 turnover. For this experiment, we selected a uba3∆ strain. By deleting 
the NAE, we hoped to abrogate conjugation through the neddylation machinery much 
like we did with the diglycine mutation in earlier experiments. In this way we do not 
need to worry about the possibly destabilizing diglycine mutations but can ensure that 
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we are following a free pool of Rub1. Without overexpression we don’t expect 
significant crosstalk with the ubiquitin pathway.  
 
In this experiment, we shut off expression of Rub1 by cycloheximide treatment and then 
collected samples for 7 hours (Figure 3.3 F). We used a growth curve to confirm that 
the cycloheximide treatment was working(Figure 3.3 G). We observed by WB that 
Rub1 levels remain stable for all 7 hours. This finding contrasts with the degradation of 
the HA-tagged overexpressed construct visible by WB after only 15 minutes. 
Endogenous free Rub1 is much more stable 
than when tagged and mutated.  
 
3.7Substrate identification in yeast 
Although we were unable to determine the 
means by which free Rub1 was degraded, we 
thought we might still be able to discern which 
proteins were conjugated to Rub1 
endogneously (Figure 3.4). 
 
3.7.1Tagged Rub1 
In our investigations of yeast strains 
harbouring the near endogenous HA-Rub1 
plasmid, we observed HA-reactive bands on 
WB that did not exactly match the MW of the 
yeast cullins (Figure 3.4). Although weak and 
 
 
Figure 3.4.Possible HA-Rub1 
substrates.  In the presence of 
HA-Rub1, the cullins and free 
Rub1 are visible by WB. There are 
nonspecific antibody reactive 
bands (denoted by #). Some 
apparent non-cullin HA-Rub1 
bands are also visible by WB 
(denoted by black triangles). 
These may represent genuine 
Rub1 substrates.   
121 
 
 
inconsistent, these bands could be interpreted as low abundant non-cullin substrates so 
we attempted to identify them.  
 
3.7.2Untagged Rub1 
Ideally, identification of substrates is undertaken with no changes to endogenous 
expression. Therefore we attempted to use the anti-Rub1 antibody generated for this 
project. This antibody generates many nonspecific bands in the MW region below the 
cullins and above free Rub1 (Figure 3.2F), which, coincidently, was where we had seen 
the putative Rub1 substrates (Figure 3.4). These nonspecific bands prevent clear 
analysis of endogenous substrates via WB. We therefore utilized two techniques meant 
to enhance substrate visibility. First we attempted to IP neddylated proteins using the 
Rub1 antibody. However attempts to do this were unsuccessful. This might bear 
revisiting because it was not extensively tested. 
 
Second, we screened DUB deletion strains for aberrant levels of free Rub1, cullin 
neddylation, and abnormal banding patterns. For this screen we also included a strain 
lacking rfu1 (a gene encoding negative regulator of the DUB Ubp4). All DUB deletion 
strains are viable and available from our yeast KO collection. Strains were grown and 
harvested in complete YPAD media under non-stressed conditions. The WBs of the 
knockout strains were probed with anti- Rub1. Most DUB deletion strains did  not 
display significant differences from the wild type strain (Figure 3.5A). 
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Figure 3.5.  DUB deletion as a means of Rub1 conjugate identification.A 
series of yeast DUB deletion strains blotted for Rub1.  There are no strongly enriched 
bands when compared to wild type except in the ubp3∆ strain (A).  The ubp3∆ 
phenotype is stronger when the WB is developed in TBST based buffers (B) and is not 
dependent upon the NAE (Uba3) or Rub1 itself (C).   
 
3.7.3Ubiquitin specific protease 3 (Ubp3) 
There was only one striking new antibody reactive band on WB significantly enriched 
by deletion of a DUB. Following the deletion ubp3, a rub1 antibody reactive band of 
about ~62kD is strengthened. This band was most striking when the wash buffer was 
TBST rather than PBST (Figure 3.5B). While some antibodies function better in one 
wash buffer than the other, such behavior may indicate that the band is nonspecific. We 
wanted to unequivocally determine whether that was the case. Towards that end, two 
double deletion strains were generated.  
 
A strain lacking uba3 cannot activate Rub1 or conjugate it to substrates. If the band of 
interest were genuinely conjugated to Rub1 through the neddylation machinery, the 
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Figure 3.6.  Mutation of the 
terminal glycine does not 
enrich for Rub1 substrates. 
observed enrichment of the band of interest would be reduced or eliminated by such a 
deletion. However, this phenotype was not rescued by deletion of the NAE uba3. WB 
of the ubp3∆ strain looked the same as the ubp3∆uba3∆ strain (Figure 3.5C). 
The~62 kD band was not neither reduced nor eliminated by NAE deletion and therefore 
is accumulating independent of the neddylation pathway.  
 
Rub1 may become conjugated through the ubiquitin pathway rather than in a NAE 
dependent manner. Therefore in order to absolutely determine if the ~62 kD band 
represented a truly nonspecific target of the anti-Rub1 antibody, the rub1 gene was 
deleted in a strain already bearing the ubp3 deletion. In such a strain there can be no 
contribution from Rub1 to the protein pool and therefore any antibody reactivity 
observed is nonspecific. The ubp3∆rub1∆ strain was generated. We observe by WB that 
the enriched band is unaffected in the double deletion when compared with the ubp3 
deletion alone (Figure 3.5C). This observation 
in, conjunction with the results of the 
uba3∆ubp3∆ double deletion WB, proves that 
this band is purely nonspecific and not 
dependent upon the neddylation pathway.  
 
3.7.4Tagged Rub1 αNEDD8 
 
3.7.1 Mutation of the terminal glycine 
The first two approaches to enriching Rub1 
conjugates were unsuccessful so alternative 
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means were investigated. Mature ubiquitin bearing a G76A mutation is a reported 
means of identifying some low abundant ubiquitin substrates (Geng and Tansey, 2008; 
Hodgins et al., 1992). We tested if this method would be applicable to neddylation as 
well. In order to test if this method would enrich for neddylation, we transformed a 
rub1∆ strain with pRS413 Rub1 pr. HA-Rub1 G76A ∆N77 3’UTR. We observed that 
mature HA-Rub1 G76A can only inefficiently conjugate to cullins and does not reveal 
new substrates by WB (Figure 3.6).  
 
3.7.2 Immunoprecipitation of HA-Rub1 
As we were unable to artificially pre-enrich for substrates or immunoprecipitate 
untagged Rub1, we initiated a large-scale immunoprecipitation program in order to 
enrich HA-Rub1 conjugates. The strains selected for this procedure were rub1∆ and 
rub1∆ubc12∆ both carrying plasmids expressing HA-Rub1 at near endogenous levels. 
These strains were selected because there would be no competing endogenous Rub1. 
Furthermore, the control strain could carry the exact same plasmid as the experimental 
strain but would be unable to conjugate the construct to substrate proteins as it lacks the 
requisite E2 enzyme (Ubc12).  
 
While a gel-free approach can often give more information about specific proteins 
pulled down by IP, the relative abundance of Rub1 and the neddylated cullins compared 
to other putative substrates was cause for concern. We believed that a gel-free approach 
would result in overwhelming low abundant substrates with peptides from Rub1 and 
cullins. We reasoned that by separating proteins by size via SDS-PAGE we could select 
specific bands of interest at various molecular weights and minimize the probability of 
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losing low abundant substrates under the noise of the cullins. Gels were silver stained 
and prepared for MS analysis.  
 
3.7.3 Mass Spectrometric analysis of Rub1 associated proteins 
Despite the success of the HA-IP (Figure 3.7A), there were no new substrates identified. 
Ultimately, the only peptides identified following this IP procedure were components of 
CRL complexes (Figure 3.7B and C). It should be noted here that only two of the three 
yeast cullins were identified. Cul3 was not found in the IP. This is consistent with the 
work of Aleksandra Zemla in our lab who has observed that Cul3 neddylation is low. 
 
 
Given the possibility that the HA tag was cleaved in these strains we cannot rule out the 
possibility that Rub1 does have non-cullin substrates. Also the lack of Cul3 
identification could indicate that our coverage of the Rub1 associated proteome was not 
high enough to identify low abundant substrates. We believe the strongest possibility is 
that any putative substrates seen were cullin degradation products. This analysis would 
account for the inconsistencies in our ability to visualize the bands of interest on WB. 
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Figure 3.7.  Rub1 substrate identification. Native HA-Rub1 IP from strains with 
and without the Rub1 E2, Ubc12.  5% of the IP was loaded on a 4-12% Bis-Tris 
polyacrylamide gel for WB (A) and the remaining 95% loaded on a 10% 
polyacrylamide gel, silver stained, and analyzed by mass spectrometry.  Top hits from 
the MS analysis are listed (B).  The Mms1 complex was identified very strongly.  This 
cullin based complex (C) may have come down with Rtt101 and scored highly because 
Mms1 is a very large protein capable of producing many peptides. 
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4: Mammalian NEDD8 
 
4.1 Introduction 
The evidence given in chapter 3 suggests that neddylation in yeast may be limited to 
cullins.  We hypothesized that in more complex organisms, with more complex NEDD8 
specific regulatory mechanisms, neddylated proteins might be more abundant or more 
easily identified.  NEDP1, for example, is a highly specific deneddylase with no yeast 
homolog (Mendoza et al., 2003). The existence of such a deneddylase suggests there 
may be non-cullin substrates regulated by neddylation and deneddylation.  Alternatively 
it could suggest that NEDP1 exists to edit proteins neddylated via atypical activation in 
the ubiquitin pathway. Given the existence of NEDP1 in mammalian cells, we decided 
to update our model organism from yeast to human and mouse cells.  We again asked 
whether we could identify non-cullin substrates of the neddylation pathway.   
4.2 Neddylation in cultured human cells 
First, we wanted to ensure that we selected a cell line where endogenous NEDD8 
expression was visible by WB.   We tested both the human osteosarcoma cell line 
U2OS and the human colon carcinoma cell lineHCT116.  We observe apparent non-
cullin bands (primarily below the molecular weights of the cullins) in both cell lines.  In 
order to ascertain if these were genuine substrates of the neddylation cascade, we 
inhibited the NAE using MLN4924 (Figure 4.1 A).  There was a significant decrease in 
apparent substrates following this treatment supporting the hypothesis that these 
substances were neddylated via the neddylation pathway.   
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Figure 4.1.  NEDD8 conjugates in cultured cells.NEDD8 conjugates depend 
upon the NAE in HCT116 and U20S cells (A). Lysis in reducing sample buffer 
(Laemmli) or in lysis buffer A on ice or at RT (B) reveals some putative 
substrates depend upon the lysis buffer stringency.  Lysis under two different 
buffers (Lysis buffer B containing complete mini EDTA free protease inhibitoror 
Lysis buffer C containing complete protease inhibitor) over different times and 
different temperatures (C).  The strong degradation product is denoted by x.
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4.3 Testing for degradation products 
Most apparent substrates appear below the molecular weight of the cullins on WB.  In 
order to rule out the possibility that these NEDD8 reactive species were cullin 
degradation products, samples were prepared under various lysis conditions.  In all of 
these related experiments, cells were harvested by trypsinization, washed with ice cold 
PBS and then split into eppendorf tubes for final lysis in various different buffers. 
Neddylated proteins that are merely products of proteolytic cleavage of genuine 
substrates should display an increase in relative abundance under conditions where 
proteases most active such as buffers with reduced protease inhibitors or when lysed at 
higher temperatures.  Putative substrates that remain consistent under such conditions 
might represent genuine non-cullin conjugates because their formation is not dependent 
upon the activity of proteases following cell lysis.  
 
The first set of lysis conditions revealed a noticeable difference in the neddylation 
profile as viewed by WB (Figure 4.1 B). In order of decreasing stringency these 
conditions were lysis directly in laemmli buffer or lysis buffer A on ice or at room 
temperature for 10 minutes. The strength of the strongest band not consistent with the 
MW of the cullins (~30kD) increases when proteolytic activity is highest (denoted by an 
x in Figure 4.1 B).  For example, in lysis buffer on ice for 10 minutes, the band is much 
less pronounced than when allowed to lyse at room temperature where proteases are 
expected to be more active. Furthermore, the band is almost indiscernible when cells are 
lysed in Laemmli buffer directly.  Laemmli buffer is the harshest buffer in this panel as 
it contains 2% SDS which can inactivate proteases via denaturation. This phenotype 
likely indicates that this anti-NEDD8 reactive band represents a degradation product 
130 
 
 
rather than a unique substrate. There are some NEDD8 reactive species falling between 
38-62kD that remain consistent under various lysis conditions so these bands may 
represent NEDD8 substrates. 
 
To confirm this observation, lysis was performed using two temperatures, three time 
points, and two different lysis buffers (B and C).  Longer and warmer lysis times are 
more likely to allow for degradation products to form.  The difference between the two 
lysis buffers was the type of protease inhibitor used.  Lysis buffer C containing a 5X 
excess of Complete Protease Inhibitor Tablets (including EDTA) from Roche should 
more effectively inhibit degradation than lysis buffer B with Complete Mini-EDTA 
Free Protease Inhibitor Tablets from Roche.  Cells were lysed either on ice or at room 
temperature for 5, 40, or 135 minutes before clarification at high speed and mixed 50/50 
with Laemmli buffer (Figure 4.1C).   
 
The major band observed in the first lysis buffer panel experiment (denoted by an x in 
Figure 4.1 B and C) increased conversely with buffer stringency.  With respect to that 
major band, similar behavior is observed here.  It is least prevalent in the lysis buffer 
containing extra protease inhibitors including EDTA and the longer the sample is 
allowed to lyse, the more pronounced the band becomes.  In addition, the level of free 
NEDD8 rises over time confirming that proteolysis is occurring and freeing NEDD8 
from substrates.  The last observation of note from this experiment is that, as with the 
previous experiment, there are potentially genuine substrates where anti-NEDD8 WB 
band intensity does not appreciably change under any of the conditions tested 
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specifically between 49 and 62 kD. These species will require purification in order to 
confirm that they are not cullin degradation products. 
 
4.4 Deneddylases 
There were two compelling reasons to evaluate the effect deneddylase knockdown 
would have on apparent NEDD8 conjugation by WB.  First, we wanted to determine if 
the anti-NEDD8 reactive bands between 49 and 62 kD were likely to be degradation 
products. CSN5 is believed to function solely as a cullin deneddylase.  If the bands of 
interest are affected by CSN5 knockdown, that is strong evidence that they are cullin 
degradation products.  If, however, levels are CSN5 independent they are more likely to 
be non-cullin substrates.  Second, by knocking down deneddylases we can inhibit 
deconjugation of NEDD8 from substrates thereby enriching our proteins of interest. If 
deneddylase knockdown provides a means to enrich substrates and enhance our ability 
to detect and identify them, such a method could be used in conjunction with 
purification techniques to isolate these substrates.  Consequently, all three definitive 
deneddylases CSN5, NEDP1, and UCHL3 were knocked down using siRNA.   
 
4.4.1 CSN5 
Following knockdown of CSN5 there was a moderate NAE1 dependent enrichment for 
bands around 49-62 kD (Figure 4.C) but other NEDD8 reactive bands were unaltered. 
While certain bands, such as those between 49-62 may represent cullin degradation 
products this is not confirmed. There are still some possible substrates that are 
consistent between the CSN5 siRNA and control siRNA treatments (especially at 
~55 kD).  Furthermore, the strong enrichment for NEDD8 reactive species observed 
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with NEDP1 siRNA is not observed here so all NEDD8 conjugates are not necessarily 
cullin degradation products.  It is possible that some low abundant substrates are simply 
not visible in these WBs. 
 
4.4.2 NEDP1 
When the highly specific (and fairly promiscuous) deneddylase NEDP1 was knocked 
down, a multitude of NAE dependent bands in WB against NEDD8 appear or are 
strengthened (Figure 4.2 B). There are several possible explanations for the observed 
enrichment.  First, NEDP1 could be deneddylating endogenous non-cullin substrates.  
This possible function would prove very useful in our exploratory efforts.  NEDP1 
knockdown may be a tool that can be used in conjunction with other purification 
techniques to identify neddylated proteins from cultured cells. Second, NEDP1 could be 
deneddylating cullin fragments.  Such a function could be important for keeping 
NEDD8 from being turned over along with the cullins.  If this is the appropriate 
function of NEDP1, then most if not all of the putative substrates observed on WB are 
cullin degradation products. One final possibility which we considered here was that 
NEDP1 plays a smaller role in vivo but during our lysis procedure NEDP1 is not 
effectively inhibited and therefore deneddylates normally neddylated proteins in 
solution in a non-physiologically relevant way. 
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Figure 
4.2.Deneddylas
e knockdown 
by siRNA in 
U2OS cells.CSN5 
knockdown 
partially 
increases 
neddylation in an 
NAE dependent 
manner when 
compared to 
control (A).  
NEDP1 
knockdown 
dramatically 
increases the 
neddylation 
profile in U2OS 
cells in an NAE 
dependent 
manner (B).  
UCHL3 
knockdown in 
U2OS decreases 
apparent 
neddylation and 
free NEDD8 
when compared 
to control siRNA 
(C). 
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The good enrichment for neddylated bands following NEDP1 siRNA that do not 
correspond to the MW of the cullins offers potential for future research. Knockdowns of 
NEDP1 may be a useful tool in identification of noncullin substrates.  Such work may 
also help illuminate the poorly understood role of endogenous NEDP1 in vivo.  A 
NEDP1 knock-in cell line is currently being developed in the laboratory and tested to 
determine exactly what that role is. Until such a cell line is tested it is hard to prove 
what functions NEDP1 is performing in vivo or in the lysis buffer.   
 
4.4.3 UCHL3 
UCHL3 is responsible for, among other things, the maturation of pro-NEDD8 to 
NEDD8 by cleavage of a 5 amino acid C-terminal extension (Hemelaar et al., 2004). It 
is possible that NEDP1 compensates somewhat for this role of UCHL3(Wu et al., 2003).  
However major contributions to Neddd8 maturation come from UCHL3.  We 
hypothesized that if NEDD8 were not matured properly following UCHL3 knockdown, 
NEDD8 would not be conjugated to substrates effectively.  This is exactly the 
phenotype we observed following UCHL3 knockdown. UchlL3 siRNA treatment 
results in widespread reduction in the appearance of NEDD8 reactive species and a 
concurrent reduction in free NEDD8 (Figure 4.2 C).   
 
There are other conclusions from the UCHL3 knockdown experiment that have 
consequences that are more immediately clear. On the level of whole organisms, the 
UCHL3 dependent regulation of neddylation could have health implications. In brief, 
problems with global neddylation levels could result in some predictable deficiencies 
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with CRLs.  Furthermore, some conditions such as AD display decreased UCHL3 
activity in affected areas of the brain (Dennissen et al., 2011).  Perhaps decreased 
activity of UCHL3 effectively functions like an in vivo knockdown of UCHL3 resulting 
in defects in neddylation like that observed following UCHL3 siRNA treatment.  
Neddylation defects could then contribute to some observed phenotypes, like inhibition 
of the UPS, in these instances. This vein of thought inspired a change of focus to 
UCHL3 related phenotypes which we then followed up. 
 
Another phenotype observed following UCHL3 knockdown is the decreased growth of 
cells, which was clearly visible during routine checks of UCHL3 knockdown plates.  
This observation was followed up with Fluorescence Activated Cell Scanning (FACS) 
analysis.  It should be noted before any analysis, that the FACS must be repeated and 
the siRNA deconvoluted as it is comprised of a pool of 4 oligomers.  The FACs 
experiment was done in duplicate on one day and should be done on an independent day 
to minimize potential experimental bias if it is to be strongly considered.  That being 
said; we know that UCHL3 itself is being knocked down as we have an antibody 
against UCHL3 and have tested the knockdown via WB. FACS analysis reveals that the 
phenotype observed by eye was the result of significant cell cycle arrest.  There is 
approximately a 32.7% increase in the number of cells in G1, and decreases in the 
percentage of cells in both S and G2/M (27.9% and 5.9% respectively) (Figure 4.3).   
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Figure 4.3.FACS analysis of cells following deneddylase 
knockdown.  FACS profiles following transfection with control siRNA 
(A), UCHL3 siRNA (B), and cotransfection with UCHL3 and NEDP1 (C).  
WB showing siRNA phenotype.  There is no Nedp1 WB because there 
was no available NEDP1 antibody when this experiment was performed 
(D).  The cell cycle profiles of the three different treatments compared 
by percent in each phase (E) 
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We reasoned that if NEDP1 knockdown increased apparent NEDD8 conjugation and 
UCHL3 knockdown decreased such conjugation, knockdown of one might be able to 
rescue the other.  Although NEDP1 knockdown alone was not included in this test, 
cotransfection of siRNA against NEDP1 and UCHL3 partially rescued the phenotype 
caused by UCHL3 knockdown both with regards to neddylation on WB and cell cycle 
(Figure 4.3 D and E).   This work needs to be repeated on an independent day if it is to 
be used as the basis for future work.  The knockdown of NEDP1 alone would also need 
to be included in the panel of siRNA conditions tested.  The important take away 
message we want to draw from these data is not the observed cell cycle defects 
themselves but rather the possible importance of a UCHL3 and NEDD8 disease 
connection. This possibility led us to reevaluate the currently available literature.  
4.5 Mammalian tissues 
The observation of the cell cycle and neddylation defects in the UCHL3 knock down 
experiments, and the recent reports that UCHL3 function may be impaired in affected 
areas of Alzheimer’s Disease brains (Dennissen et al., 2011), convinced us to review the 
pertinent literature.  The UCHL3 knockout mouse displays growth retardation 
(Semenova et al., 2003), and certain tissue specific phenotypes but the ubiquitylation 
profile appears consistent between WT and knockout mice by WB of tissue lysates 
(Setsuie et al., 2009a). There are clear phenotypes in distinct tissues, specifically 
adipose tissue (Setsuie et al., 2009b), skeletal muscle (Semenova et al., 2003; Setsuie et 
al., 2009b; Setsuie et al., 2010), photoreceptors of the retina (Sano et al., 2006; 
Semenova et al., 2003), and the testis (Kwon et al., 2004). Knockout mice also have 
been reported to have short-term memory loss and abnormalities of the brain (Kurihara 
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et al., 2001; Wood et al., 2005). It is unclear whether it is the failure of UCHL3 as a 
deneddylase, a deubiquitylase, or a combination of the two that results in these specific 
deficiencies.  Tissues of the UCHL3 KO mouse have been compared to WT tissues by 
anti-ubiquitin WB. I am unaware of a similar NEDD8 focused experiment.  We 
therefore posited that there might be tissue specific neddylation that could account for 
the tissue specific phenotypes of the UCHL3 KO mouse. TheUCHL3 mouse data could 
hint that neddylation is tissue specific and by working with cancer cell lines we might 
miss some obvious substrates.  
4.5.1 Tissue Panels 
In order to confirm whether there were tissue-specific neddylated proteins we lysed 
mouse tissues for WB analysis.  We probed the WBs with rabbit monoclonal anti-
NEDD8 from Millennium Pharmaceuticals (Mil10) or from Epitomics (Epitomics). 
Neither the Mil10 nor the Epitomics rabbit anti-NEDD8 monoclonal antibodies are 
believed to have nonspecific bands and both were able to detect primarily the same 
tissue specific banding patterns (Figure 4.4). 
4.5.1.1 Heart 
The main point of divergence between the two rabbit monoclonal antibodies against an 
N-terminal fragment of NEDD8 was observed in heart.  There is a very pronounced 
anti-NEDD8 reactive band of about 40kD that appears stronger than the cullins when 
probed with Mil10. However, it is not recognized by Epitomics anti-NEDD8.  These 
antibodies otherwise behave very similarly and we therefore concluded that this 
discrepancy was likely due to nonspecific interactions between Mil10 and a heartprotein.  
We decided to focus instead on a tissue such as testes with a high degree of neddylation 
but no such incongruity between the antibodies.  We believed the putative substrates in 
such tissues were less likely to constitute nonspecific bands.   
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Figure 4.4.  Mouse tissue panels blotted for NEDD8.  40 µg of protein from 
each tissuesuspended in reducing sample buffer separated by SDS-PAGE and 
blotted for NEDD8 using Mil10 (A) and Epitomics (B) anti-NEDD8 antibodies by 
WB.  Possible nonspecific band noted with the * symbol. 
 
 
4.5.1.2 Testes 
Our main focus shifted to Testes.  Not only did the UCHL3 knockout mouse have an 
abnormal heat shock response in testes (Kwon et al., 2004), but we also observed an 
elevated amount of anti-NEDD8 reactive species by WB using two different antibodies.  
Promisingly, there were some high molecular weight species (~250kD) too large to 
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correspond to the cullins or cullin degradation products.   As these samples were all 
prepared under reducing conditions these bands cannot constitute cullin dimers.   
4.5.1.3 Brain 
There is also an increased banding pattern in brain.  It is interesting to note that some of 
the anti-NEDD8 reactive bands with increased intensity in brain match up with some of 
the unidentified bands that were observed to be stable across various lysis buffers when 
cultured cells were checked for degradation products. These could represent genuine 
substrates. It is attractive to postulate that these neddylated proteins are associated in 
some way with the memory loss or the dorsal root ganglion degeneration phenotypes of 
the UCHL3 KO mouse.  That hypothesis needs to be tested. 
4.5.2 Substrate Identification 
In order to ascertain whether we were observing genuine non-cullin substrates, it was 
necessary to develop a means of purifying proteins modified by NEDD8. We elected to 
pursue several affinity based purification techniques in parallel.   
4.5.2.1 NEDD8 Affinity Matrix 
First, we attempted to develop a NEDD8affinity matrix (NAM) by exploiting the 
specificity NEDP1 has for NEDD8 to selectively isolate neddylated proteins.  This 
technique, discovered by Roland Hjerpe, involves using N-terminally 
taggedcatalytically dead NEDP1 (tagged-NEDP1 C163A) to pull on neddylated 
proteins. Dr. Hjerpe has demonstrated that the NAM was able to specifically isolate 
NEDD8 from a mixture of purified ubiquitin and NEDD8. I then took over the project 
and optimized this process for use on cell lysate.  While the NAM can be used to purify 
neddylatedproteins, its greatest preference is for pulling down free NEDD8 (Figure 4.5).  
While the NAM may prove viable in the future when used in conjunction with 
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othertechniques, it is not a functional way to purify neddylated proteins from a complex 
mixture using current experimental design.   
 
 
 
 
Figure 4.5.  NAM used to purify neddylated proteins from HCT-116 cell 
lysate.Cells incubated in lysis buffer with His-HA-NEDP1 C163A or an 
equivalent volume of Ubiquigent buffer vehiclethen immunoprecipitated using 
HA-agarose beads.  The pulldown was tested for the ability to isolate NEDD8 (A) 
and ubiquitin (B) associated proteins by WB.  Although the NAM pulls down 
Nedd8 and some associated proteins, it does not pull down ubiquitin. 
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4.5.3 Immunoprecipitation 
4.5.3.1 Antibody production 
In parallel with the work developing the NAM pulldown procedure, we also worked to 
establish an IP procedure.  In addition to the two commercial monoclonal anti-NEDD8 
antibodies already discussed (Mil10 and Epitomics), two polyclonal anti-Nedd8 
antibodies were specifically developed for this project.  
4.5.3.2 Polyclonal anti-NEDD8 
Polyclonal sheep and rabbit anti-NEDD8 antibodies were generated using the same 
antigen (residues 11-32 of human NEDD8) as with the monoclonals.  These antibodies 
were tested by dot blot for specific NEDD8 interaction, ubiquitin cross-reaction, and 
generic interactions with large quantities of control protein (BSA).  Both the sheep and 
the rabbit anti-NEDD8 are capable of specifically recognizing small quantities of native 
and denatured NEDD8 by dot blot (Figure 4.6 A). The rabbit anti Neddd8 may display 
some nonspecific interactions with high quantities of protein (~500 ng).  To see if these 
results translated to WB the antibodies were tested at 1:500 overnight on membranes 
containing one lane with a sample where the NAE was functional and one lane with a 
sample where the NAE was inhibited by MLN4924. While the sheep polyclonal is able 
to recognize the cullins and to a limited extent, free NEDD8 in HCT116 lysate, it is 
much weaker than Mil10.  The Rabbit anti-NEDD8 is stronger than the sheep and is 
perhaps comparable to Mil10 with the exception of 1 nonspecific band at ~40kD 
(Figure 4.6 B).   
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Figure 4.6.  Polyclonal rabbit and sheep anti-NEDD8 characterization by 
dot blot and WB.  The current standard, Mil10 was used for comparison.  
There is some nonspecific reaction to high levels of protein with the polyclonal 
antibodies (A).  The rabbit polyclonal anti-Nedd8 is effective by WB compared to 
the Mil10 (B) however there is a nonspecific band (denoted by +). 
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4.5.3.3 Immunoprecipitation from testes: Non-denaturing 
While methods of pre-enrichment like deneddylase knockdown may still be useful in 
attempting to identify neddylated proteins in cultured cells, we elected to IP from testes.  
Testes were chosen for two reasons.  First it made our samples biologically relevant.  
Cancer cells can be wildly misregulated so use of endogenous tissue can help attain a 
clearer picture of what is happening in normal tissue.  Secondly, the increased 
neddylation profile in testes WB meant that the putative non-cullin NEDD8 substrates 
are already enriched for in tissue samples.  
 
For these experiments we extracted proteins from mouse testes and immunoprecipitated 
from those samples overnight using one of the anti-NEDD8 antibodies or preimmune 
IgG control.  Under non-denaturing conditions, the Epitomics antibody was most 
efficacious and was therefore the primary antibody of choice.  Even with 1mg of testes 
protein the Epitomics antibody was able to IP known NEDD8 pathway members 
including CUL9. Coverage was increased with increasing amount of protein in the IP.  
We have also tried 4mg, and 20mg IPs but the 1 and 4 mg IPs had the least background.   
Samples were separated by molecular weight using SDS-PAGE.  Gels were either silver 
or Coomassie stained then cut into slices that were prepared for MS analysis.  
4.5.3.3.1 MS Scores 
Samples were run on an LTQ Orbitrap classic (Thermo). Hits were then analysed using 
MASCOT and peptides were filtered for an ion score higher than 28.  Peptides for the 
common contaminants keratin, serum albumin, and immunoglobulin were excluded 
from analysis.  A score above approximately 100 is considered a very solid hit.  While 
scores can be compared within a single run they should not be compared quantitatively 
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between two different runs—for example COPB was assigned a score of 200 in the 1mg 
IP and 140 in the 4mg IP.  From that we can extrapolate that COPB is a strong hit but 
not that the 1mg IP was better than the 4mg IP.  In fact, for most proteins the scores 
would follow the opposite trend by scoring higher in the 4mg IP.  That being said, 
knowing that there is a high degree of confidence for a hit is beneficial and some scores 
are included here to illustrate our relative confidence in the observed proteins.   
 
 
 
 
 
 
 
Figure 4.7.  Epitomics anti-NEDD8 native IP.  The WB and Coomassie stained 
gel obtained from immunoprecipitation of 4 mg of mouse testes proteins using 
50 µg antibody overnight. 
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4.5.3.3.1.1 NEDD8 pathway members found in the non-denaturing IPs 
Many expected pathway members were identified by MS of testes extract IPs including 
cullins (Table 4.1).  First, we found NEDD8 peptides confirming that our technique was 
successful.  We were also able to identify the NAE component ULA1.  Surprisingly, the 
strongest hit amongst the cullins was CUL9.  CUL9 is a very atypical cullin with no 
reported adaptor protein or substrate recognition protein (Sarikas et al., 2011).  CUL9 
has not been shown to make use of the typical RING domain proteins RBX1/2 all other 
cullins interact with (Sarikas et al., 2011). CUL9 plays a regulatory function for p53 and 
is known to dimerize with CUL7(Skaar et al., 2005).  Of all the cullins, only CUL7 has 
not clearly been shown to be neddylated (Skaar et al., 2007).  However CUL7 came 
down in these nondenaturing IPs.  It should be noted that CUL7 consistently scored less 
than CUL9 and may be coming down as part of a heterodimer.   Currently CUL7 is the 
only cullin not conclusively found to be neddylated (Sarikas et al., 2011). Other cullins 
including cullins 3, 4a, and 5 were identified in these native testes IPs as well.  
NEDD8 Pathway 
NEDD8 
ULA1 
Cullins 3, 4a, 5, 7, 9 
COP9 signallosome  
CAND1/2 
Table 4.1.NEDD8 pathway members identified  
in native NEDD8 IPs by MS.  Data from three  
IPs was used to compile this list. 
4.5.3.3.1.1.1 CAND1 
One surprising NEDD8 pathway component observed in these nondenaturing testes IPs 
was cullin-associated-NEDD8-dissociated 1 (CAND1).  CAND1 has also been reported 
to associate with overexpressed GST-NEDD8(Jones et al., 2008).  CAND1 binds to the 
cullin backbone of CRL complexes preventing both the binding of NEDD8 and 
substrate adaptors (Schmidt et al., 2009). As CAND1 is believed to exclude NEDD8 
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Figure 4.8.  CAND1 reciprocal IPs.CAND1 was immunoprecipitated overnight 
with 200 uL of beads, 2mg of testes, 15ug antibody and a total volume of 750 uL.  
The standard wash and elution protocol was followed.  The WBs done to confirm 
the efficacy of the IPs were then blotted with anti-CAND1 and Epitomics anti-
NEDD8.The MS result that CAND1 comes down in native NEDD8 IPs is 
confirmed (A). There are NEDD8 reactive species that associate with CAND1 in 
non-denaturing IPs but these are not at the same molecular weight as CAND1 
itself (B).   
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from the CRL complex we did not expect it to associate with NEDD8.   Cullins have 
been known to dimerize, therefore it is possible that CAND1 is coming down associated 
with a cullin that is dimerized to a neddylated cullin.  
 
In order to determine if CAND1 was itself neddylated or if it was merely associated 
with neddylated proteins we performed a reciprocal IP using anti-CAND1.  Pulling on 
CAND1 results in a specific enrichment for some neddylated species.  However these 
bands do not correspond to the molecular weight of CAND1 itself and are likely the 
proteins with which CAND1 complexes.  Such behavior indicates that NEDD8 is not 
directly bound to CAND1 (Figure 4.8). We believe CAND1 binds to a cullin that is 
dimerized to a second neddylated cullin and is therefore associating with NEDD8 
indirectly. This theory needs to be substantiated, perhaps through identification of the 
cullins involved. 
 
4.5.3.3.1.2 Ubiquitin pathway members found in non-denaturing IPs 
Ubiquitin associates with CRL complexes and has been reported, under conditions of 
overexpression, to form mixed chains with NEDD8(Leidecker et al., 2012).  It is not 
surprising therefore, that ubiquitin comes down in this IP.  What is surprising, is the 
association between NEDD8 and UBA1 the ubiquitin activating enzyme (UAE) and 
UBA1Y the mouse testes specific isoform of UBA1.  The fact that these enzymes are 
identified strongly indicates that NEDD8 may be activated by the UAE at endogenous 
levels.   
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4.5.3.3.1.3 Other families of proteins in the NEDD8 associated proteome 
Other families of proteins were also found in the non-denaturing testes IPs.  There are 
numerous proteins involved in nuclear transport that were identified including exportins 
1/2/7, importin 7/B1, and nucleophosmin.   
 
Another recurring protein in both IPs is matrin-3 which is involved in retention of 
hyperedited RNA in the nucleus (DeCerbo and Carmichael, 2005).  It forms a trimeric 
complex with NONO and SFPQ to perform this role (Salton et al., 2010; Zhang and 
Carmichael, 2001).  Both of these other proteins also come down specifically.  Proteins 
which have been linked to matrin-3 including importin 7, nucleophosmin, exportin1, 
DHX9, and HNRNPK (www.amigo.geneontology.org) are also found in these IPs 
(Table 4.2) lending credence to the solidity of this find.  However none of these proteins 
has been found bearing a diglycine modification and it is unclear why these proteins 
associate with NEDD8.  We are unsure if any of these proteins directly bind NEDD8. 
 
  Epitomics     
protein 1 mg  4 mg  20 mg 
antibody 50 ug 50 ug 200 ug 
Matrin-3 700 892 709 
FNONO   96 311 
SFPQ   305 658 
IPO7   56 230 
NPM   860 721 
XPO1 42 353 528 
Table 4.2. Matrin-3 associated proteins identified from non-
crosslinked native NEDD8 IPs using the Epitomics anti-NEDD8 
antibody.  Settings for protein and antibody loading are used to 
distinguish the IPs.  Scores for each protein in each IP are listed. All 
proteins were identified by more than one unique peptide 
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4.5.3.3.1.3.1 Structural Maintainance of Chromosomes (SMC) 
The SMC family of proteins has also been found to associate with NEDD8 (Table 4.3).  
The SMC proteins are, as their name implies, involved in regulation of chromosome 
maintenance.  SMC2 and 4 are integral components of the condensin complex while 
SMC1A and SMC3 are components of the cohesin complex.   
 
SMC1A is in all testes IPs.  SMC2 and SMC3 are found strongly with the Epitomics 
antibody. SMC4, however, is not identified as robustly.  Using the Mil10 and Epitomics 
antibodies, the signal for these SMC proteins is vastly decreased. Also noteworthy, is 
the observation that in a native mouse heart IP, SMC3 was observed.  While only one 
peptide was seen, that peptide bore a diglycine modification on a lysine.  It is possible 
that SMC3 is a substrate of neddylation but as we have not replicated this finding and 
the modification in the heart IP was based on a single peptide no conclusions can be 
drawn.  One further caveat to any such identification is that if SMC3 were ubiquitylated, 
preparation of the peptides by trypsinization would leave the same diglycine 
modification as would be observed for neddylation. 
 
Other members of condensin (NCAPD2, NCAPA, NCAPH, NCAPD3)  and cohesin 
(RAD21, REC8, RAD21L, STAG2 and STAG3)  (as listed by 
www.amigo.geneontology.org) were not found in the NEDD8 IPs. Confidence in our 
finding that NEDD8 and the SMC family are linked is strengthened by the work of 
Jones et al. demonstrating that the SMC family associated with overexpressed GST-
NEDD8.We are unclear on why non-SMC complex components do not co-
immunoprecipitate with the SMC proteins.  We are also unsure why SMC proteins have 
been identified in the NEDD8 associated proteome. However given the repeatability 
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and published support for the interaction this may be a real association.  Possible ways 
to improve this signal include using benzonase to help dissociate DNA bound proteins 
or nuclear enrichment before IP. 
   Testes     Heart 
   Epitomics   Rabbit Mil10 
protein 1 mg  4 mg  20 mg 20 mg 8 mg 
antibody 50 µg 50 µg 200 µg 200 µg 20 µg 
SMC1A 34 84 328 30   
SMC2   213 164     
SMC3   567 783 39 32 
SMC4   53 97     
Table 4.3.SMC proteins identified in non-denaturing NEDD8 IPs. IPs were 
done from mouse testes and mouse heart using the following anti-NEDD8 
antibodies: Epitomics, rabbit polyclonal anti-NEDD8, and Mil10.  IPs are 
further identified by amount of protein and antibody loaded.  MASCOT scores 
are given as an indication of signal strength.  Yellow boxes denote proteins 
identified by one unique peptide.  Red box denotes a peptide identified by one 
peptide bearing a diglycine modification. 
 
 
4.5.3.3.1.4 Coatomer 
One of the highest scoring recurring proteins in the non-denaturing testes IPs was the 
coatomer family of proteins (Table 4.4).  We observed components of the COPI 
complex which coat vesicles for retrograde transport from the Golgi to the Endoplasmic 
Reticulum (Lee and Goldberg, 2010).  Specifically, coatomer γ2 (COPG2) was 
extremely high scoring in even in the IP of 1mg of testes extract as was the γ1 (COPG1) 
subunit (scoring 2388 and 1301 respectively).  Other complex components also came 
down in multiple IPs including COPA, B, and B2. Another protein that came down in 
repeated IPs, N-terminal kinase like protein (NTKL), or mitosis-associated kinase-like 
protein NTKL, is known to bind COPB1 (Burman et al., 2008).  It is therefore possible 
NTKL came down with the complex.   
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   Testes     Heart 
   Epitomics   Rabbit Mil10 
protein 1 mg  4 mg  20 mg 20 mg 8 mg 
antibody 50 ug 50 ug 200 ug 200 ug 20 ug 
COPA 108 656 1083 502   
COPB 200 140 237     
COPB~ 34 31 105    
COPE           
COPG1 1301 1943 1365    
COPG2 2388 3621 3276     
COPZ1       
COPZ2           
      
NTKL 718 1008 1273     
TMED3       
AP4E1           
 
Table 4.4.  Scores for coatomer and associated proteins that were found in non-
denaturing NEDD8 IPs.  The COP family are coatomer proteins.  The bottom box, 
NTKL, TMED3, and AP4E1 are proteins reported to associate with the coatomer1 
complex by The Gene Ontology AmiGO. MASCOT scores are given as an indication of 
signal strength. Yellow boxes denote proteins identified by only one unique peptide. 
 
 
 
The structure of the COP1 complex is remarkably similar to that of clathrin and its 
adaptors, which also serves to coat vesicles (Lee and Goldberg, 2010).  Clathrin, and 
some of its adaptors, were also identified in these IPs albeit to a lesser extent.  The 
clathrin adaptor subunit most like the γ subunit of coatomer, AP2 (Popoff et al., 2011), 
is known to selectively recruit ubiquitylated proteins (Kumar et al., 2007).  It is possible 
that the enrichment for the COPγ subunit is due to a similar interaction with the 
ubiquitin pathway or direct ubiquitlyation of a COP1 subunit rather than direct 
interaction with NEDD8.   
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Figure 4.9.  Denaturing NEDD8 IP.  IP of 7.5 mg of mouse testes using 30 µg of 
rabbit polyclonal anti-NEDD8 is able to deplete free and conjugated NEDD8 as 
seen on WB (A).  NEDD8 pathway members were identified by MS analysis.  The 
two significant hits not associated with NEDD8 (red, B) were also found 
specifically with this polyclonal antibody in the top three hits of the native 
Rabbit-anti-NEDD8 IP (C). 
 
 
4.5.3.4 Denaturing IPs 
As NEDD8 modifies CRLs, we expect non-denaturing IPs like those described above to 
bring down NEDD8 or CRL associated proteins. In order to specifically narrow those 
findings to NEDD8 modifiers, denaturing IPS are required as they interfere with 
transient associations and enrich for covalently bound substrates.  We again attempted 
to identify neddylated proteins using mouse testes extract.  We lysed the testes in the 
same nondenaturing lysis buffer as with the nondenaturing IPs.  We then TCA 
precipitated these proteins and resuspended them in denaturing lysis buffer.  Denatured 
proteins were incubated with anti-NEDD8 antibody.  The rabbit polyclonal anti-
NEDD8 was much more effective at isolating denatured neddylated proteins than the 
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Epitomics antibody and was used for the denaturing IP that we then sent for MS 
analysis (Figure 4.9 A).  We again elected to prepare our samples from a Coomassie 
stained gel.  Samples were run on a LTQ Orbitrap Classic (Thermo) and spectra were 
analysed by MASCOT.  
 
4.5.3.4.1 NEDD8 pathway members in the denaturing NEDD8 IP 
As expected, we found NEDD8 pathway members and cullins in the denaturing 
NEDD8 IP (Figure 4.9 B). We identified NEDD8 in the molecular weight region for 
free NEDD8 and also in the region where the majority of cullins were identified.  We 
were also able to identify both components of the NEDD8 E1 heterodimer (ULA1 and 
UBA3).  We again were unable to identify the NEDD8 E2 UBC12.  However we were 
able to strongly identify the main known substrates, the cullins. Cullins that were 
identified include cullins 3, 4A, 4B, and 5.  Again we were able to identify CUL9 as the 
strongest hit among the cullins.  
 
We could not identify cullins 1, 2, or 7.  Cullins 1 and 2 were not identified in the 
nondenaturing IPs either.  It is possible that these cullins are not expressed as highly as 
the others in testes or are not as highly neddylated as the other cullins in this tissue.  The 
relative abundance and neddylation of cullins 1 and 2 will need to be checked directly 
to determine if this is the case.  CUL7, however, was extremely high scoring in the 
nondenaturing IPs but is not present here.  One possible reason for this disparity may be 
that as described by Skaar et. al, CUL7 is not actually neddylated.  This experiment will 
need to be repeated and optimized to conclusively state that there is no neddylated 
CUL7 in testes.   
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4.5.3.4.2 Polyclonal rabbit anti-NEDD8 specific interactions 
The strongest scoring hit in the rabbit anti-NEDD8 IPs both native and denatured was 
the Tudor domain containing protein 7 (TDRD7).  The one native NEDD8 IP using the 
rabbit antibody that was sent for MS analysis, had very low coverage in general but 
TDRD7 scored extremely well (5873) (Figure 4.9 C).  The top hit from the denaturing 
NEDD8 IP using the same antibody was also TDRD7 which scored more than 5 times 
higher than CUL9, the highest scoring cullin (5021 and 962 respectively).  Due to the 
fact that TDRD7 appears stronger than the known substrates of NEDD8 and is only 
identified with one of the two antibodies used for IP, we believe that TDRD7 binds 
nonspecifically to the Rabbit anti-NEDD8 antibody.  This theory has not been directly 
tested. 
 
There are not many other non-cullin hits from the denaturing IP.  In addition to TDRD7, 
we have also identified with confidence one other protein: Golgin subfamily A, 
Member 2 (GOLGA2).  When we BLAST the peptide used to generate the Rabbit anti-
NEDD8 antibody, GOLGA2 is found.  This leads us to believe that this protein is 
coming down in IPs as a result of nonspecific binding of the antibody rather than 
because of a genuine NEDD8 interaction.  Like what we observe for TDRD7, the non-
denaturing NEDD8 IP further supports this analysis as GOLGA2 is the third highest 
scoring hit, after TDRD7 and CUL9 (Figure 4.9 C), but is not similarly 
immunoprecipitated by the Epitomics antibody. 
 
We have not identified any strong contenders for non-cullin substrates using this 
denaturing IP.  However, coverage is low because we have not identified all of the 
cullins, Ubc12, or probable NEDD8 substrates like p73 or BCA3. It is possible that 
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there are no non-cullin substrates.  It is also possible that such substrates exist but are 
beyond the detection limit of the protocol used for this IP.  This experiment will need to 
be optimized in order to conclude one way or the other.  
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Chapter 5: Discussion 
 
5.1 Yeast Rub1 turnover 
As reiterated in the introduction of recent work done byBuchsbaum et al., 2012, on 
FAT10 degradation, the common belief in NEDD8 field is that NEDD8 is rapidly 
turned over. We report here that tagging, overexpression, and mutation of the diglycine 
motif induce rapid UPR mediated Rub1 turnover in yeast.  However, using a direct 
antibody against Rub1 we have been able to demonstrate that this observation is an 
artifactas both tagging and mutation destabilize the protein.  Endogenous Rub1 is 
actually quite stable.  
 
Possible implications of this finding might generalize to ubiquitin and other UBLS.  
Studies where the diglycine motif has been mutated might have erroneously made the 
same assumptions about stability as we have.  It is possible that the diglycine mutations 
and deletions have resulted in observed half-lives that are quicker than endogenous 
turnover rates. One possible explanation for this destabilization comes from NMR 
studies of ubiquitin stability. Kitahara et al., 2006a, reports that at high temperatures the 
short unstructured region bearing the diglycine motif is one of the first to become 
disordered.  While we are not inducing heat stress here, this mutation could encourage 
instability by mimicking that condition. 
 
Another contributing factor to Rub1 instability was the use of a tag.  Even the short HA 
tag could be cleaved from the N-terminus of Rub1. The tag might also lead to unfolding 
and degradation via the UPR. Using a tagged system was a flawed approach both 
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because of this cleavage and because of destabilization of the protein.  One possible 
explanation for this destabilization is that the N-terminal region is the first to fold in 
ubiquitin, and likely also in Rub1.  It is upon this initial fold that all the others 
resolve(Mishra et al., 2009; Zerella et al., 1999). Rub1 is very similar to ubiquitin 
structurally but has decreased structural integrity when compared ubiquitin (Kitahara et 
al., 2006b).  Interfering with the endogenous N-terminal fold by tagging may further 
destabilize the folding of Rub1.  It is possible that many other proteins have been 
mistakenly attributed to the UPR because of tag induced unfolding. Based on the results 
observed with Rub1, we would recommend that tagging should only be used in cases 
where it is unavoidable and should be avoided altogether in studies of protein turnover.   
 
In order to truly observe Rub1 turnover a radioactive pulse chase assay may be required.  
This technique will avoid the pitfalls of tagging and mutation already described.  If a 
cycloheximide chase is not used in conjunction with this technique, there should be 
even less concern that an artifact is being analyzed.  If the turnover of Rub1 is studied in 
the future, this is one technique that we would recommend. 
 
With respect to endogenous Rub1, we were able to make a few novel observations.  
First, deletion of the Rub1 pathway enzymes uba3 and ubc12 results in an accumulation 
of free Rub1 on WB. In these strains, Rub1 cannot become conjugated to substrates. As 
Rub1 is not turned over quickly, we believe the Rub1 that would normally bind to 
substrates is simply allowed to accumulate in the free form. If Rub1 levels were being 
tightly regulated we would not expect this accumulation.  We believe the fact that Rub1 
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appreciably increases in such strains indicates that Rub1 levels are not under strict 
control to remain at a WT levels.   
 
A second interesting observation is that Rub1 is stable over the course of a 7hour 
cycloheximide chase. Therefore, Rub1 does not have the short half-life we initially 
believed it did.  This finding is further substantiated in overexpression work where the 
tag free construct is stable when compared to its tagged counterpart.  Our initial 
hypothesis that regulation of speedy Rub1 turnover provides a means of preventing 
cross talk with ubiquitin enzymes is therefore incorrect. Furthermore, the current belief 
in the field, that NEDD8 is turned over quickly, does not hold true in yeast. 
 
It would be interesting to see if the destabilizations observed with mutations and 
tagging of Rub1 similarly destabilized other UBLs when compared to their wild type 
counterparts.  One possible way of testing this is by using a pulse chase system with 
heavy amino acids followed by immunoprecipitation of yeast collected at various time 
points.  Samples could then be analyzed by MS in order to determine quantitatively how 
much of the heavy Rub1/NEDD8 remains free or associated with substrates at any 
given time point.  To determine if conjugated Rub1/NEDD8 has a different half-life 
than free Rub1/NEDD8, the free Nedd8 could be separated using a low molecular 
weight spin filter.  The pool of free and conjugated NEDD8 would then be separate and 
degradation rates of the labeled Rub1/Nedd8 could be compared over time.  
 
While we were unable to ascertain the pathway by which Rub1 was turned over, we 
were able to show that variations in the pool of free Rub1 are not corrected immediately.  
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Rub1 levels do not appear to be under extremely tight control.  One possible 
explanation for this observation is that a small level of crosstalk with the UAE is natural.  
In conditions of stress, such as heat shock (Hanna et al., 2003), ubiquitin pools are 
depleted.  In order to temporarily alleviate stress on the ubiquitin system it might be 
advantageous for Rub1 to become conjugated via the ubiquitin pathway. In emergencies 
Rub1 might therefore be temporarily utilized to assist to the beleaguered ubiquitin 
system so that the cells can survive until the stress is removed.   It is possible that, as we 
have suggested (Hjerpe et al., 2012a), relative amounts of free ubiquitin serve as the 
factor responsible for minimizing Rub1/ubiquitin crosstalk.  This would ensure that 
Rub1 could serve as an emergency back-up system for use by the ubiquitin pathway 
enzymes when and as needed.    
 
5.2 Yeast Rub1 Substrates 
Although non-cullin substrates of Rub1 (including Lag2(Siergiejuk et al., 2009)) have 
been reported, we were unable to identify any such substrates at the endogenous level in 
our IP experiment.  The only proteins confidently identified co-immunoprecipitating 
with Rub1, were CRL complex components.  Cullins are the major accepted substrate 
of neddylation (Rabut and Peter, 2008) and we were expecting them to be found.  
Similarly the identification of F-box components lends credence to our analysis as they 
form part of cullin-RING-ligases.  We are unable to say if non-cullin substrates exist at 
an endogenous level.  If such substrates exist, we were unable to identify them.  One 
possible reason for this is that coverage was not high enough and these alternative 
substrates are low abundant.  Another possible explanation is that there are no non-
cullin substrates in yeast under endogenous unstressed conditions.   
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Possible ways to look for novel roles of Rub1 in yeast include inducing stresses such as 
DNA damage and heat shock and then looking for Rub1 conjugates.  Such experiments 
would require a control strain lacking Rub1 conjugation enzymes such as Uba3 or 
Ubc12. This way, possible conjugates could be specifically attributed to the 
ubiquitylation or the neddylation machinery.  One other possible additional control 
strain is the TS UAE strain.  The limitation of that control is that by impairing the whole 
ubiquitylation pathway, more off target effects may be induced than those that might be 
observed in the uba3 and ubc12 deletion strains.  A series of similar experiments in 
mammalian cells might be simpler as MLN4924 can inhibit the NAE specifically.  
Unfortunately this drug is not useful on yeast (most likely because it cannot pass 
through the cell wall). 
 
5.3 Mammailan NEDD8 
In cultured cells we are able to observe multiple neddylated species.  Many of these fall 
below the molecular weights of the cullins and might therefore be degradation products.  
Lysis in different lysis buffers helped us identify anti-NEDD8 reactive bands on WB 
that might represent degradation products.  There are a couple bands between 49 and 
62 kD which were of particular interest because they seem unaffected by changes in 
lysis buffer. This could mean that these proteins are not being cleaved after cell lysis.  It 
is still possible that they are cullin degradation products formed in vivo.  This analysis 
is supported by the CSN5 siRNA experiment.  CSN5 deneddylates cullins.  Therefore 
when CSN5 is knocked down, neddylated cullins are enriched.  We observed that the 
bands of interest are also enriched in this experiment.  It is possible therefore that 
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cullins are cleaved in vivo and degraded as fragments.  It is also possible that these 
substrates are independent of the cullins and also deneddylated by CSN5.  Knocking 
down the deneddylase NEDP1 increases the neddylation of these bands as well.  
Therefore these bands could constitute novel substrates or NEDP1 could be 
deneddylating cullin fragments.  The proteins represented by these bands could also 
play a tissue specific role as they are strongly represented in brain tissue.   
 
The attempt to purify these and other neddylated proteins using the NAM was initially 
promising.  It could specifically recognize NEDD8 over ubiquitin in vitro and purify 
free NEDD8 and lower molecular weight NEDD8 conjugates.  I have concluded that the 
current NAM probes are not a viable route for purification of neddylated proteins.  
Despite repeated attempts using different settings and tags we did not efficiently purify 
the lower abundant NEDD8substrates we were after.  The TUBES system which was 
the basis for the NAM theory relies upon tandem repeats of ubiquitin associated 
domains to increase ubiquitin binding. Within the Kurz lab it has been suggested that is 
possible that using tandem repeats of catalytically dead NEDP1 could similarly result in 
increased NEDD8 binding.  However, in my opinion, this is unlikely to parallel the 
success with ubiquitin as NEDD8 is not as frequently bound in chains as ubiquitin is.  I 
have postulated thatmixing ubiquitin binding domains with NEDP1 C163A could help 
pull down mixed NEDD8 ubiquitin chains.  There are possible problems with this 
approach as well because the size of NEDP1 could separate NEDD8 binding from 
ubiquitin binding.  The other possible use for the NAM is in conjunction with another 
purification technique. For example, it could be used following immunoprecipitation to 
163 
 
 
reduce IgG in the elution.  However as it stands, I believe this approach should be 
abandoned. 
 
The main challenge to specifically identifying the neddylated bands by IP arises 
because the MW of the proteins is almost the same as that of the IgG heavy chain.  On 
silver or Coomassie stained gels, it is difficult to distinguish specific bands from the 
heavy chain of the IgG in this MW region. MS analysis does not solidly identify these 
proteins from bands cut from these regions either.  One way of combatting this problem 
is by crosslinking the antibody to beads.  Once crosslinking is successful, dependence 
on gels will be eliminated and the contribution of IgG to overall protein eluted will be 
minimized.  Although attempts were repeatedly made using various crosslinkers, we 
have had difficulty crosslinking the rabbit anti-NEDD8 antibody to beads for this 
purpose.  This process can be optimized. The Epitomics antibody had more luck with 
respect to crosslinking but it was not useful for denaturing IPs.  Therefore future work 
should focus on crosslinking the polyclonal rabbit anti-NEDD8 so that these bands of 
interest can be identified. 
 
Another way to purify these proteins is to first enrich for them.  A recently generated 
NEDP1 knock-in cell line may do just that.  Lysate from this strain may be 
immunoprecipitated to purify neddylated proteins.  Stable isotope labeling by amino 
acids in cell culture (SILAC) analysis may also be used to specifically label and 
compare the proteins that are differentially regulated in this cell line when compared to 
a cell line with WT NEDP1.  In the SILAC approach, one cell line is grown in heavy 
media while one is grown in light.  For example, the NEDP1 knock-in cell line is grown 
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in light media and the WT cell-line in heavy media.  The same amount of protein from 
each condition is combined and processed together.  This joint sample can then be 
analyzed by MS and the peptides bearing heavy amino acids can be quantitatively 
compared to the peptides bearing light amino acids.  In this way, the two cell lines can 
be directly compared to one another in an unbiased manner.  In order to eliminate 
possible media based artifacts, the experiment is repeated with the inverse cell line 
media assignment (in this case NEDP1 knock in grown in heavy media and WT grown 
in light).  The proteins that are upregulated or downregulated by NEDP1 knock in 
should remain consistent regardless of the media they are grown in.  If NEDD8 is 
signaling for degradation or stabilization of any substrates, SILAC analysis will be able 
to demonstrate that.   
 
Another important line of investigation with the knock in cell line would be to induce 
certain cell stresses and to observe if new conjugates are formed.  In overexpression 
experiments, for example, DNA damage has been associated with NEDP1(Watson et al., 
2010).  As NEDD8 is the only known substrate of this protease it is possible that by 
inducing damage and then checking for novel neddylated proteins something new may 
be discovered.   
 
Another telling experiment that may be done with this cell line, possibly in conjunction 
with one of the other approaches, is to isolate different cellular components.  BCA3, for 
example, has only been reported to be neddylated in the nucleus and is also a reported 
substrate of NEDP1(Gao et al., 2006).  Therefore, enriching for a nuclear fraction might 
help confirm this finding endogenously.  It also might help identify other neddylated 
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nuclear proteins.  Inclusion of a buffer component such as benzonase could help isolate 
DNA associated proteins which may be neddylated.  During most of the cell cycle, 
NEDD8 is primarily localized to the nucleus (Kamitani et al., 1997; Kurz et al., 2002)so 
it is possible that there are more non-cullin substrates that may be found specifically in 
that organelle.  Another membrane bound organelle of interest is the Golgi bodies.  
Golgi related proteins such as the coatomer proteins are enriched in our non-denaturing 
IPs.  It is possible that there are some associated substrates that will be clearer following 
the knockdown of the NEDP1 deneddylase.  This cell line may be the key to properly 
enriching for these putative non-cullin substrates.   
 
With respect to CAND1, there are some obvious experiments that should be undertaken 
in the future.  First, the cullins we believe are linking CAND1 to NEDD8 in NEDD8 
IPs should be identified.  Some possible ways to address this problem are by WB, MS, 
or a combination of the two. One possible way of doing this is to do two sequential IPs: 
first, IP for CAND1 under native conditions, and then using the eluent, IP for NEDD8.  
The cullins that associate with CAND1 but not with NEDD8 are likely bound to 
CAND1.  The cullins that come down in the CAND1 IP and in the subsequent NEDD8 
IP are likely to represent the neddylated cullin. By comparing the cullins found in 
bothIPs, it is possible to find out which cullin dimer pair is linking CAND1 to NEDD8. 
These findings can then be confirmed by reciprocal IPs of the cullins or MS analysis of 
the CAND1 IP. Once the composition of the complex is known, the function of the 
CAND1 bound cullin/NEDD8 bound cullin complex could then be investigated.  At the 
moment it is unclear what CAND1 is doing in this complex.  One possibility is that the 
CAND1 bound cullin somehow serves to increase or decrease the ubiquitylation activity 
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of the neddylated cullin.  Whether it actually plays such a role in vivo will need to be 
tested. 
 
One other interesting observation from the NEDD8 IPS was the interaction of the UAE 
with endogenous NEDD8.  This interaction enhances our belief that there is a low level 
of endogenous neddylation occurring in a UAE mediated pathway.  Based on the fact 
that the UAE may be charged withNEDD8 in vivo, it is possible that substrates 
identified by overexpression of NEDD8 might be genuinely neddylated via the UAE 
under endogenous conditions.  This observation also further supports the theory that 
NEDD8 is being maintained as a free pool against conditions of stress where it may 
provide support for a strained ubiquitin system.  However this theory will need to be 
tested by using various cell stresses without NEDD8 overexpression.  Further work 
could include comparing UAE and NAE charging under various conditions.  The 
separation between the ubiquitylation and neddylation pathways may not be as distinct 
as previously believed. 
 
The observation that UCHL3 knockdown resulted in neddylation and cell cycle defects 
was interesting for many reasons.  First, tissues bearing defects in the KO mouse such 
as brain (Wood et al., 2005) and testes (Kwon et al., 2004) have abnormally high 
neddylation profiles when compared to other tissues like lung and kidney.  We believe 
that in the UCHL3 KO mouse these proteins are either no longer neddylated or 
minimally neddylated and that results in the observed phenotypes.  This theory will 
need to be tested by directly examining the UCHL3 KO mice.  Towards this end, it 
would be of interest to examine the neddylation profile in tissues of this UCHL3 KO 
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mouse compared to WT littermates.  The ubiquitylation profile has already been 
examined in this manner and is ostensibly the same between KO and WT (Setsuie et al., 
2009a).  We believe that the phenotypes likely result from neddylation specific 
problems. If this can be proven it would demonstrate that NEDD8 could be responsible 
for the observed phenotypes. 
 
Another possible outcome of such investigations would be to confirm the second half of 
the UCHL3 story.  This is the connection between UCHL3 and sickness. While this 
protein is strongly linked to cancers (Miyoshi et al., 2006; Nam et al., 2003), there is 
also a reported connection with hypoxia and AD (Dennissen et al., 2011).  It was this 
link in conjunction with the tissue specific phenotypes of the UCHL3 KO mouse that 
really kept the tissue specific idea in the forefront of this work despite the fact that the 
focus of this laboratory is not related to AD, hypoxia, or UCHL3 and our model 
systems do not typically include mice or tissues in general.   There are some promising 
similarities between AD and UCHL3 impairment such as short-term memory loss, 
atypical gait, UBB+1 accumulation and ataxia.  The idea behind this connection is in its 
infancy as these similarities do not prove causation.  Much more work would be needed 
to illuminate any possible interactions.  
 
 There are other experiments that can be tested in the immediate future.  For example, 
the finding that there are tissue specific neddylation profiles by WB means that there 
could be tissue specific neddylated and NEDD8 associated proteomes.  These 
differences have never, to my knowledge, been examined in a tissue specific manner at 
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the endogenous level.  It could be important to find out if there are tissue specific means 
of regulating NEDD8 conjugation or CRL substrate selection.  
 
Admittedly, we have not been able to identify non-cullin substrates of neddylation. This 
failure may be due to incomplete coverage of the neddylated and NEDD8 associated 
proteomes.  Alternatively there may be no neddylatd non-cullin proteins under 
endogenous conditions. Coverage of the denaturing NEDD8 IP must be increased.   
Then this optimized method may be used on various different tissue types.  Other 
possible routes that may be taken to identify novel substrates include the use of different 
stress conditions.  Leidecker et al., 2012, demonstrated that there may be UAE 
dependent increases in NEDD8 conjugation following stress situations.  However, there 
has not been a comprehensive study of which proteins are most effected and if any 
stress induced conjugates are NAE dependent. The last means of enriching neddylated 
proteins that will be investigated in the immediate future is elimination of deneddylase 
activity.  The NEDP1 knock-in cell line will prove invaluable in future work.  It will 
have to be characterized and examined for neddylated proteins.  While there are no 
guarantees that this future work will identify novel substrates of neddylation, the 
techniques are in place to continue the search. 
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